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Abstract 
The extent of regeneration is often limited after spinal cord injury (SCI), due to 
the post-injury microenvironment that is unsupportive of nerve fibre regeneration 
and the limited intrinsic reparative capacity of neurons. Current mainstream clinical 
therapies focus on reducing the extent of damage in the early stages of injury, rather 
than promoting regenerative mechanisms in sites of pathology. In this context, one 
promising biomedical engineering strategy emerging globally to promote repair 
following SCI is the reconstruction of neural circuitry in injury sites via the 
implantation of polymer scaffolds, or ‘structural bridges.’ To date, the development 
of such synthetic bridges has faced two major challenges: an overwhelming reliance 
on basic 2-D scaffolds functionalised with single cell types (which therefore fail to 
mimic the complex circuitry of the neural lesion environment); and heavy 
dependence on live animal models of neurological injury for functional screening 
and developmental testing, in the absence of in vitro injury models that mimic the 
complex pathological sequelae of neurological injury in vivo.  
To this end, this thesis demonstrates an enhancement of the spatial and cellular 
complexity of both nanofibre-based scaffolds for spinal cord repair and in vitro SCI 
models for screening efficacious scaffold formulations. Nanofibre-hydrogel 
constructs containing aligned glial cell co-cultures (derived from primary sources) 
were successfully developed by systematically optimising the assembly protocol and 
construct design features. Further, protocols were developed to demonstrate the 
feasibility of increasing the number of constituent nanofibre layers in constructs with 
astrocyte mono-cultures, for further processing of constructs into an implantable 
form.  
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A safe and effective method of inducing complete transecting lesions in 
organotypic spinal cord slice cultures was developed following the production of a 
prototype double-bladed lesioning tool. The development of quantitative image-
based assays of fluorescently labelled astrocyte, microglial and neuronal cell 
populations within slice lesion sites showed mimicry of multiple cardinal features of 
neurological injury in vivo. Finally, a method was developed to coat portable frames 
of aligned nanofibres with therapeutic biomolecules and incorporate frames into 
lesioned slices. Patterns of nanotopography induced outgrowth/alignment of 
astrocytes and neurons in the in vitro model were strikingly similar to that induced 
by comparable materials in related studies in vivo. This demonstrates the predictive 
utility of the model and the potential to reduce and refine the use of lower-
throughput live animal models for screening applications. 
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Chapter 1: General introduction  
2 
 
1.1. An overview of spinal cord injury (SCI) 
In the UK there are an estimated 40,000 individuals with traumatic SCI, with a 
prevalence of approximately 10-15 people per million in the population each year.1 
The economic burden of SCI in the UK is estimated to be over £500 million every 
year.2 In addition to many detrimental effects that the injury has on patient quality of 
life, many years of patient care and medical treatment have profound socioeconomic 
consequences. The spinal cord and its spinal nerves are responsible for transmitting 
information between the brain and the body and therefore hold great functional 
importance because these pathways essentially enable animals to interact with the 
environment they are in. Furthermore, the inability of the adult central nervous 
system (CNS) to undergo significant functional repair following neurological injury 
(a trait common with all mammals) often results in paralysis of tissue below the 
injury site. Indeed, the most debilitating injuries are those that occur at the level of 
the neck, between the first and fourth cervical nerve, because they can result in the 
complete paralysis of the four limbs (quadriplegia). The initial damage to the spinal 
cord can arise from one or more mechanisms, including non-penetrating insults.3 
Current methods of treatment are limited in their ability to regenerate the spinal cord 
and hence, finding a cure is currently the subject of intensive biomedical research 
globally. In this context, results from the field of neural tissue engineering have 
shown promise in promoting regeneration across spinal cord lesions. However, the 
heavy use of in vivo SCI screening models that have significant drawbacks is 
necessitating the development of higher-throughput in vitro models of SCI. The 
above topics pertaining to spinal cord anatomy, injury pathology, modelling SCI and 
neural tissue engineering are discussed below. 
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1.1.1. Anatomy of the spinal cord 
The nervous system is divided into the CNS, which consists of the brain and 
spinal cord, and the peripheral nervous system (PNS) that consists of the cranial 
nerves and the nerves that project between the spine and the body. CNS tissue can be 
divided into the grey matter, which consists of neural cell bodies, dendrites and 
synaptic contacts and white matter, which consists of ascending and descending 
nerve fibre tracts. With regards to the latter, these are commonly grouped according 
to their origin, course and projection (Figure 1). Promoting the regeneration of these 
essential tracts represents a major therapeutic goal in the restoration of motor and 
sensory function after SCI. 
The spinal cord contains multiple cell populations that mediate highly 
specialised functions. The basic structural and functional unit of the nervous system 
is a neuron, which transmits electrical signals along its axon to neighbouring cells. 
The neuroglial cells are the other major cellular components of the CNS that act to 
support the function of neurons. Astrocytes have numerous roles crucial for the 
optimal function of the nervous system, which include the formation and control of 
the blood-brain barrier, the regulation of neuronal development, removal of neuronal 
waste and regulation of CNS pH.4 Microglial cells constitute an immunocompetent 
cell population that essentially form the immune system of the CNS. In the mature 
CNS they may appear as resting, activated or phagocytotic microglia, depending on 
the surrounding environment.5 Oligodendrocytes form the myelin sheath surrounding 
axons in the CNS and can myelinate as many as 30-50 separate axons.6 They arise 
from oligodendrocyte precursor cells (OPCs) that populate the brain and spinal cord 
in waves during development,7 with subpopulations remaining into adulthood for the 
migration and replacement of damaged oligodendrocytes in injury.8 A myelin sheath 
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is a section of membrane wrapped spirally around the axon that extends out from the 
soma via thin projections. The myelin insulates the axons and markedly increases the 
propagation rate of action potentials by reducing the conductive surface area to small 
gaps that lie in between consecutive myelin sheaths (nodes of Ranvier).9  
 
 
Figure 1. Ascending and descending pathways of the spinal cord essential for 
neurological function (adapted from Crossman & Neary, 2005).10 
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1.1.2. Pathology of SCI 
SCIs can be characterised according to the type of injury and resultant damage 
caused. Possible mechanisms of injury include shear or compressive forces; 
dislocation; compression; fracture; and laceration.11 These can be caused by extrinsic 
objects or bone fragments that penetrate the cord, haematoma formation, a local 
shock wave at the time of impact, or a combination of these.3 The injuries that either 
completely or partially transect the spinal cord cause the greatest neurological 
damage, commonly resulting in loss of sensory or motor function (depending on the 
tracts affected) below the site of injury. However, compressive, non-penetrating 
injuries are more common and some level of neural function is preserved below the 
site of injury.12 The acute injury occurs in the initial minutes to days after the initial 
impact.13 The extent of damage that occurs during this period determines the severity 
of the pathological processes that develop in the following weeks to months, 
resulting in a chronic injury that can last for many years after the initial injury.  
 
1.1.2.1. Acute injury 
The extent of the initial structural damage inflicted during the initial 
mechanical insult is dependent on the particular mechanism, but can include the 
severing of axons, disruption to the vascular system (leading to wider-spread 
swelling and ischemia) and the necrosis of neurons and glia. As a result, the acutely 
traumatized spinal cord experiences: significant neurotoxicity from the excessive 
release of glutamate neurotransmitter and free radicals from cellular apoptosis; ionic 
fluxes; and alterations in blood flow, resulting in ischaemia.3,14 The necrosis of 
oligodendrocytes releases myelin debris into the surrounding extracellular 
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environment, within which are several known inhibitors of nerve fibre growth, such 
as Nogo-A,15 myelin-associated glycoprotein16 and oligodendrocyte myelin 
glycoprotein.17 Microglia are also activated following damage, resulting in rapid 
migration towards the lesion site.  
 
1.1.2.2. Chronic injury 
A range of pathophysiological changes occur at the injury site, which 
progresses in both rostral and caudal directions from the lesion epicentre over the 
following days to months, termed the secondary injury.18 The chronic injury 
manifests as ischemia, micro-vascular damage, glutamatergic excitotoxicity, 
oxidative stress, and inflammation.19 Cord swelling and a reduction in blood flow 
causes the apoptosis of oligodendrocytes and subsequent degeneration of axonal 
tracts due to a loss of trophic support.20 Under the conditions of prolonged damage 
and cellular death in the lesion environment activated microglia further transform 
into phagocytotic microglia.9 They have been shown to release pro-inflammatory 
cytokines such as tumour necrosis factor-α and infiltrate into lesion sites, where they 
are responsible for the breakdown and phagocytosis of cellular debris and toxic 
substances.21,22 Their activation can be a significant barrier to the development of 
efficacious interventions as there is evidence implicating them as inhibitors of axonal 
regeneration via expression of inhibitory guidance molecules such as Netrin-1 and 
repulsive guidance molecules.23,24 These environmental factors stimulate astrocytes 
surrounding the damaged, necrotic area to undergo a complex response called 
‘reactive astrogliosis.’ This response is characterised by a hypertrophy and likely 
proliferation of the astrocytes immediately surrounding the damaged, necrotic area. 
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Reactive astrocytes upregulate expression of the astrocyte specific glial fibrillary 
acidic protein (GFAP) within and adjacent to lesions, to form a glial scar,25 which 
constitutes a critical physical barrier to axonal regeneration.26 The glial scar 
functions to 'seal' lesion sites and the blood-brain barrier, to protect the remaining 
functional tissue from injury mechanisms.27 Reactive astrocytes and other neural cell 
types in the area of glial scarring also produce chondroitin sulphate proteoglycans 
(CSPG), such as neurocan and brevican,28 which are potent inhibitors of neurite 
outgrowth and contribute to the establishment of an environment non-permissive to 
axonal growth.29 The final manifestation of chronic injury is the formation of a fluid-
filled cavity at the lesion site, a major obstacle for the regeneration of host tissue.30 
 
1.1.3. Current treatments and challenges 
There are two major pathological causes for a lack of axonal regeneration in 
the CNS; the limited intrinsic regeneration capability of the injured neurons per se 
and the non-permissive environment to axonal growth that surrounds the lesion.31 
However, when injured neurons are exposed to permissive signals, some have been 
shown to regenerate, although this regenerative capability differs between neuronal 
types,32 the neuronal age33 and distance from the site of injury.34 Current repair 
strategies to treat SCI are centred on neural protection during the acute phase of SCI. 
They do not initiate regeneration per se but act to reduce the onset and extent of the 
secondary, more permanent damage as a result of glial scar formation. This strategy 
aims to preserve and optimise any neurological function remaining by maintaining 
axonal function and preventing apoptotic cell death. Repair strategies include: (i) the 
induction of systemic hypothermia in the patient to slow the onset of inflammation, 
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local oxidative stress and the metabolic rate;14 (ii) drugs that either antagonise or 
breakdown inhibitory molecules to axonal regeneration e.g. Nogo-A inhibitors;35 and 
(iii) therapies that deliver growth factors to the injury site.36 Whilst these treatments 
have been reported to reduce the extent of injury in animal models and human 
studies,14 significant improvements in axonal regeneration have thus far been 
elusive, highlighting the limited ability of current treatments to promote regeneration 
of the spinal cord. However, there is a general consensus that a more effective way 
of promoting repair and functional recovery is the use of multiple strategies within 
the same treatment to reverse multiple facets of the complex response to injury. In 
this regard, combinatorial strategies from the field of neural tissue engineering aim 
to simultaneously breakdown the glial scar and reverse the environment inhibitory to 
nerve fibre outgrowth, whilst supporting and guiding any regenerative events that 
occur from spared host tissue at the lesion margins. These strategies will be 
discussed later.  
 
1.1.4. Models of SCI 
The two main transection models available to study axonal regeneration (and 
thus transecting SCIs) are complete and partial transection.11 Complete transection is 
regarded to be the better of the two as the injury is complete and does not introduce 
questions regarding the axonal regeneration of specific nerve fibre tracts that can 
differ in their regenerative potential. Partial transection models attempt selective 
injury of particular tracts and are widely used because animal care is easier post-
surgery. Another advantage is that these lesioned tracts can be compared with the 
contralateral uninjured side, although it is harder to determine how complete the 
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transection is in severing all the nerve fibres of the tract and whether any functional 
improvement in the animal observed is because of compensatory mechanisms 
occurring from other functional systems.19 Axonal regeneration is harder to verify 
anatomically in non-penetrating, contusion force models because of the incomplete 
nature of this injury. However, this type of SCI is more prevalent in the population 
and these models more accurately reflect the patho-physiology encountered. The 
most commonly used model is the New York University (or NYU) impacter that 
drops a 10g weight from various heights onto the exposed dorsal surface of the 
spinal cord and reproducibly creates spinal cord lesions.37 Others, for example, look 
to more consistently evaluate the impact delivered38 or simulate ongoing 
compression.39,40 
Animal models are extremely important for studying SCI in the laboratory 
setting and as a testing platform, enable the development of experimental therapeutic 
strategies and facilitate their validation before use in humans. Live SCI models in 
animals are most commonly used because they represent a living system able to 
mimic the human body to a greater extent than more simplistic in vitro models. 
However, there are many associated drawbacks associated with their use including 
their cost and high associated animal usage for screening purposes. In vitro 
reductionist models such as microfluidic devices are useful for isolating specific 
aspects of the response to injury and examining regenerative processes in a higher-
throughput screening system, 41,42 although in general they suffer from a lack of 
spatial and cellular complexity compared to in vivo injury models, which limits their 
predictive utility. 
Alternatively, organotypic slice culture has been used to culture thin sections 
of animal brain and spinal cord tissue for many years43 and its use in generating SCI 
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models has only recently been realised. Organotypic spinal cord slice cultures 
represent an in vitro, 3-D, multicellular model of tissue that can be maintained at the 
air-medium interface for several weeks. Numerous slices can be produced in the 
parasagittal plane from each spinal cord and they have been successfully lesioned to 
form a SCI model.44 This model has the potential to reduce and refine the use of live 
animal SCI models for screening novel treatments that promote regeneration, in 
accordance with the 3 R’s principle (reduction, refinement and replacement), 
because animal SCI models have a much lower throughput. The use of this 3-D, in 
vitro model alternative as a testing platform for the evaluation of promising 
strategies to enhance spinal cord repair may increase the throughput of initial 
therapeutic testing and ultimately help to develop better designed, more efficacious 
treatments. However, there have not been many published reports using this model to 
evaluate the efficacy of new therapies to promote spinal cord regeneration. Thus 
there remains an unexplored potential for translatable in vitro animal models of SCI 
that can model the injury in 3-D and provide a more rapid assessment of promising 
strategies for spinal cord repair, such as nanofabricated polymer scaffolds produced 
within the field of neural tissue engineering. 
 
1.2. Principles of tissue engineering for spinal cord repair 
Tissue engineering has been extensively described as ‘an interdisciplinary 
field that applies the principles of engineering and life sciences towards the 
development of biological substitutes that restore, maintain, or improve tissue 
function or a whole organ.’45 Tissue engineering strategies attempt to support the 
development of new tissue, according to the structural, chemical and cellular 
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requirements of the injured tissue. One of the major focuses within the field is the 
production of scaffolds, which are implanted into injury sites to fill the lesion cavity. 
Scaffold design strategies in the context of spinal cord repair include: (i) 
extracellular matrix (ECM) mimicry, to facilitate the attachment and proliferation of 
cell populations within and/or into the scaffolds;46 (ii) interactions with spared host 
tissue on a macro- and micro-cellular level to direct regeneration of nerve fascicles47 
and individual axons48 across the injury site along their specific neuronal pathways; 
(iii) the incorporation of therapeutic cell populations e.g. neural stem cells49 to 
repopulate the injury site and/or release growth factors at basal or enhanced levels 
(transfected cells) to stimulate axonal growth; and (iv) the incorporation of 
biomolecules e.g. chondroitinase ABC (ChABC), to make the environment more 
permissive to axonal outgrowth (Figure 2).50 These strategies aim to promote 
regeneration of the tissue and restore lost function, in comparison with current 
treatments that aim primarily to reduce the onset of chronic injury, and will be 
discussed individually in the following sections. 
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Figure 2. The strategic approaches to tissue repair that form the basis of tissue 
engineering. Scaffolds can be implanted into injury sites in isolation, or together 
with various combinations of cells and/or biomolecules. Combinatorial strategies 
aim to address multiple aspects of injury pathology to maximise the reparative 
processes occurring at the injury site. 
 
1.3. Scaffolds for spinal cord repair 
Tissue engineering strategies utilising scaffolds to form micro-environments 
for tissue regeneration present a promising alternative for future, more-efficacious 
treatment options for spinal cord repair. General scaffold design considerations 
include: (i) biodegradability to remove the requirements for further post-operative 
surgery; (ii) biocompatibility with the host (including non-toxic degradation 
products) to prevent an adverse immune response;51 (iii) sufficient mechanical 
properties to withstand the mechanical loads applied in the injury site of the 
particular tissue (for the spinal cord a stabilising structure has been shown to 
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improve scaffold performance);52 and (iv) adequate porosity to provide sufficient 
blood flow, neuronal attachment and outgrowth.53  
 
1.3.1. Scaffold materials 
The choice of material for the scaffold can have a large influence on the 
overall design, the combination of strategies utilised and the efficacy following 
introduction into relevant injury models. Many different polymers have been used to 
produce scaffolds, which may be grouped according to their natural or synthetic 
derivation. However, no material has emerged as a clear favourite. Overall, the main 
consideration is the extent that the scaffold mimics the ECM environment found in 
vivo, to maximise the interaction of the scaffold with injured host tissue. 
Natural polymers represent a class of naturally occurring materials that are 
biocompatible. They include hyaluronic acid, agarose, alginate, gelatin, fibronectin, 
fibrin, chitosan and collagen.54 The latter four are perhaps the most promising 
polymers for use in tissue engineered scaffolds for spinal cord repair, since they can 
support orientated axonal growth and sequester growth factors.55 Type I collagen is 
one of the most common natural materials used,56 due to its abundance in the ECM 
of connective tissues in animals and its natural fibre morphology.57 Additionally its 
gellation at physiological temperatures allows it to be used as an injectable delivery 
device supporting cell attachment and release of bound growth factors upon 
implantation.58 Hydrogels such as collagen and gelatin have been widely used to 
form the internal matrix of scaffolds, to help prevent their collapse following 
implantation and to mimic the ECM for improved neural cell attachment.59 However, 
the hydrogels do not possess aligned topographical cues, unless the fibrils are 
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aligned prior to use,60 and the adhesion of cells can be limited e.g. unmodified 
alginate scaffolds.61 It has been recognised that the use of hydrogels in combination 
with another material (e.g. aligned nanofibres) to form a composite can overcome 
limitations inherent with using either material alone and produce scaffolds that 
mimic both the fibrous protein network and the ground substance of the ECM.62  
Synthetic polymers are generally cheaper to produce than natural polymers and 
in general use more controlled and reproducible synthesis techniques.59 However, a 
considerable subset are non-degradable so there is an ongoing risk of inflammation, 
scaffold displacement and nerve compression, which may necessitate additional 
surgery for scaffold removal.63 Poly(2-hydroxyethyl methacrylate) (or PHEMA) is 
an example of a more commonly used non-degradable synthetic material, due to  
tuneable mechanical properties, cell permeability and synthesis without the use of 
solvents, facilitating the incorporation of bioactive compounds into the scaffold.64 
However, possible toxicity, mechanical issues and relatively simple scaffold designs 
have limited its potential use for SCI.63 Aliphatic polyesters represent a class of 
biocompatible synthetic materials, which are food and drug administration (FDA) 
approved and produce endogenous metabolic degradation products that can be 
readily resorbed.65 The aliphatic polyesters consist of lactide, caprolactone and 
glycolide monomers or there combinations e.g. poly-lactic acid (PLA) and poly-
lactic-co-glycolic acid (PLGA).56 However, they are often hydrophobic and non-
adhesive to cells, thus failing to mimic the ECM. As a result they are often combined 
with natural materials e.g. peptides to produce biosynthetic scaffolds that display 
better cellular attachment than the synthetic polymer alone e.g. polycaprolactone 
with chitosan,66 gelatin67 or collagen.68 A common technique is to immobilise a cell 
adhesive peptide (GRGDY) onto the surface of the scaffold.69 The results showed 
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that the modified nanofibre scaffolds were a preferable environment for cellular 
attachment, proliferation, and differentiation, compared to unmodified control 
scaffolds.  
  
1.3.2. Scaffold architecture 
Scaffolds have been fabricated to give a number of various structural features, 
ranging from simple injectable hydrogels to arrays of fibres fabricated at the 
nanoscale. They can have an entirely random orientated structure or are constructed 
with an aligned configuration at either the macro- or microscale. Termed ‘contact-
guidance’, scaffolds with aligned features are able to guide attached outgrowing 
neurons along features on the surface e.g. microgrooves, or along the surface itself 
e.g. micro- or nanofabricated fibres, or a combination of both.70 The topographical 
cues may be presented to the host tissue at two different scales, representing different 
strategies for repair.  
The macro-structure of the spinal cord refers to the organisation of the spinal 
cord and the nerve fibre tracts that run in both rostral and caudal directions with 
diameters of between 100-1000 µm. Scaffolds with multiple aligned channels 
reflecting this organisation have been created to optimise the regeneration of axons 
in their fascicular groups.47,71,72 The channel diameter appears to affect the number 
of regenerating axons in scaffolds when implanted with Schwann cells into 
transected rat spinal cords, as smaller channel diameters of approximately 450µm 
promoted greater regeneration than larger diameter channels.73 
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Larger axons have a diameter of between 15-20µm,55 so micro-engineered 
scaffolds e.g. fibrous scaffolds try to promote more specific outgrowth at the cellular 
level towards the corresponding separated fascicular bundles. Overall, the total 
cross-sectional area of the topographical cues is the most important determinant for 
the extent of host cellular attachment to the scaffold and the potential of the scaffold 
to direct tissue regeneration by contact-guidance. Various scaffolds have been 
produced that incorporate this aligned topography,59 but nanofibrous scaffolds 
produced by electrospinning have arguably produced the most promising to date. 
 
1.3.3. Cell sources for spinal cord transplantation 
One hallmark of SCI is a disruption to the intricate supporting circuitry of glial 
cells in the lesion site, which are necessary for the function and integration of 
spontaneously regenerating nerve fibres with host neuronal networks.74 One strategy 
for repair is the replacement of the injured/dying cells in the injury site with 
immature populations of glial cells, to replace those lost and to create a pro-
regenerative niche in the normally inhibitory environment to axonal outgrowth.28,75 
There are many candidate transplant cell types identified to-date as cell sources for 
spinal cord repair.  
Stem cells are characterised by two key features: their ability to self-renew and 
their ability to generate a wide range of progeny (i.e. multipotentiality).76 They can 
be obtained from embryonic, foetal, or adult tissue. Embryonic stem cells have great 
potential as a cell source. The first cellular regenerative therapy to undergo clinical 
trials was the human ESC-derived oligodendrocyte progenitor, named GRNOPC1  
(developed by Geron).77 In general however, the current challenges of differentiating 
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them to more specific progenitor and primary cell types with a high degree of 
efficiency make other cell types more attractive for current tissue engineering 
applications. Other stem or progenitor cells that are relatively more lineage-restricted 
may be more translatable into clinical therapies in the short term. For example, 
neural stem cells (NSC),78 Wharton’s Jelly-derived, human umbilical mesenchymal 
stem cells,79 olfactory ensheathing cells80 and Schwann cells81 have shown positive 
results following testing in live animal models of SCI. Furthermore, they have both 
been shown to express therapeutic concentrations of growth factors which may 
stimulate nerve fibre outgrowth.79,82,83  
 
1.3.4. Biomolecule delivery 
Growth factors are polypeptide signalling molecules synthesised by cells. 
These signals can induce growth, proliferation and differentiation, both positively 
and negatively in the cells that they act upon, thus guiding cellular growth and 
development. They have the potential to augment the regenerative capacity of CNS 
neurons through the stimulation of many regeneration-associated genes (RAGs), 
whose expression profiles are either upregulated or constitutively active during 
development and regeneration.19 Many growth factors have been discovered thus far, 
but only a few of the main growth factors for the specific tissue to be repaired have 
been incorporated into scaffolds, with an uncertainty over their multiple (therefore 
unwanted) effects on different tissues.84 Growth factors that promote neuronal 
survival, axonal growth and remyelination are most important for SCI. These include 
nerve growth factor, brain-derived neurotrophic factor (BDNF), glial cell line-
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derived neurotrophic factor, neurotrophic factor-3 and -4 (NT-3 and -4); and basic 
fibroblast growth factor.85 
A further strategy exists to suppress the activity of molecules inhibitory to 
nerve fibre growth found in the environment of the lesion site. For example, CSPGs 
are intensely upregulated following SCI and associated with the ECM of the 
neuroglial scar.86 The bacterial enzyme ChABC is able to break the 
glycosaminoglycan chains from the core of the protein, attenuating its inhibition of 
axonal growth.87 Furthermore, the administration of ChABC in a rat SCI model was 
found to promote regeneration and functional repair, including the recovery of 
locomotor and proprioceptive function. An additional example of a molecule 
inhibitory to axonal regeneration is Nogo-A,35 a constituent of CNS myelin that has 
been shown to activate the Rho intracellular signalling pathway.88 Anti-Nogo 
antibodies have been tested in rat89 and primate90 models of SCI following 
intrathecal application. Results showed an increase in the sprouting of axons into 
lesion sites and improvements in behavioural tests. Further, Novartis have recently 
conducted a human clinical trial to assess the safety and pharmacokinetics of the 
antibody in patients, demonstrating the interest surrounding this strategy to promote 
regeneration (ClinicalTrials.gov identifier: NCT00406016 ). A further strategy is to 
use antagonists or pharmacological agents that specifically target the Rho signalling 
pathway, which regulates axonal growth and cellular apoptosis following activation 
by multiple inhibitory components of CNS myelin.91,92 Preclinical findings from 
transecting SCI models in mice show improved behavioural recovery following 
treatment93 and phase II clinical trials have shown no major adverse effects, with 
some improvements to the American spinal injury association (or ASIA) scores in a 
quarter of patients (ClinicalTrials.gov identifier: NCT00500812). 
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1.4. Current scaffold design strategies for spinal cord repair 
An assessment of different scaffold design strategies reported in the literature 
is given below, in the context of scaffold complexity, combination with multiple 
treatment strategies and the potential of nanofibre-based scaffolds to direct the 
regeneration of neural tissue.  
 
1.4.1. Channelled scaffolds 
Multiple or single channelled scaffolds represent a relatively basic scaffold 
design, capable of guiding axonal growth in fascicles or at a more macro scale. 
Studies have shown them to promote contact-guidance of axonal regeneration, 
although a combinatorial approach has improved regeneration above what would 
otherwise be possible. For example, Silva, et al. (2010) report the fabrication of 
single channelled, tubular structured scaffolds produced by rapid prototyping 
followed by post-processing thermal treatment.94 Rapid prototyping represents a 
highly reproducible fabrication technique permitting the precise control of the 3-D 
architecture of the scaffold. The produced scaffolds were 2-3 mm in diameter and 
consisted of a starch/PCL blend, containing encapsulated human oligodendrocyte 
cell line MO3-13 within a gellan gum hydrogel in the central space. They were 
shown to elicit minimal inflammation and integrate well within a rat hemisection 
SCI model. Further characterisation of this scaffold is needed in vivo with regards to 
axonal regeneration and the incorporation of inhibitory molecule suppressors and/or 
growth factors may improve scaffold efficacy further. The major disadvantage to this 
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scaffold design is the level of guidance possible on a local cellular level due to the 
limited surface area of the aligned channels available for the contact-guidance of 
spared host tissue. 
More promising multiple channelled scaffolds have been produced, 
incorporating a combinatorial approach into their design. Templated agarose 
scaffolds were produced with multiple channels at a diameter of 200µm each.95 The 
axons of the ascending dorsal column sensory pathways in rat models were 
transected at the C4 level and the extent of regeneration was assessed following a 
combination of: (i) scaffold implantation; (ii) delivery of bone marrow stromal cells 
within scaffolds transfected with NT-3; (iii) lentiviral vectors expressing NT-3 
injected at sites adjacent to the lesion; and (iv) the compression of the sciatic nerve 
to induce a growth state in the injured neuron. Animals with all four treatments 
continued to grow 83% (±13%) of their axons along the full length of the lesion 
(greater than 2 mm) to distal scaffold areas. Unfortunately axonal growth into the 
opposite side of the lesion was prevented by the formation of a reactive cell layer. A 
different PLGA polymer scaffold with seven parallel channels has been fabricated by 
injection moulding-solvent evaporation.96 Seven wires (508 or 660 µm in diameter) 
were uniformly spaced as an array inside a mold with 3 mm internal diameter. A 
PLGA polymer solution was injected into the mold to fill the empty space and 
subsequently vacuum-dried for at least 24 hours to remove solvent from the polymer 
solution. Finally the wires were removed, leaving a porous multiple channelled 
scaffold. Schwann cells were loaded into the channels and the scaffolds transplanted 
into completely transected rat spinal cords at the T9 level. ‘Fast Blue’ fluorescent 
dye was used to trace the source of regenerating axons and they were found to have 
regenerated through the scaffold and up to 14 mm into the distal cord.  
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Scaffolds with smaller channel diameters have been produced that focus on 
the outgrowth of single/multiple axons in a spatially orientated manner.97 In this 
study the scaffold was fabricated from alginate and the capillary channels formed by 
copper nitrate addition, creating multiple parallel channels with an average diameter 
of 27 µm. Produced scaffolds were initially screened to analyse the effect of scaffold 
coating with laminin, collagen, poly-L-ornithine and fibronectin ECM components 
on the linearly orientated regrowth of axons in completely transected entorhino-
hippocampal organotypic slice cultures. The in vitro study showed that there was no 
improvement with coated scaffolds and thus proved to be a valuable tool for initial 
scaffold screening and avoiding unnecessary animal experimentation. The most 
promising scaffold was subsequently transplanted into a rat dorsal column 
transection model with NSCs to assess the capacity of the scaffold to support a 
population of viable cells. The scaffold was shown to possess more regenerative 
capacity with the NSCs and mediated the guidance of axons. Scaffolds with these 
smaller, much more numerous channels may offer a better solution to directed 
axonal outgrowth than macro-scale channel scaffolds but more combinatorial 
strategies are required to validate this hypothesis. 
Finally, PLGA scaffolds have been produced incorporating both multiple 
channels and significant porosity by injection moulding, thermally induced phase 
separation and particulate leaching.98 Scaffolds were transplanted into completely 
transected rat thoracic spinal cords either in isolation or with a dose of recombinant 
human neurotrophin-3 (rhNT-3) applied dorsally to the scaffold. The high porosity 
and channel interconnectivity facilitates the entry of neurotrophin-3 and the drainage 
of waste from the scaffold, which is more limited in the multichannel scaffolds listed 
above that do not contain such porosity. The animals displayed a significant 
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functional improvement when administered with the scaffold and rhNT-3, supporting 
this hypothesis. 
 
1.4.2. Porous scaffolds 
Porous scaffolds have been produced with less uniaxial directionality than 
channelled scaffolds, but the results have been promising due to a more diverse set 
of combinatorial approaches employed. Highly porous PLGA scaffolds mimicking 
the structure of the spinal cord have been fabricated using a thermal-induced phase 
separation technique.99 The central portion of the scaffolds (representing grey 
matter) were seeded with either NSCs or NSCs and Schwann cells and the outer part 
of the scaffolds consisted of orientated pores for axonal growth (representing white 
matter tracts). The scaffolds were transplanted into a 3 mm gap in the right hemicord 
of rats, with the scaffolds incorporating both cell types showing greater axonal 
regeneration and functional improvement than acellular scaffolds or those with just 
one cell type. Hyaluronic acid hydrogels100 with pore sizes of 100 µm were 
constructed incorporating poly-L-lysine to permit the attachment of cells and 
antagonists to the Nogo-66-receptor to help lessen glial scar formation. This receptor 
becomes activated upon binding to myelin-derived molecules that inhibit axonal 
regeneration, such as Nogo-A, myelin associated glycoprotein and oligodendrocyte 
myelin glycoprotein.101 Results from scaffolds implanted into rats after lateral 
hemisection found that there were more cells and myelinated axons in scaffolds with 
the antagonists than in those without. 
Overall, the channelled and porous scaffolds produced thus far were 
generally more successful in permitting axonal regeneration and functional recovery 
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when they were administered with growth factors, molecular antagonists and cells, 
supporting the theory that more complex scaffolds simultaneously utilising a 
combination of strategies can address multiple facets of the injury response. While 
results have been promising, the designs of the scaffolds mentioned above do not 
fully exploit the benefits offered by fibrous scaffolds, including a higher surface area 
to volume ratio for increased cellular attachment and contact-guidance of 
regenerating axons.  
 
1.4.3. Fibrous Scaffolds  
Overall, scaffolds with a fibrous topography possess greater mimicry of 
spinal cord cellular architecture. Fibrous scaffolds with a fibre diameter at the 
micrometer scale have been published, composed of linearly ordered collagen fibres 
bundled together. 102 The fibre diameters were less than 200µm. BDNF was fused 
with a collagen binding domain and bound to the collagen fibres, as well as 
covalently cross-linked epidermal growth factor (EGF) receptor neutralising 
antibody. The EGF receptor has been identified as a downstream target of the 
molecules inhibitory to axonal regeneration (mentioned above).103 This scaffold was 
inserted into 6 mm complete transecting lesions in rat models and was shown to 
bridge the cavity, promote axonal outgrowth into the scaffold, significantly 
neutralise the growth inhibitors present at the injury sites and show signs of 
functional improvement in animals.   
Poly-L-lactic acid (PLLA) nano- and microfibres were both produced by 
electrospinning with a high degree of alignment and their ability to induce contact-
guidance and differentiation in NSCs in vitro was evaluated.104 Their results show 
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that NSC elongation and neurite outgrowth both occurred, parallel to the direction of 
nanofibre scaffold alignment, and that NSC differentiation occurred at faster rates for 
the nanofibres compared with microfibres. This was the first published evidence for 
the important role that the nanofibre scaffolds can play to promote the contact 
guidance of neural cell populations and justifies their subsequent use in neural tissue 
engineering for spinal cord repair. Nanoscale fibres more strongly mimic the ECM 
and thus can control the sub-cellular processes, such as differentiation, to a greater 
degree.105 
Nanofibrous scaffolds can be produced by template synthesis, drawing, self-
assembly or phase-separation.56 The disadvantages of these production techniques 
include: discontinuous fibre production and therefore unsuitability for large scale 
production;106 the use of viscoelastic materials and inconsistencies in the fibres 
formed;107 slow reaction rates and difficult larger scale production;108 and more 
complicated, time-consuming production than electrospinning,109 respectively. 
Electrospinning is an inexpensive, fast, relatively easy, larger scale production 
method for the collection of highly aligned and randomly orientated nanofibres as 
small as 3 nm in diameter.110 The principle is simple but the optimisation and control 
of many processing parameters is required for accurate and reproducible fibre 
fabrication. Through the subsequent manipulation of various setup parameters and 
conditions, including grounded collector design, many aligned fibrous structures 
may be formed with varying arrangements, fibre diameters and densities.111 More 
common published collector set-ups for aligned nanofibre fabrication include a 
rotating drum,112 parallel electrodes,113 rotating wire drum114 and rotating tube 
collector with knife-edged electrodes underneath.115 However, difficulties exist in 
post-collection processing for the 3-D scale-up of nanofibre scaffolds that permit 
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significant cellular infiltration following implantation in vivo.116 Furthermore, the 
number of studies published testing nanofibre scaffolds as the principle 
topographical cue across the cross-sectional area is limited, given the potential of the 
strategy to direct cellular growth in vitro.104,117 These in vivo studies also use 
scaffolds that are relatively simple in spatial design and cellular complexity. 
 
1.5. Aims and objectives of the project  
In the preceding sections I have attempted to highlight the benefits of a range 
of tissue engineering strategies for the repair of SCI. This thesis aims to address 
three specific issues that I have identified in preceding sections. 
Clinically relevant live animal injury models show the potential of implanted 
nanofibre scaffolds to promote regeneration of the injured spinal cord, in contrast to 
the majority of current treatment strategies that rely on minimising early damage 
post-injury. The capacity to maximally exploit the benefits of such scaffolds requires 
a few major issues to be addressed.  
The first aim of this thesis is to address the lack of spatial and glial cell 
complexity in  implantable constructs reported so far using aligned nanofibre 
scaffolds, with a view to more efficient and neuromimetic constructs for CNS repair. 
This will be addressed by developing a methodology to fabricate nanofibre-collagen 
hydrogel composites, for the co-culture and alignment of multiple neuroglial cell 
populations. A method of scaling-up the number of constituent nanofibre layers will 
be developed, to aid the production of more complex bridges that facilitate the 
infiltration of host tissue and transplanted cells throughout the depth of the structure.  
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The second aim is to develop and optimise a more complex model of SCI in 
vitro (compared with systems currently available to the neural tissue engineering 
community) based on the use of organotypic cultures of spinal cord tissue. The 
mimicry of multiple cardinal features of injury in vivo will be assessed by 
developing quantitative image-based assays of fluorescently labelled cell populations 
in the slice lesions.  
Finally, a method to safely deliver frames of aligned nanofibres into lesioned 
spinal cord slice cultures will be developed, in order to test the utility of the slice 
injury paradigm for screening efficacious, pro-regenerative neural tissue engineering 
strategies, towards the reduction and refinement of live animal experimentation 
(according to the 3’Rs principles) for SCI research.  
More detailed descriptions of the chapter objectives follow: 
 
Chapter 2: Alignment of multiple glial cell populations in 3D nanofibre 
scaffolds - toward the development of multicellular implantable scaffolds for 
repair of neural injury 
This chapter will follow the development and optimisation of methodologies to 
assemble nanofibre-hydrogel constructs with increased spatial and cellular 
complexity. The compatibility of nanofibre-hydrogel constructs to support the 
growth, alignment and elongation of neural cells will be assessed with primary 
astrocyte and OPCs, in isolation and in co-culture. The feasibility of increasing the 
cellular complexity of constructs further with populations of seeded microglial cells 
will be assessed. The ability to scale-up the number of constituent nanofibre layers 
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for the culture and alignment of glial cells in a 3-D construct will be tested with 
astrocyte mono-cultures. 
 
Chapter 3: Development of a complex 3-D in vitro model of SCI 
This chapter will follow the development and optimisation of methodologies to 
produce a 3-D, multicellular model of SCI in vitro based on organotypic cultures of 
neonatal mouse spinal cord tissue. A method will be developed to induce lesions of a 
range of sizes that completely transect the spinal cord and the reproducibility of the 
lesion size quantified. Analyses will be developed to quantify the pathological events 
within lesion sites and characterise the mimicry of the cardinal features of injury in 
vivo within the slice injury paradigm. Re-useable slice culture inserts that permit the 
culture and lesioning of slices will be developed and tested in comparison with the 
commercial, gold-standard slice culture insert and an existing alternative insert, 
towards lowering the cost of generating the injury model for screening applications. 
 
Chapter 4: Evaluating the screening utility of an in vitro model of SCI for 
nanofibre-based repair strategies 
This chapter will assess the potential of using the lesioned organotypic spinal 
cord slice culture model as a prototype screening system for nanofibre scaffolds ± 
coating with relevant biomolecules, intended to promote spinal cord regenerative 
processes post-injury. A method to incorporate frames of aligned nanofibres across 
lesion sites will be developed and tested. Finally, the potential of the implanted 
constructs to enhance regenerative processes will be evaluated. 
28 
 
 
A chapter dedicated to ‘Materials and Methods’ has been omitted from this 
thesis, as a significant proportion of the work pertains to the development of 
protocols, tools and methods of analysis. I believe that the current layout should 
improve the flow and make clear which protocols were developed/adapted, within 
each respective experimental chapter. 
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Chapter 2: Alignment of multiple glial cell 
populations in 3-D nanofibre scaffolds - 
toward the development of multicellular 
implantable scaffolds for repair of neural 
injury   
30 
 
2.1. Introduction 
As discussed in section 1.4, combinatorial repair strategies utilising structural 
bridges have the potential to reverse the multifaceted pathology of SCI.95,118,119 
Briefly, the scaffold supports the regeneration of spared host tissue following 
implantation.120,121 The addition of cells and biomolecules into the scaffold, as part 
of a combinatorial repair strategy, can promote repair mechanisms, reverse the 
growth-inhibitory environment of the lesion site and support the function of 
regenerating tissue.51,54,59,122 Nanofibres fabricated by electrospinning have emerged 
as a favourable scaffold for tissue engineering because they have a large surface area 
to volume ratio for the attachment of cells123 and can be collected as assemblies of 
varying designs and structures, including a highly aligned configuration.46,124 
Scaffolds fabricated with aligned topographical cues are considered more efficient at 
directing tissue regeneration, which is particularly relevant for the reconstruction of 
the intricate cytoarchitecture of spinal cord tissue.54,125 Studies in vitro have 
highlighted the strong influence of aligned nanofibre scaffolds on the morphology of 
astrocytes and the distance of nerve fibre outgrowth from dorsal root ganglion 
(DRG) explants (as a model for PNS nerve fibre outgrowth), via contact-
guidance.60,68,111,117,126–128 Furthermore, preliminary studies assessing the feasibility 
of nanofibre bridge implantation within animal SCI models have corroborated the 
potential to enhance repair (Table 1). However, in general, these studies have been 
sparse and the constructs assembled were relatively simple, highlighting the 
technical challenges that have been associated with the scale-up of nanofibre-based 
scaffolds for therapeutic testing in vivo.  
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Table 1. Summary of constructs containing aligned nanofibres implanted into 
models of SCI in vivo 
Construct features 
Model of 
Rat SCI  
Overall performance Ref 
Multiple tubes (10-13 per 
spinal cord; diameter 360 
µm) of aligned nanofibres 
(tube wall thickness 90 µm)  
filled with self assembling 
nanofibre peptides (SANPs) 
± (BDNF + ciliary 
neurotrophic factor + 
vascular endothelial growth 
factor + ChABC). 
Contusion via 
Multicenter 
Animal 
Spinal Cord 
Injury 
Study  (MAS
CIS) 
impacter. 
Chronic 
injury model. 
Significant anatomical, 
histological and neuronal 
regeneration and functional 
recovery seen in the channels 
with added biomolecules 
(greater than any other report 
using constructs that contained 
aligned nanofibres). 
129 
One half-cylinder per spinal 
cord (length 4 mm). 
Consisted of two layers: an 
inner mesh of aligned 
nanofibres (100 µm thick) 
and an outer mesh of 
random nanofibres (500 µm 
thick) ± rolipram. 
Hemisection Nerve fibre outgrowth mainly 
on the aligned nanofibre layer. 
Also a reduction in GFAP and 
CSPG staining intensity and 
significantly increased Basso, 
Beattie and Bresnahan (BBB) 
scores from animals implanted 
with constructs containing 
rolipram. 
130 
Aligned collagen nanofibres 
rolled into a spiral tubular 
structure (2.5 x 2 mm). 
Hemisection Significant cell penetration and 
infiltration into constructs. 
Absence of neuroglial scarring. 
Scaffolds supported nerve fibre 
sprouting. 
126 
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A tubular scaffold (4 x 2 
mm) containing a central 
nanofibre bundle (<100 µm 
diameter) embedded in a 
laminin-hyaluronic acid gel 
(± human nasal olfactory 
mucosa or embryonic spinal 
cord cells). 
Complete 
transection 
Partial recovery of function 
three months following lesion 
induction. Some evidence of 
axonal outgrowth and re-
myelination. 
131 
Rolled nanofibres. Hemisection Integration of scaffolds with 
host tissue evidenced by the in-
growth of connective tissue, 
blood vessels, Schwann cells 
and neural cell processes. 
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2.1.1. Controlling nanofibre density  
Conventionally, aligned nanofibres are collected during electrospinning onto a 
2-D substrate, such as glass coverslips or aluminium foil, attached to a rotating 
mandrel collector. The relatively short duration of each unit operation produces 
nanofibre meshes that typically contain supracellular pore sizes for the infiltration of 
cells seeded on the scaffold surface. Further manipulation of the nanofibre mesh is 
required after collection for the production of implantable scaffolds, so in this 
context, to-date the duration of each unit operation has been increased to fabricate a 
free-standing scaffold with superior stability.133 With most collector designs an 
increase in the duration of each unit operation to increase the thickness of the fibre 
mesh collected usually decreases the local attraction of the spinning polymer for the 
collector, thus reducing the aligned configuration. Furthermore, collecting more 
nanofibres concurrently increases the packing density of the mesh (the fraction of the 
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mesh volume occupied by nanofibres), resulting in significantly smaller pore sizes 
that restrict cellular growth to the outermost layer of nanofibres: essentially a 
roughened 2-D surface.111,116,133–135 This limitation is apparent from the designs of 
the scaffolds tested in live animal models of SCI (Table 1), which contain a sub-
optimal contribution from the nanofibre component across the diameter. The 
nanofibre meshes were produced with a high packing density and typically rolled 
into tubes (Figure 1A), or a spiral structure (Figure 1B) containing less than ten 
layers across the diameter of the scaffold. By comparison, if the number of mesh 
layers was increased there would be a greater number of surfaces for the attachment 
of cells from spared host tissue (Figure 1C). However, without reducing the 
nanofibre mesh packing density, there would also be a greater impenetrable cross-
sectional area. This suggests that the capability of aligned nanofibres as a strategy to 
direct outgrowth of spared host tissue has not been adequately assessed in the 
literature. In comparison, Gelain, et al. (2011) reduced the diameter of each scaffold 
and implanted between 10-13 into the lesion cavity of each spinal cord (Figure 1D), 
which is a simple method of enhancing the surface area of the aligned component of 
the repair strategy.129 Furthermore, in this particular study, the central space within 
the tube of nanofibres was filled with SANPs, therefore substantially increasing the 
cross-sectional area of the aligned scaffold topography available for contact with 
spared host tissue. This may partly explain why extent of repair observed for this 
scaffold design was superior compared to all others reported. Furthermore, it shows 
the potential of a scaffold containing nanoscale topographical cues throughout the 
diameter to direct tissue regeneration and repair. 
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Figure 1. Schematic diagrams of cross-sections through the designs of current 
3-D scaffolds containing aligned nanofibres with supracellular pore sizes, 
highlighting the current limitations in the area available for interaction with 
spared host tissue. (A) A tubular structure represents the simplest scaffold design 
that requires the least manipulation following nanofibre (black) fabrication. At a 
nanofibre packing density with supracellular pore sizes there is also minimal surface 
area for contact-guidance of cells (red). (B) A spiral tubular structure is a more 
common used processing technique to increase the number of surfaces for cellular 
interaction across the scaffold diameter. (C) Rolling the nanofibre mesh further, 
enhances the number of surfaces for interaction. However, the impenetrable cross-
sectional area will also accumulate unless the pore sizes are concurrently increased 
to permit cellular infiltration within each mesh layer. (D) Using multiple, smaller 
scaffolds within the same lesion volume is a simple method of increasing the number 
of surfaces available for cellular interaction without the use of more complex 
processing methodologies.  
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2.1.2. Reconstructing the circuitry of supporting glial cells  
A promising strategy to enhance regeneration is to reconstruct neuroglial cell 
circuitry in lesion sites via the implantation of constructs containing multiple 
populations of supporting neuroglia (viz. astrocytes, cells of the oligodendroglial 
lineage and microglia). These cells have important and diverse roles that maintain an 
optimal environment for neurological function (section 1.1.1). Furthermore, these 
cells play vital roles in regeneration following injury. Astrocytes are involved in 
synaptogenesis, which is necessary for the reconnection of regenerating nerve fibres 
with host neuronal circuitry.136,137 Oligodendrocytes are responsible for the genesis 
of the insulating myelin sheath around regenerating nerve fibres, providing trophic 
support and conferring a faster rate of action potential conduction.6 Microglia, the 
immune-competent cells of the CNS, infiltrate into lesion sites, where they are 
responsible for the breakdown and phagocytosis of cellular debris and toxic 
substances that are inhibitory to the outgrowth of nerve fibres.21,22 Thus, the 
incorporation of organised glial circuits into lesion sites could provide a pro-
regenerative niche for the outgrowth of nerve fibres with the ability to support the 
function of nerve fibres within the scaffold. Additionally, in vitro studies have 
demonstrated that a bed layer of pre-aligned astrocytes enhances the distance of 
nerve fibre outgrowth from co-cultured DRG explants.60,138–140  
Despite the potential of this strategy to promote regeneration and support the 
function of nerve fibres within the scaffold, there are two principle explanations for 
the lack of reports testing their therapeutic potential in combination with aligned 
nanofibre scaffolds. Firstly, as mentioned above, the production of aligned nanofibre 
scaffolds has proved challenging without more sophisticated methods of processing 
nanofibres fabricated with a lower packing density: only one study has used cells 
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seeded onto scaffolds containing nanofibres, prior to implantation.131 Second, the 
issues associated with the co-culture of multiple glial cell populations on scaffolds 
within a single compatible medium have limited the cell types used in the literature 
to predominantly NSCs. These cells are able to generate astrocytes, neurons and 
oligodendrocytes, making them a useful cell source for co-culture studies and also in 
the context of repair.141 However, these cells tend to differentiate predominantly into 
astrocytes so they cannot be used to generate multiple defined ratios of the three cell 
types on demand. Furthermore, the use of NSCs for construction of the complete 
glial cell circuitry is limited as they are unable to produce microglial cells, which are 
generated in development from primitive myeloid progenitors.142 
 
2.1.3. Technological gap: can the limitations of fabricating aligned nanofibre 
scaffolds with greater spatial and cellular complexity be addressed? 
Techniques that separately address: (i) the difficulties of processing nanofibres 
with a low packing density for the production of 3-D implants; and (ii) the co-culture 
of all the glial cell sub-types have been reported. First, Ying, et. al (2011) describe a 
technique for the fabrication of a 3-D nanofibre-hydrogel composite, containing 
handleable nanofibre meshes with a relatively low packing density.133 In brief, a 
knife-edged parallel electrode collector was used to capture a mesh of aligned 
nanofibres, which were unsupported between the electrodes. The use of this collector 
permitted the transfer of the nanofibre mesh onto portable acetate frames, which 
were then stacked and filled with collagen hydrogel to create a multiple layer 
nanofibre-hydrogel construct. The low line density (450 nanofibres/mm) and 
thickness (0.5-3.0 µm) of the nanofibre meshes used circumvented the problem of 
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cellular infiltration through each nanofibre mesh layer, when cells were applied 
within the hydrogel to the top mesh layer. The hydrogel supported the nanofibre 
configuration and further enhanced the 3-D environment of the scaffold. The 
constructs were used for mono-cultures of either corneal fibroblasts or nucleus 
pulposus cells, so the applicability for the culture of neural cells remains unknown. 
However, the other potential techniques reported, combining nanofibres with a 
hydrogel to assemble a 3-D composite, either produced a tubular structure143 or 
contained random nanofibre configurations.144,145 These are of much less benefit for 
the regeneration of neural tissue due to the uniaxial orientation of ascending and 
descending pathways in the spinal cord (section 1.1.1).  
Second, mixed glial cultures represent a system whereby primary astrocytes, 
microglia and OPCs can be maintained together in one medium and pure populations 
of each consistently derived.146 They have been used previously to generate co-
cultures of astrocytes and oligodendroglia, although they were cultured on 
polystyrene nanofibres that were collected on a 2-D surface (glass coverslips) and 
used in vitro in the context of studying the processes of oligodendrocyte 
myelination.147  
Hence, there is unexplored potential to enhance the spatial and cellular 
complexity of aligned nanofibre scaffolds by using 3-D, multiple layer nanofibre-
hydrogel constructs to culture and align multiple glial cell sub-types in defined 
orientations.  
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2.1.4. Objectives 
This chapter follows the development and optimisation of methodologies to 
assemble nanofibre-hydrogel constructs in order of increasing glial cell co-culture 
and nanofibre layer complexity:- 
(i) Astrocyte/OPC mono-cultures on single layer constructs, to optimise the 
assembly process, establish cultures of viable cell populations in highly aligned 
conformations and quantify the extents of cellular elongation. 
(ii) Astrocyte and OPC co-cultures on single layer constructs, to demonstrate the 
feasibility of increasing the glial cell complexity.   
(iii) Astrocyte mono-cultures on multiple layer constructs, to optimise the 
assembly of constructs containing aligned glial cells over multiple stacked nanofibre 
layers. 
The overall aim was to demonstrate the feasibility of enhancing the complexity 
of nanofibre-based constructs as part of a combinatorial strategy, towards the 
development of a multicellular, implantable scaffold for the repair of SCI.  
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2.2. Materials and methods 
For all tissue extraction procedures, the care and use of animals was in 
accordance with the Animals (Scientific Procedures) Act of 1986 (UK) with 
approval by the local ethics committee. 
 
2.2.1. Reagents and equipment 
The syringe pump was obtained from KD Scientific (Holliston, MA, USA) and 
a high voltage power supply from Spellman HV (Pulborough, UK). Poly-L,D-lactic 
acid (PLA; 96% L: 4% D) was obtained from Purac BV (Gorinchem, Netherlands). 
Chloroform, dimethylformamide and rhodamine B were all from Sigma-Aldrich 
(Poole, UK). Collagen type I from rat tail was obtained from BD Biosciences 
(Oxford, UK). Tissue culture-grade plastics, media and media supplements were 
from Fisher Scientific (Loughborough, UK) and Sigma-Aldrich (Poole, UK). 
Recombinant human platelet-derived growth factor (PDGF-AA) and basic fibroblast 
growth factor were from Peprotech (London, UK). The following primary antibodies 
were used: rabbit anti-GFAP (DakoCytomation, Ely, UK), monoclonal anti-A2B5 
(Sigma-Aldrich, Poole, UK) and monoclonal anti-myelin basic protein (MBP; 
Serotech, Kidlington, UK). Cy3- and Fluorescein isothiocyanate (FITC)-conjugated 
secondary antibodies were from Jackson ImmunoResearch Laboratoratories Inc. 
(West Grove, PA, USA). Vectashield mounting medium with and without 4’, 6-
diamidino-2-phenylindole (DAPI) was from Vector Laboratories (Peterborough, 
UK). DAPI powder was from Sigma-Aldrich (Poole, UK). VybrantTM carbocyanine 
dyes were obtained from Fisher Scientific (Loughborough, UK). The live/dead cell 
viability kit was from Invitrogen (Paisley, UK). 
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2.2.2. Fabrication and processing of electrospun aligned nanofibres 
The experimental setup and operational parameters used in the production of 
all nanofibres were previously optimised to the laboratory environment (24oC with 
45 % humidity). A 2% (w/v) poly-L,D-lactic acid solution was prepared by 
dissolving the polymer in chloroform prior to the addition of dimethylformamide 
(7:3 solvent volume). The addition of rhodamine B into the solution (0.1 mg/mL) 
produced fluorescent nanofibres, to permit the visualisation of nanofibre interaction 
with multiple neural cell populations. The electrospinning setup (Figure 2A) 
consisted of a syringe filled with polymer solution and a mobile, knife-edged, 
parallel electrode collector (produced in-house) connected to a copper plate. A 
syringe pump forced the polymer solution at a rate of 0.025 mL/min from the needle 
of the syringe, towards the electrodes of the collector. A potential difference of ±6 
kV was applied between the needle and the collector, which were separated by a 
working distance of 20 cm. Nanofibres were deposited between the parallel 
electrodes (separated by 4 cm) in an aligned configuration. The nanofibres used for 
all experiments were obtained across the central width (ca. 15 cm) of the collector 
where the nanofibre line density (number of nanofibres along a distance 
perpendicular to the axis of nanofibre orientation) remained homogeneous. 
Nanofibres were transferred onto cellulose acetate frames to be handleable and 
maintain nanofibre alignment. 
Nanofibres fabricated for nanofibre-collagen hydrogel constructs (herein 
termed ‘nanofibre-hydrogel constructs’) with a single nanofibre layer were collected 
over a unit operation less than ten min in duration and acetate frames were affixed 
using a spray adhesive directly onto the parallel electrodes of the collector (Figure 
2B). This produced portable ‘nanofibre sheets’ with a low line density per acetate 
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frame. To fabricate ‘nanofibre meshes’ with an increased line density for use in 
multiple layer nanofibre-hydrogel constructs, whilst maintaining the nanofibre 
alignment, an intermediate processing step was employed utilising a ‘densification 
tool’ (Figure 2C). This compacted all of the nanofibres obtained after each unit 
operation, from the deposition area of the collector (60 cm2) to the area of the tool 
(13.2 cm2; Figure 2D). To further increase the line density, nanofibres from between 
one to two unit operations were combined onto the tool and transferred to a single 
acetate frame. The maximum length of each unit operation was restricted to 10 mins 
to prevent the build up residual charges and consequently the collection of 
misaligned nanofibres on the top layer of the nanofibre mesh.104 All nanofibres were 
desiccated overnight and sterilized with ultra-violet light using a GS Gene Linker TM 
UV chamber (Bio-Rad Laboratories, Hercules, CA) before use in experiments. 
Nanofibres were discarded if unused for periods longer than 2 months.  
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Figure 2. Schematic diagram showing the production of sheets of portable 
aligned nanofibres adhered to acetate frames. (A) The electrospinning setup, 
consisting of a syringe loaded with polymer (pink), syringe pump (grey) and knife-
edged parallel electrode collector (beige). (B) For single unit operations less than 
ten min, acetate frames (black) were sprayed with adhesive and applied directly onto 
the nanofibre collector. (C) The use of a ‘densification tool’ (blue) to increase the 
overall line density (number of nanofibres perpendicular to the axis of orientation) 
of nanofibres on each acetate frame. All nanofibres collected from the central area 
of the collector, from a single unit operation (≤10 min), were processed onto the 
tool. The line density could be increased further by adding nanofibres from more 
unit operations onto the tool. (D) The application of a single acetate frame onto the 
densification tool. 
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2.2.3. Mixed glial cultures 
Primary mixed glial cultures were prepared and each cell population 
(astrocytes, OPCs and microglia) subsequently purified using an established 
protocol.146 Briefly, the cerebral cortices were dissected from whole rat brains of 
neonatal Sprague-Dawley rats (P1-3). Cells were dissociated and cultured at 37oC in 
5% CO2/95% humidified air in flasks containing D-10 medium [Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 2 mM glutaMAX-I, 1 mM 
sodium pyruvate, 50 U/mL penicillin, 50 µg/mL streptomycin, and 10% fetal bovine 
serum]. After 8-10 days, a confluent layer of astrocytes had attached to the bottom of 
the flasks, with a more loosely attached layer of OPCs and microglia proliferating 
above. The use of a rotary shaker at 200 rpm for 2 h preferentially removed 
microglia into the medium. To obtain OPCs, this medium was replaced with fresh, 
re-gassed medium and shaken for a further 16 h. Residual microglial contamination 
was removed from OPCs through the transfer of the resultant medium to non-tissue-
culture grade Petri dishes for 30 min. Finally, by trypsinizing the remaining astrocyte 
bed layer and seeding astrocytes into a new culture flask, relatively pure populations 
of each glial cell sub-type could be obtained. Flasks containing mixed glial cultures 
or pure astrocyte cultures were maintained with medium changes every 2-3 days. 
 
2.2.4. Nanofibre-hydrogel construct fabrication 
The established protocol133 for assembling 3-D constructs with multiple 
nanofibre layers was adapted for the culture of neural cells, on single layer 
constructs, as a basis for the optimisation and the scale-up of the number of 
constituent nanofibre layers. In this regard, many alterations and refinements were 
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made to the design and assembly of constructs, which are all detailed in section 2.3. 
However, the initial methodology used to fabricate both single and multiple layer 
nanofibre-hydrogel constructs is detailed below.  
 
2.2.4.1. Single nanofibre layer mono-culture experiments (astrocytes or OPCs) 
The first step in the assembly procedure (Figure 3)  was the formation of a 
collagen hydrogel solution at a final concentration of 3 mg/mL, containing a stock 
solution of type I rat tail collagen, 10x DMEM solution, distilled water and 1N 
sodium hydroxide (all sterile). The volumes of each hydrogel component were 
calculated according to the stock collagen concentration, and the desired collagen 
solution concentration and volume. All the components were mixed thoroughly and 
the homogeneous collagen hydrogel solution left on ice (≤ 4 h) until required. Next, 
a pre-cut filter paper frame was placed on the centre of a hydrophobic 
polytetrafluoroethylene (PTFE) block in a Petri dish. Drops of collagen gel solution 
were slowly applied to the centre of the filter paper frame to produce a level base, 
which was cured for 30 min at 37oC. During this time period, either astrocytes or 
OPCs were resuspended at a cell concentration of 2.5 x105 cells/mL (from pure 
cultures or mixed glial cultures, respectively; section 2.2.3). A single frame of 
aligned nanofibres was placed on top of the base and the cells were seeded over the 
central seeding area. Cells were incubated for 30 min to permit their initial 
attachment to constructs and collagen hydrogel subsequently added around the 
outside perimeter of the seeding area to seal the nanofibres in place. After curing the 
hydrogel seal (15 min; 37oC), the acetate frame was removed from the construct by 
cutting the nanofibres with a scalpel in between the frame and the seal. The PTFE 
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block was then removed and the construct transferred to a Petri dish, for culture 
purposes and to permit visualisation using light microscopy. Culture medium was 
added to all constructs (D10: astrocyte mono-cultures and glial cell co-cultures; OPC 
maintenance medium: OPC mono-cultures) and changed every two days thereafter.  
Refinements to the seeding procedure, including the addition of numerous glial 
cell sub-types to produce ‘mixed glial constructs,’ were made according to the 
design and quality of the constructs formed. Nanofibre-hydrogel constructs were 
used to evaluate the morphological effects of nanofibres on both astrocyte and OPC 
mono-cultures following culture. Cells seeded onto hydrogel constructs without 
nanofibres were used as a control for these experiments and constructs containing 
glial cell co-cultures. Furthermore, during the initial culture period, cells were 
simultaneously seeded onto tissue culture plastic ± nanofibre sheets (adhered to the 
surface), to monitor differences in the proportions of cells that: were phase-bright 
with light microscopy; had attached; and had aligned on nanofibres, compared with 
cells simultaneously seeded onto constructs. These parameters were considered 
important readouts of cell viability that significantly helped troubleshoot any 
procedural problems and optimise construct assembly.  
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Figure 3. Schematic diagram depicting the process of single nanofibre layer-
hydrogel construct production, adapted from an established methodology to 
produce 3-D constructs with multiple nanofibre layers.133 
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2.2.4.2. Multiple nanofibre layer mono-culture experiments (astrocytes) 
The production of constructs with two nanofibre layers was used as an 
intermediate increase in complexity from single layer constructs and was used 
throughout the assembly of three-layer constructs as a control. Constructs containing 
multiple nanofibre mesh layers (Figure 4) had a few key differences in the design 
compared to the single layer constructs. The nanofibre meshes were produced with a 
significantly greater line density than the nanofibre sheets, in order to sequester the 
cells sequentially seeded onto each nanofibre layer. The density used previously by 
Ying, et al. (2011) was much lower to facilitate cellular infiltration, because their 
construct was pre-assembled prior to seeding cells simultaneously across all three 
nanofibre layers.133 A square filter paper frame was placed on top of each nanofibre 
mesh layer to create distinct layers and to anchor the hydrogel after curing. The 
nanofibre meshes were stacked perpendicular to the adjacent layer to help visualise 
the influence of aligned nanofibres on the orientation of cells through the depth of 
the 3-D nanofibre construct formed.  
Astrocytes were cultured as a basis for assessing the potential to further 
increase the complexity of the multi-cellular constructs produced. In initial 
experiments, 6 x 103 astrocytes were sequentially seeded onto each layer in equal 
intervals ranging between 40-120 min, to permit the initial attachment. Cells were 
plated onto tissue culture plastic immediately after each construct layer was seeded 
as a control to monitor cell viability at each stage of assembly. Excess medium was 
removed 60 min after seeding the final nanofibre layer with cells and collagen 
hydrogel was added to the centre of the construct to stabilize the nanofibres and 
complete the construct assembly. Following the removal of acetate frames (at 12 h), 
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culture medium was added and was changed every 2 – 3 days. Astrocytes were 
cultured for two weeks before imaging.  
 
 
Figure 4. Schematic drawing illustrating the assembly of nanofibre-hydrogel 
constructs with three nanofibre layers. One acetate frame (dark grey) with a 
nanofibre mesh adhered to the underside of the frame (black arrows indicating 
nanofibre direction) was placed on top of a collagen base (pink). Cells were seeded 
onto the nanofibre mesh and a spacer (light purple), nanofibre frame and cell 
seeding solution added two more times to produce a three layered construct. 
Collagen (pink) was added to the centre of the construct to finalise the fabrication 
process.  
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2.2.5. Cell labelling 
In every case, constructs were washed with phosphate buffered saline (PBS), 
fixed with 4% paraformaldehyde [PFA; room temperature (RT); 20 min] and washed 
again. Constructs were incubated in blocking solution [5% normal donkey serum 
(NDS) in PBS supplemented with 0.3% Triton X-100, RT; 30 min] and then 
incubated with primary antibodies [raised against A2B5 (marker of OPCs; 1:200 
dilution), GFAP (marker of astrocytes; 1:500) and MBP (marker of mature 
oligodendrocytes; 1:200)] in blocking solution. Astrocytes and oligodendroglia were 
both visualised on constructs by double-staining with antibodies raised against 
GFAP, and A2B5 (two day co-cultures) or MBP (eight day co-cultures). Following 
washing, constructs were incubated with blocking solution and then with respective 
Cy3- and/or- FITC-conjugated secondary antibodies (1:200). The protocol for 
immunostaining constructs required optimisation from that used for staining 
dissociated cells on glass coverslips, as the intensity of fluorescence was too faint for 
the adequate microscopic detection of cells. Therefore the lengths of primary and 
secondary antibody incubations were increased to 24 h and 4 h, respectively. 
Performing these steps at room temperature (RT) enhanced the staining quality 
without concomitantly increasing the levels of background staining, so the protocol 
was considered optimal. Constructs were washed and mounted with Vectashield 
mounting medium containing DAPI nuclear stain (or without for constructs 
containing microglia stained with DAPI).  
A live/dead cell viability kit was used to label astrocytes in multiple layer 
nanofibre-hydrogel constructs. Briefly, cell culture medium was removed from 
constructs and washed three times with PBS. Constructs were incubated in PBS 
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containing 10 µM calcein-AM and 1 µM propidium iodide (30 min; 37oC), washed 
in PBS and immediately visualised.  
A commercial cell tracking kit was used to visualise the co-existence of 
multiple glial cell sub-populations on single layer mixed glial constructs. 
Carbocyanine dye (5 µL/mL) was added to 1 x106 cells/mL suspended in culture 
medium and incubated at 37oC. Cells were washed in culture medium to remove 
residual stain. The optimal incubation time for each neuroglial cell was investigated 
by removing cells incubated with dye every five min up to a total of 25 min and 
visualised with a fluorescence microscope. As the quality of staining was suboptimal 
(section 2.3.5), a different method was developed to stain live microglia with DAPI 
and then subsequently immunostain astrocytes and oligodendrocytes. To a 
suspension of microglia in 5 mL of D10 medium, stock DAPI was incubated at 20 
µg/mL (15 min; 37oC). Cells were subsequently centrifuged and resuspended in 
fresh medium twice before seeding onto constructs.  
 
2.2.6. Imaging 
 
2.2.6.1. Fluorescence microscopy 
Constructs were imaged using an Axio Scope A1 fluorescence microscope 
(Carl Zeiss MicroImaging GmbH; Goettingen, Germany) fitted with an Axio Cam 
ICc1 digital camera. Filter sets 20 (to detect CY3 fluorescence), 49 (to detect DAPI 
fluorescence) and 38 (to detect FITC fluorescence) were from Carl Zeiss 
(MicroImaging GmbH; Goettingen, Germany), and the excitation and emission 
51 
 
wavelengths for these filter sets are 546/575-640 nm, 365/445-50 nm and 470/525-
50 nm, respectively. Fluorescence images were captured with AxioVision software 
and merged in Adobe Photoshop CS5.1 (version 12.1). 
 
2.2.6.2. Confocal microscopy 
An inverted confocal laser scanning microscope (Olympus FV 300, Olympus, 
UK) was used to observe the segregation and orientation of live/dead stained 
astrocytes in nanofibre-hydrogel constructs over three layers. This employed in-line 
barrier filters for 510-530 nm (green) and 565-660 nm (red). All images were 
captured using a X10 lens objective. Visualisation of the constructs in 3-D was 
achieved by scanning sections at 10 µm intervals along the z-axis over a range of 
250 µm. Three individual images over the full z-axis range were merged into a single 
representative image using ImageJ software (version 1.45s).  
 
2.2.6.3. Scanning electron microscopy 
Nanofibre frames at different packing densities and with and without 
fluorescence were mounted on aluminium stubs. Pre-cut O-rings of carbon pad were 
used to adhere nanofibres to the stubs and facilitate acetate frame removal without 
disrupting the nanofibre configuration. Nanofibres were sputter coated with gold for 
2 min and nanofibers within the centre of the circular carbon pad visualised using a 
high resolution field emission scanning electron microscope (SEM; Hitachi S4500) 
operated at an accelerating voltage of 5 kV. 
 
52 
 
2.2.7. Analyses 
 
2.2.7.1. Nanofibre characterisation 
A Nikon Eclipse 80i fluorescence microscope was used with manual focus 
stepping at 0.5 µm to estimate the thickness of the collected fluorescent nanofibre 
mesh layer (TRITC emission wavelength of 605 nm). The distance between the top 
and bottom fibres was measured for six randomly chosen fields, across three 
nanofibre frames, produced in discrete electrospinning unit operations. For diameter 
analysis, nanofibres were fabricated ± rhodamine B and captured at X 5000 
magnification by SEM. The nanofibres measured had a uniform shape across the 
length of the image and were visually separated from any clumps. At least 20 
nanofibres were measured on each stub, across six stubs ± rhodamine B (n = 6 per 
group). For analysis of the nanofibre line density (number of nanofibres along a 
distance perpendicular to the axis of nanofibre orientation), images were captured at 
X 2000 magnification, which was the best compromise between the visualisation of 
an adequate number of nanofibres per field and sufficient resolution for the 
identification of individual nanofibres. The number of nanofibres across a 60 µm 
distance was counted for each image, three images per stub, across three stubs ± 
rhodamine B (n = 3 per group). 
 
2.2.7.2. Assessment of cellular elongation 
To assess the potential of nanofibre-hydrogel constructs to induce the 
elongation of astrocytes and OPCs, ImageJ software was used to measure the lengths 
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and widths of at least 90 individual cells per construct (three fields per construct; 
three constructs per group) from fluorescence images of constructs stained for GFAP 
or A2B5. The aspect ratio (length ÷ width) was calculated for individual cells as 
described previously.60 Cells that showed evidence of attachment to nanofibres but 
remained rounded, without evidence of elongation, were excluded from the aspect 
ratio analysis. The aspect ratio for each cell was classified into three bins describing 
the extent of elongation: ‘low’ (2-4); ‘medium’ (4-8); ‘high’ (> 8). 
 
2.2.8. Statistical analysis 
Data were analysed using GraphPad Prism statistical analysis software 
(version 5.0). All data are expressed as mean ± standard error of the mean (S.E.M.). 
The number of experiments (n) refers to the number of mixed glial cultures from 
which astrocytes and OPCs were derived, with each primary culture established from 
a different rat litter. Nanofibre diameter analysis: A Student’s t-test (two-tailed) 
was used to quantify differences in nanofibre diameter between nanofibres ± 
rhodamine B. Nanofibre line density analysis: Data were square-root transformed 
and a Student’s t-test (two-tailed) was used to quantify differences in nanofibre line 
density between nanofibres ± rhodamine B. 
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2.3. Results 
 
2.3.1. Electrospinning for the production of fluorescent aligned nanofibre 
frames 
Portable sheets of non-fluorescent, aligned nanofibres were successfully 
produced over multiple unit operations using the existing setup and post-collection 
processing methodologies (Figure 5). Additional adjustments were made to the 
setup to reduce the incidences of misaligned fibres deposited between the parallel 
electrodes of the mobile collector. To ensure the overall conductivity of the collector 
remained constant, the soldering wire that linked the electrodes with the copper plate 
was replaced with copper wire. However, incidences of misalignment were mainly 
found when the nanofibres accumulated at specific regions along the knife-edged  
 
Figure 5. The production of portable frames of aligned nanofibres by 
electrospinning. (A) Photograph showing the formation of the Taylor cone from the 
tip of the needle during a unit operation. (B) Photograph of an acetate frame 
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containing a mesh of fluorescent, aligned nanofibres produced for multiple layer 
nanofibre-hydrogel construct experiments. 
 
electrodes, due to the presence of residual adhesive after the application of acetate 
frames (during the processing of nanofibre sheets), or the build up of indentations 
along the surface of the sharp edges that formed over time. Therefore particular care 
was taken to remove any residual adhesive from the after each unit operation with an 
abrasive sponge soaked in 70% industrial methylated spirits (IMS) and the edges of 
the electrodes were regularly sharpened with a knife sharpener, respectively. 
Fluorescent nanofibres were fabricated by the introduction of rhodamine B into 
the PLA polymer solution at 1 mg/mL. At this concentration no leaching of the 
bound dye was observed from the nanofibres into the surrounding hydrogel of the 
construct or the culture medium, and there was an absence of any noticeable uptake 
by cells cultured on the nanofibres as judged by fluorescence microscopy. 
Substantial leaching of dye was found at a higher concentration of 10 mg/mL, so the 
initial concentration used was considered suitable for all nanofibre-construct 
experiments. 
Analysis of micrographs captured using SEM confirmed the production of 
electrospun fibres in the nano-scale size range, with representative micrographs of 
diameter for both fluorescent and non-fluorescent nanofibres shown in Figure 6. 
There was no significant difference between the diameters of fluorescent and non-
fluorescent nanofibres produced (540 ± 16 nm versus 604 ± 33 nm, respectively).  
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Figure 6. Representative SEM micrographs showing diameters of nanofibres 
collected. (A) Non-fluorescent nanofibres. (B) Fluorescent nanofibres. 
 
2.3.2. Optimisation of nanofibre line density 
The duration of each electrospinning unit operation was based on the optimal 
nanofibre line densities required for single and multiple layer nanofibre-hydrogel 
construct experiments. In order to investigate the potential of nanofibres to induce 
elongation of astrocytes and OPCs on single layer constructs, the optimal line 
density was considered one where the topographical cues from individual nanofibres 
acted on single cells. It was apparent that the nanofibre sheets fabricated from unit 
operations greater than four minutes contained too many incidences of overlapping 
nanofibres, which acted as a conflicting topographical cue and induced the 
elongation of astrocytes along multiple nanofibres. This increased the difficulty of 
visualising the processes of individual cells with respect to the nanofibres that they 
were attached to, which confounded the attempts made to standardise the analysis. 
Conversely, the nanofibre line density was considered too low from unit operations 
less than four min in duration, because there were not enough nanofibres over the 
cell seeding area. Therefore a unit operation of four min was chosen as the optimal 
duration for the production of nanofibre sheets (Figure 7). An analysis of SEM 
micrographs found no significant difference in line density between non-fluorescent 
57 
 
and fluorescent nanofibre sheets (136 ± 35 nanofibres/mm versus 108 ± 22 
nanofibres/mm), suggesting the addition of rhodamine B into the polymer solution 
had negligible effects on the quantity of nanofibres deposited on the mobile 
collector. 
The line density of the nanofibre meshes used in multiple layer nanofibre-
hydrogel constructs needed to be high enough to prevent the astrocytes seeded on 
each distinct layer from mixing with layers below, thus distributing them evenly over 
each layer of the construct.  There was an uneven distribution in cells found over the 
three nanofibre layers of constructs produced, when the densification tool was used 
to process all the collected nanofibres from a single ten min unit operation onto each 
acetate frame. The addition of nanofibres onto the tool from a further five min 
collection appeared to increase the number held on the top two nanofibre mesh 
layers, but after frames incorporating nanofibres from two separate ten min 
collections were used the cells were considered evenly distributed throughout each 
layer. The line density of the fluorescent nanofibre meshes (Figure 7) was 1563 ± 56 
nanofibres/mm; approximately a 14 fold increase in line density compared to 
nanofibre sheets. The thickness of each mesh layer was 25 ± 1 µm. 
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Figure 7. Representative SEM micrographs showing the line densities of aligned 
nanofibres used in constructs. (A) Non-fluorescent nanofibres for single layer 
nanofibre -hydrogel constructs. (B) Fluorescent nanofibres for single layer 
nanofibre -hydrogel constructs. (C) Fluorescent nanofibres at a higher line density 
for multiple layer nanofibre -hydrogel constructs. 
 
2.3.3. Fabrication of single layer nanofibre-hydrogel constructs  
A series of pilot experiments were performed to optimise the assembly process 
of single layer nanofibre-hydrogel constructs for the culture and elongation of 
astrocytes or OPCs, as a basis for increasing the complexity of constructs produced 
(viz the number of co-cultured neuroglial sub-classes and scale-up of the number of 
constituent nanofibre layers). The procedural modifications undertaken with respect 
to the initial production methodology (section 2.2.4.1) are summarised in Table 2.  
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Table 2. Summary of the main alterations made to the methodology of single 
layer nanofibre-hydrogel construct assembly 
Problem Solution 
The collagen hydrogel seal 
was ineffective at adhering the 
nanofibres to the construct 
The timings of cell seeding and seal addition to 
the constructs were altered to prevent the 
hydrogel mixing with any remaining cell seeding 
solution and form an ineffective seal as a result. 
Expense of experiments The construct size was reduced to save on the 
cost of materials, medium components and the 
volumes of antibodies required. 
Construct stability and 
mobility during transfer 
following assembly 
The area of the filter frame base was extended to 
provide a surface to hold the assembled construct 
during transfer with forceps. 
The hydrogel base broke apart 
during transfer  
The hydrogel that formed the base was applied 
in sections to prevent it from getting under the 
frame before curing.  
Issues containing the spread of 
fungal infection 
Petri dishes small enough to contain an 
individual construct were used for glial cell 
culture in favour of 6-24 well plates.  
Variability in production of the 
collagen hydrogel solution 
A lower stock concentration of collagen solution 
was used to produce the neutralised solution, and 
refinements were made to the storage and 
handling of the solution.  
Difficult to assess the 
elongation of individual cells 
when they are in contact with 
numerous other cells and 
nanofibres  
The density of cells and nanofibres used was 
reduced, to visualise the processes of single cells 
on individual nanofibres. 
The fluorescence intensity of 
immunostained cells was too 
faint for adequate detection 
The protocol was altered to allow for longer 
primary and secondary antibody incubations, at 
room temperature. 
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2.3.3.1. Order of the assembly protocol 
The main change made to the assembly protocol was re-ordering the timings of 
cell and nanofibre seal addition. The rationale for adding the cells before the 
completion of construct fabrication was to maximise the cellular attachment to the 
nanofibre sheet before any of the nanofibres had begun to descend into the hydrogel 
base. This was observed via light microscopy as discontinuous nanofibres across the 
base. However, this phenomenon was observed at least one hour after nanofibres 
were added, so there was ample time for the addition and attachment of cells. It was 
also hypothesised that the addition of the cells immediately following preparation 
from culture (trypsinisation and re-suspension) would ensure maximal viability of 
the seeded population. In practise, the viability of astrocytes remained optimal 
following three hours in suspension (and up to 30 min for OPCs), as confirmed by 
cells plated onto tissue culture-plastic controls.  
The final issues were associated with the difficulty of producing an effective 
nanofibre seal. After the cell seeding solution was applied onto the construct base it 
was very difficult to restrict the positioning of applied hydrogel to the perimeter of 
the cell seeding area, even following removal of the majority of the seeding volume. 
This reduced the area available for the assessment of cell-nanofibre interaction and 
the effectiveness of the seal to anchor the nanofibres to the construct, resulting in the 
detachment of the nanofibres from the construct upon removal of the supporting 
acetate frame (Figure 8A). In light of these findings, the cells were removed from 
the culture flask and resuspended at the required density whilst the hydrogel seal was 
cured in the incubator. The acetate frames were detached from the construct 
immediately afterwards and the finished constructs transferred into suitable container 
for the addition of the cells (Figure 8B). This protocol alteration had the following  
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Figure 8. Schematic flow diagrams illustrating the changes made to the timings 
of cell and nanofibre seal addition. (A) The existing methodology: (1) The 
construct base (pink) with a frame of aligned nanofibres (black) placed on top. (2) 
Cell seeding solution (gold) added over the construct seeding area. (3) After removal 
of the majority of the seeding solution, hydrogel was added around the perimeter of 
the seeding area, which flowed into the seeding area and formed a weak seal. (4) 
Detachment of the nanofibres from the construct following removal of the supporting 
acetate frame and transfer to a culture dish (circle). (B) Altered methodology: (1) 
Construct base with nanofibres. (2) Addition of the hydrogel to seal nanofibres. (3) 
Removal of acetate frames maintaining the aligned nanofibre configuration and 
construct transfer to a culture dish. (4) Addition of cells over the full area designated 
for cell addition.  
 
additional advantages: (i) any disruption to the cells and the nanofibres in the 
immediate time after seeding was kept to a minimum as the construct assembly had 
finished; (ii) the seal acted as an additional barrier maintaining the seeding volume in 
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place on the construct; (iii) the cells could be observed immediately after seeding as 
the PTFE block had been removed, thus allowing the initial cellular viability, 
attachment and elongation to be monitored; and (iv) the total time for construct 
production was reduced. 
 
2.3.3.2. Design of constructs 
The major technical problems experienced with the assembly of the initial 
constructs (Figure 9A) were attributed to their design, which was centred on the 
filter frame restricting the spread of the applied hydrogel to form a base with defined 
area. This component was re-designed to incorporate additional features and improve 
the reproducibility and ease of construct assembly. As a starting point, the 
dimensions of the constructs were reduced to permit culture and post-experimental 
staining inside a 6 well plate (Figure 9B) and to permit transfer to glass microscope 
slides for mounting and storage. With this design there was a combined decrease in 
the area of the cell seeding window and the area designated for binding the hydrogel 
base to the filter frame. However, sufficient room remained for the observation of 
cellular interactions with nanofibres. Another key design change was the increase to 
the length of the filter frame adjacent to the area designated for the hydrogel base. 
This increased the ratio of the total filter frame area to seeding window area with 
respect to the initial design tested (from 1.4 to 5.3), which gave the whole construct 
added stability following transfer to well plates for culture and post-culture staining. 
Elongated ‘tabs’ constituted a small section of the increased filter frame area and 
provided a surface to hold the assembled construct during transfer with forceps, 
which significantly reduced the disruption to the attached nanofibre-hydrogel 
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composite and enhanced the portability, overall quality and reproducibility of the 
constructs formed. The remaining area was used as a surface to cut the nanofibres 
prior to the detachment of the acetate frame from the constructs. It was found that the 
nanofibres remained adhered to the surface that they were cut onto; when this 
surface was the PTFE block surrounding the hydrogel base, removal of the block 
pulled on the nanofibres and detached them from the construct. Cutting the 
nanofibres on the filter frame itself ensured that they remained associated with the 
construct even if this occurred. Also, the area of the filter extensions was 
proportionally large compared to the size of the hydrogel base so that the nanofibres 
could be cut down on relatively far from the edge of the hydrogel base. This aimed 
to reduce the downward force acting on the fibres over the construct seeding area 
and prevent the nanofibres from sinking into the base due to this mechanism.  
Further refinements were made to the size of the constructs to reduce the costs 
associated with their culture and post-culture staining. In this context, a single well 
within a 24 well plate was considered to be the smallest chamber that a construct 
could be reproducibly fabricated to fit within (Figure 9C). All of the features from 
the previous filter frame design were kept, although the position of the tabs was 
rotated 90o in order to reduce the overall length. Also, the number of cells and the 
volume of the hydrogel base were reduced to reflect the size change. While the 
design of this construct was considered optimal, the tabs and the area for applying 
the nanofibre seal and cutting the nanofibres were all produced disproportionately 
small compared to the cell seeding window. This increased the difficulty of construct 
assembly and the incidences of error, which significantly affected the reproducibility 
of the constructs fabricated. Additionally, the development of a fungal infection 
during the culture period raised serious containment concerns about the culture of up  
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Figure 9. Schematic diagrams of the constructs produced at each stage of 
development, highlighting new features incorporated into the design of the filter 
paper frame. (A) The initial design of the construct, illustrating the seeding area 
(grey) with horizontally aligned nanofibres (black) and the surrounding area 
containing the collagen seal (pink). (B) The first prototype construct designed for 6-
well plates, featuring an elongated filter frame (purple) at the sides of the hydrogel 
base for cutting nanofibres onto and tabs at either end for construct transfer 
following fabrication. (C) The second prototype construct that was modified to fit 
24-well plates, with re-positioned tabs to minimise the total size. (D) The final 
construct design used for all construct experiments, modified to fit 12-well plates. 
(Sizes of all diagrams are relative; units in mm). 
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to 24 constructs in a single well plate, because potentially it could have spread across 
an entire batch of experiments. 
Additionally, in an attempt to further reduce the costs of chemicals and 
procedures used for these smaller constructs, the size of the nanofibre sheets was 
decreased in combination with the width of the frame border (from 5 to 1.5 mm). 
However, these alterations were found to have detrimental consequences on the 
fabrication procedure. The thinner acetate frame was significantly more flexible, 
which increased the difficulty of attaching and removing the frames to the mobile 
electrospinning collector to produce level nanofibre frames. Also the removal of the 
acetate frame from constructs was more demanding due to the reduction in the area 
surrounding the construct for cutting the nanofibres. Thus the original frame size was 
unaltered for all remaining construct designs and experiments. However, these 
nanofibre frames could be adhered onto much smaller Petri dishes than used 
previously, which significantly reduced the volume of culture medium required for 
the production of the controls without hydrogel. 
The constructs were re-sized a final time (Figure 9D) to permit their staining 
in 12 well plates and their culture within an individual, small Petri dish. In this 
context, the volumes of culture medium and immunostaining solutions required were 
considered reasonable. Furthermore, the use of individual dishes for each construct 
dramatically reduced the potential for the spread of infection between constructs in 
culture, maximising the number available from each batch for analysis in the event 
of any further infections arising. Also, this format reduced the duration that 
individual constructs were outside of the optimal culture conditions within the 
incubator reducing any deleterious effects caused by manipulation (e.g. medium 
changing, observation by light microscopy and post-culture fixation).  
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2.3.3.3. Preparation and use of collagen hydrogel  
The neutralised collagen hydrogel was identified as a critical factor to the 
quality and reproducibility of the constructs assembled. The successful production of 
the hydrogel solution was dependent on the addition of four distinct components 
together in accurate volumes ranging between millilitres to microlitres. Incorrectly 
measured components resulted in hydrogels that were too structurally weak to 
produce constructs after curing and displayed a blotchy appearance under both phase 
and fluorescence microscopy. This made the observation of cells and nanofibres 
during culture sub-optimal and increased the levels of background fluorescence in 
post-culture immunostaining. In this context, stock collagen concentrations at 3.5 
mg/mL were used, which had a relatively low viscosity compared to higher 
concentration solutions at 10.2 mg/mL and were easier to accurately measure 
volumes and mix with the other hydrogel components. Additionally, the added 
handling difficulties inherent with the higher stock concentration resulted in the 
introduction of bubbles into the final collagen solution, which were transferred into 
the produced constructs and further impacted on the visualisation of cells. Thus the 
lower stock concentration was used to produce the solution. Additionally, the final 
concentration of collagen hydrogel was varied to 2 mg/mL to validate the use of the 
3 mg/mL concentration in constructs for neural cell culture.133 However, construct 
production was less reproducible, the hydrogel was more difficult to manipulate and 
dispense into defined areas, and the structural integrity (important for building 
layered structures) was not maintained throughout the assembly and culture process. 
Additional protocol refinements with respect to the storage and handling of the 
neutralised hydrogel solution were implemented to maintain the homogeneity of the 
solution with time. The physical integrity of the solution appeared to deteriorate after 
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storage on ice (> 2h). Furthermore, a rise in solution temperature increased the time 
constraints during production because the solution began to cure. This was especially 
evident when the ambient temperature in the laboratory reached up to 34oC. Using 
compacted ice to chill both the hydrogel components and the neutralised hydrogel 
prevented the accumulation of air pockets within as it melted over time and 
maintained the solution at a constant temperature. The effects of high ambient 
laboratory temperature were overcome by restricting the length of time the solution 
was out of ice to a maximum of five min and the effects of body heat mitigated by 
using a rack to place the final hydrogel (and the components during production) in 
the culture hood. 
Following the production of a robust collagen hydrogel solution, refinements 
were made to the methods of applying the hydrogel to reproducibly form the 
construct base. Two critical features were the filter paper frame and the hydrophobic 
PTFE block. The latter was a hydrophobic, non-stick preparation surface that 
permitted the transfer of the construct after curing. It was found that the filter frame 
needed to be flush with the PTFE block otherwise a proportion of the hydrogel cured 
beneath the filter frame and contributed to the disintegration of the base during 
transfer off the PTFE block. This was achieved through the application of the 
hydrogel volume in numerous sections, firstly to the outer edges of the filter frame to 
hold it down onto the block and define the outer base boundary, followed by the 
remainder of the volume evenly across the middle. A reduction in the total volume of 
hydrogel used assisted the production of a level base, which helped disperse cells 
homogeneously over the seeding area. 
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2.3.3.4. Cell seeding 
The final optimisations made to the assembly of constructs were the density of 
cells seeded and the volume of solution applied onto constructs. To visualise the 
attachment of individual cells to nanofibres, the concentration of the cell seeding 
solution was reduced from the 2.5 x105 cells/mL applied initially to 1.0 x105 
cells/mL. The maximum volume of solution used for seeding onto constructs sized to 
fit within 12 well plates was 100 µL, but it was nonetheless difficult to maintain in 
position on the construct without it spilling over the edges before the cells had 
attached, which reduced the cell density. Conversely, cells were poorly distributed 
within volumes under 20 µL as the solution did not cover the entire seeding area. 
Thus, 60 µL was chosen as the optimal volume. Further, the solution was dispensed 
multiple times to control the distribution of the solution evenly over the seeding area, 
taking care to avoid contact with the nanofibres and the base hydrogel. Cells were 
seeded onto a similar sized area on tissue culture plastic to confirm cell density 
before application onto constructs. Cells were left to attach (2 h) before a larger 
volume of medium for culture was added. Cells were cultured on the initial 
constructs produced for approximately seven days, during which regular 
observations were made of the approximate percentage of cells aligned with 
nanofibres. It was found that four days of culture was a sufficient duration for greater 
than 95% of the astrocytes associated with nanofibres to have commenced 
elongation (ca 5% were associated with nanofibres without evidence of elongation). 
Thus mono-culture construct experiments were fixed at this time point for 
subsequent staining.  
An overview of the final optimised protocol for the assembly of single layer 
nanofibre-hydrogel constructs is shown in Figure 10. 
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Figure 10. Schematic diagram depicting the final, optimised protocol used for 
the production of single layer nanofibre-hydrogel constructs. (A) A 3 mg/mL 
collagen hydrogel was produced and kept chilled. (B) A frame of filter paper was 
placed on a block of PTFE. (C) Collagen hydrogel (125 µL) was applied across the 
filter frame to form the base of the construct. (D) One nanofibre frame was placed 
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over the base and collagen hydrogel (20 µL) was applied around the perimeter of 
the seeding area. (E) Nanofibres were cut around the base (blue dashed line) on the 
filter frame. (F) The acetate frame was removed and the construct transferred to a 
small-sized Petri dish for culture. (G) Cells (at 1 x105 cells/mL) were applied over 
the seeding area in a 60 µL volume. (H) Constructs ± nanofibres were incubated in 
antibodies at RT (primary: 24 h; secondary: 4 h) and transferred onto glass 
microscope slides with mounting medium (blue).  
 
2.3.4. Characterisation of single nanofibre layer mono-culture experiments 
(astrocytes or OPCs) 
Astrocytes seeded onto control hydrogel constructs without nanofibres 
generally maintained rounded morphologies over the observation period (Figure 
11A). In approximately 6% of astrocytes some evidence of process elongation was 
detected and one third of these cells assumed a bipolar morphology, which is 
possibly attributable to cellular attachment and elongation along straight sections of 
collagen fibrils. However, such cells had far shorter lengths and longer widths (ca 
fivefold lower aspect ratios) compared to those observed on nanofibre constructs.  
The alignment and fluorescence of nanofibres remained within the nanofibre-
hydrogel constructs after post-culture processing (Figure 11B). Furthermore, the 
fluorescence was still visible following storage at 4oC for at least two years. 
Following the addition of astrocytes onto nanofibre-hydrogel constructs, cells 
initially displayed rounded morphologies characteristic of detached cells, but 
associated and attached to nanofibres by 15 min. Approximately 25% of the seeded 
population displayed evidence of elongation within two hours and both glial 
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fibrillary acidic protein-positive (GFAP+) type I and II astrocytes could be observed 
in the cultures. Type II astrocytes are derived from OPCs and characteristically 
contain a smaller cell body and thinner processes, with considerably more processes 
than type I astrocytes. Significant cellular alignment with evidence of cell 
proliferation on nanofibres was observed over the following four days (Figure 11C 
& inset). The aspect ratios of individual astrocytes cultured on nanofibre-hydrogel 
constructs exhibited higher median values with a considerably wider distribution 
compared to control constructs (Figure 11D). On average, the length of aligned 
astrocytes was approximately 15 times greater than their width and six times the 
length of astrocytes on control hydrogel constructs. 
Strikingly, OPC mono-cultures lacked evidence of elongation at all time points 
in both control and nanofibre-hydrogel constructs. Extensive attachment of cells to 
nanofibres was observed by four days (> 80%). However, the majority of cells 
appeared rounded and phase dark, with extensive cell clumping and debris, 
suggestive of cell death (Figure 12). This was found irrespective of whether OPCs 
were cultured in maintenance medium, which is a chemically-defined medium that 
maintains OPCs in culture, or D10 medium, used to culture astrocytes, microglia and 
parent mixed glial cultures, and typically results in the differentiation of OPCs into 
mature oligodendrocytes. 
  
72 
 
 
Figure 11. Aligned nanofibre-hydrogel constructs support astrocyte 
proliferation, alignment and elongation. (A) Fluorescence micrograph of GFAP+ 
astrocytes following culture on control hydrogel constructs for four days. (B) 
Fluorescence micrograph illustrating the alignment and retention of fluorescence by 
nanofibres within the collagen-hydrogel constructs during the post-culture period 
(white arrowheads demarcate nuclei of some astrocytes associated with nanofibres). 
(C) Fluorescence micrographs of the proliferation (inset) and elongation of 
astrocytes over the four day culture period. (D) Aspect ratios of individual astrocytes 
cultured on control constructs versus nanofibre-hydrogel constructs. 
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Figure 12. OPC viability was poor on constructs ± nanofibres. A typical phase-
contrast micrograph showing the majority of OPCs cultured on constructs with 
aligned nanofibres (white arrows) as rounded and phase dark, with extensive cell 
clumping and debris (white arrowheads). 
 
2.3.5. Development of seeding and staining protocols for multicellular construct 
assembly 
Strategically, OPCs were sequentially seeded onto constructs with a bed layer 
of pre-aligned astrocytes following two days of culture and co-cultured for a further 
two days to permit the attachment and alignment of OPCs to the nanofibres for 
analysis of cellular aspect ratios. In pilot experiments, OPCs and astrocytes 
simultaneously seeded onto constructs displayed poor viability in the initial 48 
hours, although they recovered after six days of co-culture. However, sequentially 
seeding the cells produced viable cultures from the start and eliminated the presence 
of cellular debris from the seeding area, which improved the quality of 
immunostaining for the imaging of constructs. The density of OPCs seeded was the 
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same for the astrocyte and OPC mono-cultures, as there was judged to be sufficient 
space surrounding the astrocytes in order to visualise the attachment and elongation 
of single cells along individual nanofibres. However, it was found that a 60 µL 
seeding volume was too difficult to maintain in position on the seeding window as 
the constructs were wet following the culture of astrocytes. Therefore the seeding 
volume was reduced to 30 µL and the density of cells doubled to 2 x105 cells/mL, 
which was used as the standard protocol for the addition of cells to constructs used 
previously for cell culture. The immunostaining of co-cultures found cross-
specificity of A2B5 antibodies for OPCs and astrocytes (a problem faced with many 
of the markers for neuroglia at various developmental stages). However, the strength 
of the fluorescence signal was considerably lower for GFAP+ astrocytes than for 
OPCs, and thus it was easy to distinguish respective neuroglial sub-populations after 
merging micrographs of the red and green channels together. Additionally, it was 
important that fluorescent nanofibres were used for the analysis of OPC aspect ratios 
in order to identify cells unattached to nanofibres, since OPCs typically display a 
bipolar morphology on tissue culture plastic, which could have confounded the 
measurements of OPCs elongated on nanofibres alone. Although both nanofibres and 
OPCs were captured using the same fluorescence channel (red), it was still possible 
to accurately distinguish cellular processes from nanofibres, the latter being 
significantly narrower under high magnification. 
The length of some co-cultures (in nanofibre-hydrogel constructs only) was 
extended for an additional six days (total duration of co-culture eight days), to 
confirm if the constructs could support the development of multiple cell types 
[importantly the differentiation of OPCs into mature myelin basic protein-positive 
(MBP+) oligodendrocytes] and to visualise the interaction of more established co-
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cultures with the topographical cues provided by the nanofibres. For identification, 
GFAP+ astrocytes and mature MBP+ oligodendrocytes produced two separate 
immunostaining profiles with greater morphological differences between them than 
astrocytes and OPCs.  
As a final level of complexity, microglia were cultured with astrocyte-OPC co-
cultures to produce proof-of-concept ‘mixed glial constructs’ containing all of the 
supporting neuroglial sub-classes together. However, the production of these 
constructs further increased the difficulty of simultaneously imaging all the cell 
types present, as only three fluorescence channels were available. In the first instance 
a commercial cell staining kit was tested, with the rationale that each cell could be 
labelled with a separate dye before seeding onto the constructs. The kit consisted of 
three carbocyanine dye solutions (DiI, DiD and DiO), each with a different 
fluorescent colour. Each dye is lipophilic, so they were separately incubated with 
cells in suspension. Optimal incubation lengths were determined with astrocytes and 
DiD, as a basis for the remaining neuroglial cell sub-types and dyes, with 
performance readouts of extent of membranous labelling and the intensity of 
fluorescence signal observed. At 20 min of incubation the cellular staining was 
punctate, which was also verified with OPCs stained with the DiO dye. Also 
fluorescence bleed-through from the red/green channel was observed, which was 
increased at 25 min. Although, evidence of elongated stained cells was observed by 
24 hours, the aforementioned problems, in addition to the inherent reduction in 
signal strength with continued culture and cellular proliferation, suggests the use of 
these dyes are ineffective and unsuitable for identifying multiple cell populations 
after short-term culture on constructs. A relatively simple solution to the overall 
imaging problem was the labelling of the nuclei of microglia with DAPI (a robust 
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and widely-used stain) before seeding onto mature, eight day co-cultures, containing 
multiple neuroglial subtypes that had been successfully imaged previously. To a 
suspension of microglia in culture medium, DAPI was initially added at 20 µg/mL, 
incubated for 15 min and re-suspended twice in fresh medium. However, the DAPI 
leached into the surrounding cells during the culture period (4 h), so the 
concentration was reduced to 10 µg/mL, the incubation time increased to 20 min and 
a further re-suspension in fresh medium performed to remove any remaining dye. No 
leaching was subsequently found and microglia had attached with some evidence of 
elongation four hours post-seeding. Constructs were fixed, stained and placed on 
glass slides in mounting medium without DAPI. 
 
2.3.6. Characterisation of single nanofibre layer co-culture experiments 
(astrocytes and OPCs ± microglia) 
The majority of OPCs seeded on control hydrogel constructs containing 
astrocytes pre-seeded for two days displayed rounded morphologies and lacked 
bipolarity (Figure 13A). By contrast, the addition of OPCs to nanofibre-hydrogel 
constructs containing pre-aligned astrocytes dramatically promoted OPC survival, 
attachment and elongation over the subsequent two days of co-culture. Cells with the 
distinctive bipolar morphology of OPCs with evidence of cell proliferation on 
nanofibres could be clearly observed from 24 h (Figure 13B & inset). An analysis of 
the aspect ratios of individual OPCs co-cultured with astrocytes shows 
morphological profiles similar to aligned astrocytes (Figure 13C). Classification of 
the distributions of astrocyte and OPC aspect ratios (Figure 13D) reveals a greater 
proportion of astrocytes displaying ‘high’ aspect ratios. The bipolar profiles of OPCs 
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 Figure 13. Increasing the cellular complexity of nanofibre-hydrogel constructs. 
(A) Fluorescence micrograph of control hydrogel constructs pre-seeded with GFAP+ 
astrocytes for two days, followed by two days of co-culture with A2B5+ OPCs. (B) 
Fluorescence micrographs of OPCs and pre-seeded astrocytes on nanofibre-
hydrogel constructs cultured for the same time as controls (inset showing OPC 
proliferation). Note the bipolar phenotype of the precursor cells. (C). Aspect ratios 
of individual OPCs cultured on nanofibre-hydrogel constructs containing pre-
aligned astrocytes. (D) Classification of the aspect ratios of astrocytes and OPCs 
cultured on nanofibre-hydrogel constructs. (E) Fluorescence micrographs after eight 
days of co-culture, showing the co-existence of astrocytes and oligodendrocytes on 
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nanofibre-hydrogel constructs with presence of complex, highly processed, 
membrane-elaborating phenotypes, characteristic of mature oligodendrocytes (for 
comparison, see precursor forms in Figure 13B). White arrows indicate potential 
contacts between aligned oligodendrocytes and astrocytes. (Inset) Clear 
morphological distinction between type II astrocytes (green arrowhead; left), type I 
astrocytes (white arrow; centre), and oligodendrocytes (red diamond arrow; right) 
within the same microscopic field. (F) Fluorescence micrograph demonstrating the 
assembly of mixed glial constructs, containing both GFAP+ type I and type II 
astrocytes, MBP+ oligodendrocytes and DAPI-stained microglia. 
 
with ‘low’ aspect ratios were more distinguished than the counterpart profiles of type 
I astrocytes, typically containing much finer processes that accentuated the circular 
shape of the cell body. When the period of astrocyte-OPC co-culture was extended to 
eight days, OPCs displayed the potential to differentiate into complex process-
bearing MBP+ oligodendrocytes elaborating large sheets of membrane. Such cells 
appeared to contact both nanofibres and pre-aligned astrocytes (Figure 13E). 
Astrocytes with distinct type I and II morphologies could also be found (Figure 13E 
inset). Additionally, it was feasible to further enhance the cellular complexity of the 
constructs with seeded primary microglial cells that showed significant attachment 
and survival following co-culture with the above glial populations over a four hour 
culture period (Figure 13F). 
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2.3.7. Scale-up and optimisation of 3-D constructs containing multiple layers of 
nanofibres 
 
2.3.7.1. Optimisation of construct assembly 
The filter frame and the hydrogel base of the multiple layer constructs were 
kept identical to that optimised for single layer constructs (12-well plate design size). 
A template was made for the reproducible production of the spacers, as inaccuracies 
in their shape increased the difficulty of placing them in the correct position around 
the cell seeding window of the filter frame. With regards to the nanofibre meshes 
fabricated, the nanofibres remained on a level plane following storage but the acetate 
frames per se were found to contort parallel to the direction of nanofibre alignment 
(Figure 14A). When placed over the base, the elasticity of the acetate frames made 
them spatially unstable which prevented the reproducible layering of the meshes and 
the accurate application of defined volumes of seeding solution. A second acetate 
frame was adhered to the underside of the nanofibre frame to decrease the flexibility 
and to keep the whole nanofibre frame level (Figure 14B). An added benefit of the 
second frame was that it shielded the forceps from the adhesive, which adhered to 
the forceps as a repercussion of using more adhesive to hold the high density meshes 
in place (compared to nanofibre sheets) and increased the difficulty of placement 
over the construct. Thus these modified nanofibre frames were significantly easier to 
use during the assembly protocol and improved the reproducibility of the constructs 
formed.  
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Figure 14. Improving acetate frame stability to fabricate multiple layer 
nanofibre-hydrogel constructs. (A) Nanofibre meshes were adhered to a single 
acetate frame and found to contort parallel to the direction of nanofibre alignment 
(white arrow). The extra adhesive applied (in comparison with frames containing 
nanofibre sheets) adhered the frame to the forceps (white arrowhead). (B) Joining 
another acetate frame to the nanofibre meshes stabilised the frames during storage 
and shielded the adhesive from the forceps (white arrowhead), so that the frames 
could be placed over constructs easily. 
 
2.3.7.2. Development of a sequential cell seeding protocol 
Astrocytes were seeded immediately following the placement of each 
nanofibre mesh layer onto constructs. It was found that doubling the number of cells 
applied per layer to 1.2 x104, from 6 x103 in single layer construct experiments, 
aided the visualisation of cellular alignment across multiple nanofibre layers. The 
increase in nanofibre line density compared to single layer constructs produced a 
more hydrophobic surface, which helped sequester the seeding solution of 60 µL 
over the seeding area. However, this concurrently increased the technical difficulty 
of spreading the solution, so approximately half was applied first to wet the area. The 
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technical difficulty associated with performing this step increased for the nanofibre 
mesh layers applied thereafter, as they were loosely suspended over the base. 
Additionally, there was a tendency for the solution to penetrate through to the mesh 
layer/s underneath, which occasionally occurred before the volume had been spread 
over the whole seeding area. An increase in seeding volume to 120 µL (at half the 
cell concentration) for the second and third layers ensured there was enough volume 
to apply over the seeding area when this occurred, but not too much in total that it 
overflowed from the construct. The seeding solutions required removal with an 
aspirator tip applied to the edge of the base filter frame after incubation, prior to the 
addition of the next nanofibre layer, to prevent the flow of solution off the construct. 
Cells were seeded onto each layer at intervals ranging between 40 to 120 min, 
although the former duration was considered long enough to permit the attachment 
of cells without unnecessarily increasing the total duration that the cells were kept in 
suspension, for seeding onto the final layer.  
Three hours after seeding cells, 200 µL of collagen hydrogel was added over 
the top nanofibre layer to stabilise the multiple layered structure. This was two hours 
later than initially anticipated to facilitate the attachment of cells to the nanofibres in 
each layer. The use of the aspirator to remove the final seeding solution critically 
prevented the dilution of the hydrogel, facilitating the formation of a solid construct. 
It was advantageous to leave the hydrogel for two hours before the acetate frames 
were detached from the constructs, to ensure the hydrogel had fully cured and to 
reduce the duration before culture medium was applied, maximising cell viability 
and the hydration of the construct for culture.  
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2.3.7.3. Development of a nanofibre frame cutting tool  
A scalpel was used to detach the nanofibre mesh layers from the acetate frames 
with the same technique applied for constructs containing a single nanofibre sheet 
layer. However, this was a challenging step due to the large increase in the number 
of nanofibres compared with nanofibre sheets, as a result of the increased line 
density and the number of layers. This influenced the reproducibility of nanofibre 
detachment from the acetate frames, which resulted in disruption to the nanofibre 
configuration within the construct following frame removal. The extra stability 
provided by the relatively large volume of hydrogel used to seal the nanofibres, 
compared to single layer constructs, failed to prevent this disruption from occurring. 
Thus, a tool was designed to surround the entire construct and cut down on all of the 
nanofibres at once. Furthermore, with the tool pressed down it could protect the 
nanofibres attached to the construct, allowing a scalpel to be used in conjunction to 
ensure the complete the detachment of all nanofibres around the perimeter of the tool 
before frame removal. Additionally, to maintain the sterility of cultures the tool 
needed to be autoclavable and to maintain physical integrity following repeated 
cycles. The simplest design conceived was four single-edged razor blades fixed in a 
perpendicular arrangement (Figure 15A). The blades were orientated with the sharp 
edges on the bottom to press the tool down from above and the blades were 
positioned relative to the size of the construct, the PTFE block and the acetate frame 
(Figure 15B). The detachment of the nanofibres on the PTFE block, compared with 
the specially designed sections of elongated filter frame (introduced during the 
optimisation of single layer nanofibre-hydrogel constructs) did not result in 
nanofibre detachment and a disruption to the aligned configuration. This is likely to 
be due to the significantly increased line density of the meshes and the increased 
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support provided by the hydrogel over the construct area. The tool was autoclaved 
several times and there was no evidence that the integrity was compromised (e.g. 
blades altering position). Overall the tool and the modified procedure prevented any 
incidences of nanofibres remaining attached to the acetate frames in this step of the 
construct assembly.  
 
 
Figure 15. The design of an in-house produced tool to reproducibly cut multiple 
layers of stacked nanofibre meshes from their acetate frames following collagen 
construct assembly. (A) Schematic of the tool consisting of four, single-edged razor 
blades (grey) that were joined together in a perpendicular arrangement. The metal 
spine (blue) on the top of the blades allowed the tool to be pressed downwards. (B) 
Schematic from the position above a partly assembled construct: the tool (blue) 
placed on a PTFE block (white) around the outside perimeter of a multiple layer 
nanofibre-hydrogel construct (pink) to detach the perpendicularly stacked nanofibre 
meshes (red) from the surrounding acetate frames (grey). 
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2.3.7.4. Staining and imaging constructs 
A three layer nanofibre-hydrogel construct was fixed, immunostained and 
mounted in a pilot experiment, using the same protocol as that optimised for single 
layer constructs. The main differences found were the use of considerably greater 
volumes of mounting medium and coverslip sealant, as a result of the greater 
thickness of the construct. Despite the satisfactory quality of the immunostaining and 
visualisation of cells on each layer (Figure 16), the use of a live/dead cell viability 
kit was the preferred option because it: (i) was a more inexpensive staining technique 
compared to immunocytochemical staining; (ii) was technically easier and quicker to 
perform; and (iii) gave an added readout of cellular viability after the two week 
culture period.  
 
 
Figure 16. Constructs containing astrocytes seeded over three distinct (stacked) 
nanofibre layers (orientated in a perpendicular configuration) were successfully 
immunostained and mounted on a glass coverslip. 
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2.3.8. Characterisation of multilayer scaffold experiments 
A photograph of the final three layer construct produced is shown in Figure 
17A. Astrocytes were successfully seeded sequentially onto multiple, stacked 
nanofibre layers (Figure 17B). Clear spatial separation of the individual nanofibre 
layers in perpendicular arrangements and associated astrocyte alignment could be 
detected in all three layers (Figure 17C). Nanofibre detachment was rarely observed 
and astrocytes were viable in all three layers (> ca 70% cell viability). 
 
 
Figure 17. The alignment of astrocytes over multiple nanofibre mesh layers 
demonstrates the potential to increase the complexity of the produced 
constructs. (A) Photograph of the assembled three nanofibre layer construct. (B) 
Phase micrograph of the nanofibre meshes, stacked perpendicularly in constructs. 
(C) Superimposed fluorescence micrographs of the three nanofibre mesh layers 
taken at depths of 30, 120 and 250 µm, showing live/dead stained astrocytes after 
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two weeks of culture. Cellular alignment with three distinct (stacked) nanofibre 
layers orientated perpendicular to each other is observed. 
 
2.4. Discussion 
This is the first report of a nanofabricated 3-D scaffold for neural applications 
with the nanofibres arranged through the depth of the structure as the principal 
topographical cue. It represents an enhanced order of spatial complexity compared to 
other nanofibre scaffolds reported to-date.54 Additionally, for the first time, primary 
astrocytes and cells of the oligodendroglial lineage were co-cultured together on 
nanofibre scaffolds by exploiting the ability to co-culture neuroglial cells, generated 
from mixed glial cultures, within a single medium. Both the astrocytes and OPCs 
survived, proliferated and aligned with the nanofibres in co-culture, attaining lengths 
far greater in magnitude than previous reports.60,139 This illustrates the strong 
potential of nanofibres as a strategy to promote the directional growth of a range of 
glial cell types. The significant attachment and survival of seeded primary microglial 
cells to the constructs containing co-cultured astrocytes and oligodendroglia 
demonstrates the potential to further enhance the cellular complexity, producing a 
complete system of CNS supporting glia. The potential to scale up the co-cultures 
with the alignment of astrocytes over multiple stacked nanofibre layers further 
demonstrates the utility of the technique for neuro-regenerative applications.  
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2.4.1. Optimisation of nanofibre-hydrogel construct assembly for neuroglial cell 
culture 
It was clear from the pilot studies that the existing assembly methodology and 
design of nanofibre-hydrogel constructs required optimisation. The identification of 
factors that were critical to the viability of cells and their interaction with nanofibres 
prompted a change in the sequence of steps to orchestrate a reproducible and 
efficient assembly procedure. The design features added to the filter frame reduced 
incidences of experimental error inherent in the more challenging methodological 
steps, whilst the reduction in filter size facilitated the culture of constructs in smaller 
chambers, thereby reducing the costs of production, culture and staining. 
Refinements made to the basic storage and handling of the collagen hydrogel 
enhanced the quality and robustness of assembled constructs, and reduced the 
influence of the ambient temperature on reproducibility. The in-house produced 
nanofibre mesh cutting device was an effective solution to simplify the task of 
detaching the multiple layers of nanofibre meshes from their acetate frames, whilst 
preserving the aligned arrangement of nanofibres within the construct. Further, it 
highlights the opportunity to design novel, bespoke tools and solutions to improve 
the reproducibility of more difficult procedures. The final innovation was the 
production of fluorescent nanofibres to facilitate the visualisation of cellular 
attachment and alignment with the topographical cue, which was invaluable for the 
optimisation of construct design and performance and the robust analysis of cell 
aspect ratio. Additionally, it facilitated the identification of cells that were 
unattached to the nanofibres but had elongated parallel to the orientation of nanofibre 
alignment from the analysis, thus eliminating incidences of type I statistical error. 
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2.4.2. The contrasting viability of OPC and astrocyte mono-cultures   
The survival/elongation of OPCs seeded as a single population on both 
nanofibre-hydrogel constructs and control hydrogels was limited and the reasons for 
this are unclear. OPCs have previously been cultured on nanofibres as mono-
cultures, with survival and differentiation into mature MBP+ oligodendrocytes (albeit 
on 2-D coverslips).147,148 Furthermore, the observation that the majority of astrocyte 
and OPC co-cultures on control hydrogel constructs remained rounded with a failure 
to extend processes suggests that the collagen hydrogel per se could have been an 
unfavourable environment for growth. This may be related, at least in part, to the 
compliance of the hydrogel substrate. Previous reports have shown that astrocytes 
show normal assembly and organisation of the actin cytoskeleton, with a larger area 
of spread, on less compliant culture substrates (greater than c.a. 2 kPa), compared to 
softer substrates below 1 kPa where the cells appear rounded and viability is 
significantly reduced.149 This is also in accordance with the rapid attachment to 
coated tissue culture plastic that has a high stiffness150 and the formation of the 
astrocyte bed layer in mixed glial cultures.146 It is reasonable to assume that the 
nanofibres provided a stiffer substrate for support of the astrocytes and therefore the 
improved viability was observed on nanofibre-hydrogel constructs compared to 
controls without nanofibres, as judged by evidence of proliferation and extensive 
elongation of processes on nanofibres versus the controls that showed morphologies 
typical of astrocytes cultured on compliant surfaces. The Young’s elastic modulus of 
the 3 mg/mL collagen hydrogel ± nanofibres requires testing in order to further 
corroborate this hypothesis and characterise the interactions with the cultured cell 
populations. Interestingly the optimal substrate compliance for the survival and 
proliferation of OPCs in vitro is ≤1 kPa,151 which falls within the range where 
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astrocytes exhibited poor survival. Furthermore, the outgrowth of DRG neurites 
grown on 3-D gels is optimal at very low compliances comparable to that of CNS 
tissue,149 so it demonstrates the need to co-culture mixed populations of neuroglia 
with neurons to determine the optimal substrate compliance for all the cells to co-
exist in culture together. Nonetheless, the significant survival and alignment shown 
by OPCs following co-culture with astrocytes is an observation that is consistent 
with the major supporting roles played by astrocytes in vivo152 and in mixed glial 
cultures as the supporting bed layer,146 suggesting that aligned astrocytes may 
provide survival cues for OPCs. Indeed, platelet-derived growth factor and leukemia 
inhibitory factor present within astrocyte conditioned medium have been shown to 
promote the survival of OPCs in vitro153 and insulin-like growth factor-1,154 ciliary 
neurotrophic factor155 and neurotrophin-3156 of astrocyte origin have all separately 
been shown to support OPC survival.  
 
2.4.3. Increasing the complexity: towards the development of a 3-D 
multicellular implantable scaffold for repair of SCI 
Repair strategies consisting of scaffolds with aligned topographical features, in 
combination with therapeutic cell populations have the potential to direct and 
enhance the otherwise randomly orientated, limited growth of spared nerve fibres 
from the margins of spinal cord lesions. In the initial development and testing of 
various aligned scaffolds, populations of cultured astrocytes are commonly used: as a 
promising cell type for transplant therapies; as a predictor of material compatibility 
for the culture of neural cells; and for assessing the potential of the material to align 
neural cells. However, there has been little focus on aligning the other supporting 
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glial cell populations, such as the cells of the oligodendrocyte lineage, which is 
surprising given the neuroprotective effects exerted by oligodendrocytes and their 
potential to enhance functional recovery through myelination of regenerating nerve 
fibres. Furthermore, aligned Schwann cells have been shown to enhance peripheral 
neuronal cell migration and myelination.157 
In this study, astrocytes aligned with nanofibres showed a far wider 
distribution of aspect ratios and higher median values than previous reports and the 
OPCs showed a similarly high potential for alignment and elongation. This 
corroborates previous results that have demonstrated aligned nanofibre scaffolds are 
particularly capable of enhancing the directional growth of supporting neural 
cells.60,68,127 Increasing the spread of the glial cell populations over the length of the 
construct should maximise their availability for interaction with host regenerating 
nerve fibres across lesion sites. The populations of astrocytes and mature 
oligodendroglia present following the extended culture period suggest that the 
constructs have significant capacity to support the growth and development of a 
range of neural cell types. Further investigation is required to determine whether a 
sub-population of OPCs remained on the constructs and the proportions that 
differentiated towards mature oligodendrocytes or type II astrocytes. 
The attachment of microglia to the constructs further enhanced the glial 
complexity achieved, producing a complete and potentially repair-mediating 
neuroglial cell supporting system. However, to test the potential in relevant models 
of SCI, further work is required to replicate the glial cell co-cultures over multiple 
nanofibre layers, towards the production of an implantable device. Proof that the 
number of constituent, stacked nanofibre layers could be scaled up was demonstrated 
with the alignment of astrocytes over three nanofibre mesh layers. However, to 
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increase the spatial complexity of constructs intended for SCI models in vivo, the 
nanofibre packing density would need to be much lower to permit the infiltration of 
host tissue within each layer. Further, these multiple layer constructs would require 
pre-assembly in order to increase the cellular complexity, using the sequential 
seeding protocol for the production of mixed glial constructs. In this context, other 
seeding protocols could be investigated as alternatives to obtain maximal glial cell 
viability, such as the simultaneous seeding of all the cell populations within the 
hydrogel seal itself.133 Following the optimisation of these steps, further work is 
required to process the constructs into an implantable form. This includes plastic 
compression of the constructs, which essentially expels a large quantity of excess 
fluid within the collagen hydrogels, drastically increasing the density of cells and 
collagen within the construct whilst reducing the overall thickness.158 Further 
viability testing would be required following this step, although previous findings 
have shown that the impact of this technique was minimal on astrocyte populations 
within hydrogels.60 Removal of the filter frame and the rolling of the constructs into 
a tight tube would constitute the final stage in preparation before insertion into a 
relevant injury model.  
 
2.4.4. Conclusions 
It is feasible to enhance the complexity of nanofibre-based constructs to 
include multiple elongated, glial cell populations and scale-up the number of 
constituent nanofibre layers. The next chapter builds on the theme of enhancing 
spatial and cellular complexity, by developing a 3-D, multicellular in vitro model of 
SCI that replicates cardinal features of injury in vivo for screening the regeneration-
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promoting capacity of combinatorial repair strategies, such as the construct 
developed here.a 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
a A considerable amount of data in this chapter has been accepted for publication by 
Nanomedicine (NBM). The article is included here as Appendix 1. Also an image 
from the study was used as Biomedical Picture of the Day, included as Appendix 2.   
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Chapter 3: Development of a complex 3-D 
in vitro model of SCI  
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3.1. Introduction 
The absence of significant functional recovery following SCI is due to the 
inhibitory environment that is non-permissive to axonal outgrowth and the limited 
intrinsic repair capacity of the spinal cord. As discussed in section 1.1.2, a 
mechanical insult to the vertebral column in the form of a blunt force or penetrating 
object causes the primary injury to the spinal cord. Possible mechanisms of injury 
include: shear or compressive forces; dislocation; fracture; and laceration. The extent 
of the structural damage induced is dependent on the particular mechanism, but 
generally includes a combination of the severing of axons; disruption to the vascular 
system, leading to more wide-spread swelling and ischemia; and the necrosis of 
neurons and glia. The disruption initiates a range of pathophysiological changes that 
progress in both rostral and caudal directions from the lesion epicentre over the 
following days to months, termed the secondary injury.18 With respect to the 
stereotypical cellular responses following the primary injury, microglia, the immune-
competent cells of the CNS, become activated in response to the damage. They 
display ‘activated’ morphologies (characteristically rounded phenotypes, in contrast 
to ‘resting’ microglia with multiple ramified processes), release pro-inflammatory 
cytokines and infiltrate lesion sites, where they are responsible for the phagocytosis 
of cellular debris and toxic substances.21,22 Astrocytes, which perform many 
homeostatic roles crucial for the optimal function of the nervous system, become 
hypertrophic, proliferate and upregulate expression of GFAP within and adjacent to 
lesions, to form a scar which constitutes a critical physical barrier to axonal 
regeneration.26 Neurons undergo necrosis and Wallerian degeneration due to the 
primary insult, the unfavourable extracellular environment (excitotoxicity, ionic 
dysregulation, free radicals and factors secreted by cells)14,19 and a lack of trophic 
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support resulting from the demyelination of nerve fibres.159 Limited, spontaneous 
sprouting of nerve fibres may occur from lesion margins, although the extent and 
duration is dependent on the particular neuronal tract and the age of the animal.160 
Over 100 years have passed since the first experiments were performed in 
animals to re-create SCI in the controlled setting of a laboratory.161 Complex 
experimental models of SCI in live animals mimic the biological sequelae of human 
SCI, and have therefore been essential to our understanding of the intricate 
pathological mechanisms that cause chronic injury. Furthermore, modern pre-clinical 
injury models have shown the potential of synthetic constructs within the field of 
regenerative medicine to enhance repair following delivery into sites of injury.99,162 
These preliminary readouts of safety, mechanism(s) of action, and functional and 
behavioural improvements are necessary for further development and optimisation of 
constructs prior to first-in-man studies. The injuries that current models can mimic 
are: compression and/or contusion; complete or partial transection; and ischemia. 
Compressive/contusive injuries are seen most commonly in patients and therefore 
have the widest clinical relevance.11 However, each different model has its own 
specific advantages. Transecting injuries provide the most effective testbed for 
assessing anatomical regeneration of axons and readily permit the implantation of 
synthetic devices of a defined size, while ischemic insults produce a unique type of 
injury, often leading to paraplegia, spasticity and rigidity.163 
It should be noted that there are several ethical and practical drawbacks 
relating to animal experimentation in the context of neurological injury. The 
production of such injury models can be a highly invasive and time consuming 
process, usually requiring high technical expertise. Depending on the model, the 
procedures can result in serious adverse effects such as infections, paralysis or 
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movement disorders, bladder dysfunction and so on.164 Even in the hands of a skilled 
operator, surgical procedures can inherently generate significant inter-animal 
variability, requiring large animal group sizes for statistical validity.164 Following 
lesion induction, introduction of synthetic constructs into injury areas usually 
requires re-anesthetization, with the second procedure involving similar risks to the 
induction of the original injury. In vivo models necessitate the use of analgesia and 
rigorous post-operative monitoring of animals, which must be housed 
individually.119 The requirements for specialist staff and infrastructure in particular, 
place major financial constraints on such work.165,166 All of these considerations have 
prompted the global drive for the Reduction, Replacement and Refinement of animal 
experimentation (the 3R’s principle).167 In particular, there is a major current need to 
develop facile, high-throughput in vitro models that mimic pathological features of 
injury sites in vivo (and therefore have biological validity), in order to reduce animal 
usage and suffering, as well as costs and technical difficulty, thereby facilitating the 
screening of pro-regenerative materials.  
Despite the need for such biologically-relevant testing systems, ‘reductionist 
models’ described to-date typically lack the ability to mimic multi-faceted 
components of SCI pathology and the complexities of cytoarchitecture in vivo.11 The 
CNS is a particularly challenging tissue system in this regard, due to the complex 
cellular dynamics and intricate (cardinal) pathophysiological events displayed after 
neurological injury, as detailed above. Nonetheless, 2-D reductionist tools in current 
widespread use, e.g. microfluidic devices, have provided useful insights for tissue 
engineering, as these permit the study of fundamental, isolated aspects of neuronal 
regeneration and response to materials/biomolecules post-injury,41,42 without the 
potentially confounding reactions of other cell types. Additionally, reports 
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demonstrating the ability to increase the complexity of the culture systems, e.g. 
spatial complexity,168,169 show the integrity of such injury paradigms and the value of 
their predictions, despite the differences in complexity compared to live animal SCI 
models. 
Multicellular, 3-D organotypic slice cultures (slices of immature tissue that 
develop comparably to the donor organ in an ex vivo environment) could offer a 
solution to the above challenges. For example, such tissue arrays are increasingly 
being used for long term, high throughput assays in experimental neurology.170 They 
provide a versatile bridge between isolated cell culture and in vivo experiments 
(Figure 1) wherein the cytoarchitecture of the tissue and structural relationships of 
cells are maintained, allowing for parameters of neural regeneration, e.g. neuronal 
survival,171 nerve fibre regeneration,172,173 and collateral axon sprouting to be 
evaluated.174 These models offer several advantages including the ease of 
manipulation/observation of in vitro preparations.170 Various ages, neuroanatomical 
areas and species, including human foetuses175 and transgenic models,176,177 can be 
used as tissue donor sources, offering high flexibility to study neural pathologies and 
disease mechanisms.  
 
 
Figure 1. The complexity of published SCI models. Schematic illustrating the 
relative complexities of SCI models. 
98 
 
Slice cultures are amenable to electrophysiological techniques,178 molecular 
biology methods,179 time lapse video microscopy180 and dynamic confocal 
imaging,166,181,182 which has greatly expanded the utility of this approach. Indeed, 
lesioned organotypic spinal cord slice cultures have been generated as a higher-
throughput tool to study specific mechanisms of injury and predict in vivo responses 
to pharmacological agents.44,166 A summary of the advantages and disadvantages of 
experimental SCI models is given in Table 1.
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Table 1. Qualitative comparison of experimental SCI models 
Model Advantages Disadvantages 
In vitro Can establish initial cellular responses to various factors/conditions 
for proof-of-principle and further development 
Lack of complexity limits the predictive value 
Most inexpensive models 
Examine mechanisms underlying injury and regeneration in 
isolation 
Technically simple and rapid to generate 
Limited ethical issues 
Can be monitored in real time 
No regulatory permissions required 
Organotypic 
slice cultures 
3-D slices possess a relevant in vivo neurocytoarchitecture and 
ECM structure 
Contain limited vascular components (i.e. blood brain 
barrier) 
Contain multiple cell populations Lack of a blood supply (no circulating component of the 
immune system in response to injury)  
Facile culture and maintenance of multiple slices for weeks/months  
Can model adult human tissues in development, injury and repair 
Provides a way of reducing animal usage, according to the 3R’s 
principle of animal use in experimentation 
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Model Advantages Disadvantages 
 Limited ethical issues  
Can be monitored in real time 
Animal 
models 
Evaluate regenerative processes following device/synthetic 
construct implantation 
High animal usage: 
- Ethical issues 
- Technically complex procedures to learn 
Predict the actions and detailed/complex side effects of treatments 
prior to testing in humans, including optimal doses and the window 
of application 
Procedural problems: 
- Infection 
- Technically demanding 
Assess behavioural and neurophysiological responses to treatment 
i.e. recovery of function 
Costly and time-consuming to generate and maintain 
Can replicate the variety of injury mechanisms  Low-throughput screening model for evaluation of 
repair strategies. 
Variability between animals: 
- Genetic 
- Anatomical 
Require regulatory permissions i.e. UK home office 
licence 
Difficult to monitor in real time 
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3.1.1. Technological gap: can the complexity of in vitro models of SCI be 
increased for screening material-based repair strategies? 
Despite the critical advantages of slice models detailed above, few laboratories 
have utilised this approach to simulate neurological injury (and subsequent 
regenerative events). In terms of SCI, three separate models have been reported to-
date. Two models of neurotrauma were established by weight drop onto slices, 
prepared either in the transverse166 or the longitudinal plane.183 Whilst these models 
mimicked some of the responses to injury in vivo, overall the characterisation of 
pathology was basic (e.g. cell death), the type of injury model is only suitable for 
assessing the effects of pharmacological agents or cells (not biomaterials) and 
transverse slices are not suitable for the assessment of regeneration in an 
anatomically relevant orientation (i.e. longitudinally). An additional, basic model of 
transecting injury in mouse spinal cord slices was described by Bonnici & 
Kapfhammer (2008).44 The parasagittal organotypic spinal cord slice cultures were 
found to maintain ventrodorsal patterning, contain neuronal synaptic connections and 
undergo myelination in vitro. They were able to induce complete transecting lesions 
in these slices and showed that younger slices with shorter pre-lesion culture times 
displayed greater endogenous regeneration than older slices and longer pre-lesion 
culture times. Whilst this pioneering study represents a significant milestone in SCI 
modelling, the size of lesions induced (100 µm, longitudinally) was sub-optimal for 
the visualisation and accurate assessment of regenerative events across lesion sites. 
Further, the model lacked versatility in terms of the induction of a range of lesion 
sizes and was limited in the ability to model different severities of injury. As detailed 
above, neurological injury in vivo results in stereotypical and cardinal 
neuropathological responses such as reactive astrogliosis and infiltration of immune 
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cells, including the resident CNS microglia. These glial responses were not 
characterised in the above study. Characterisation of the cardinal pathological 
features following injury was conducted only in neurons and the analysis of the 
extent of outgrowth was semi-quantitative (subject to interpretation).  
 
3.1.2. Objectives 
The aims of this chapter are:- 
(i) Primarily, to enhance the versatility of the basic slice model of SCI described 
above by facilitating the induction of different lesion sizes, in order to cater for a 
range of model severities. In order to do this, the production and handling of slice 
cultures was optimised for lesion induction and an in-house tool designed to 
reproducibly induce complete transecting lesions in slices.  
(ii) To characterise and quantify pathological events such as reactive gliosis and 
immune cell infiltration following lesion induction. The protocols developed were 
used to conduct quantitative assessments in order to characterise the multicellular 
response to injury.  
(iii) To reduce the cost of producing this SCI model, which may be prohibitively 
expensive for screening applications. The utility of the model developed here for 
evaluating the regeneration-promoting effects of synthetic polymer scaffolds is 
described in Chapter 4.  
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3.2. Methods 
 
3.2.1. Reagents and equipment 
Millicell culture inserts (PICM0RG50), OmniporeTM (JHWP04700) and 
IsoporeTM (HTTP01300) membranes were from Millipore (Watford, UK). Needles 
(21 gauge) were obtained from BD Biosciences (Oxford, UK). Disposable scalpels 
and size 15 surgical blades were obtained from Swann-Morton (Sheffield, UK). 
Rabbit and mouse anti-neuronal class III β-tubulin antibodies (clone TUJ-1) were 
from Covance (Princeton, NJ), biotin-conjugated lectin (microglial marker; from 
Lycopersicon esculentum, tomato) and monoclonal anti-biotin FITC-conjugated 
secondary antibodies were from Sigma-Aldrich (Poole, UK). 
 
3.2.2. Organotypic spinal cord slice cultures 
Mouse pups aged 0-5 postnatal days (P0-P5) were anaesthetized by 
cryoanaesthesia and rapidly decapitated, followed by removal of the forelimbs and 
transection across the lower abdomen with removal of the abdominal organs. The 
skin surface was sprayed with 95% ethanol, a dorsal midline incision made using a 
scalpel, and the skin flaps retracted to expose the spinal column along with retraction 
of the thick dorsal neck muscles to increase the ease of tissue extraction. Next, a 
midline incision was made along the length of the spine using fine microdissecting 
Vannas spring scissors (Stoelting UK). A 1.5 cm length of spinal cord was rapidly 
dissected out from the thoracolumbar region (using the point of attachment of the 
last true rib to define the upper margin for dissection) and placed in ice-cold slicing 
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medium [Earle’s balanced salt solution (EBSS), supplemented with 100 U/mL 
penicillin, 100 µg/mL streptomycin and 250 ng/mL amphotericin B, and buffered 
with 25mM HEPES].44,184,185 The cord was transferred onto the chopping plate of a 
pre-set McIlwain tissue chopper and sliced lengthways in the parasagittal plane (350 
µm thickness). Slices from the extreme lateral margins of the cord were discarded as 
these showed a tendency to fragment. Using our procedures, five to seven slices 
could be derived from each spinal cord. Slices to be used in experiments were 
selected under a dissection microscope to check for intactness and transferred to pre-
cut Omnipore membrane ‘confetti’, resting on the Millicell culture insert membrane 
(two/three slices per insert). A wide-bore pipette (plastic Pasteur pipette with the 
narrow end cut off) was used to facilitate ease of slice transfer. The sectioning 
procedure from dissection to preparation of slices was rapid (10-15 min), with the 
entire procedure taking no more than one hour. Slices were cultured at the air-
medium interface (Figure 2) within 6-well plates, with culture medium [50% 
minimum essential medium, 25% heat-inactivated horse serum and 25% EBSS 
supplemented with 36 mM D-glucose, 100 U/mL penicillin, 100 µg/mL 
streptomycin and 250 ng/mL amphotericin B] for up to 16 days in vitro (DIV). 
Cultures were incubated in humidified 95% air/5% CO2 at 37
oC with 80% medium 
changes every two days. In all cases the number of experiments, n, refers to slices 
obtained across different animals and litters. Cultures were lesioned at 1-8 DIV and 
were fixed within 7 days of lesioning. Both ‘younger’ (P0 mice: lesioned after 1 
DIV; fixed 7 days later) and ‘older’ (P5 mice: lesioned after 8 DIV; fixed 7 days 
later) models of intrinsic nerve fibre outgrowth were established. A series of 
improvements were made to the culture and handling of slices (with respect to the 
procedures described above), which are detailed in section 3.3.1. 
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Figure 2. The production of organotypic spinal cord slice cultures. Schematic 
diagram illustrating spinal cords cut lengthways in the parasagittal plane and 
transfered to culture inserts, where they were maintained at the air-medium 
interface. 
 
3.2.3. Lesioning spinal cord slice cultures 
Tissue was lesioned in preliminary experiments using a basic setup. The aim 
was to produce a complete transecting lesion of a reproducible size, with regular, 
evenly spaced lesion margins, in a rapid procedure to prevent the slices from drying 
out. A dissection microscope (X 40 magnification) was sterilised with 70% IMS, 
then the sharp edge of a 21 gauge needle (Figure 3) was used to lesion slices. Two 
sequential transecting motions were performed and a ruler used as a guide to 
generate lesion sizes ≤ 1 mm. However, this was not reliably achieved using this 
procedure. First, the membrane of the culture insert and the confetti were deformable 
when pressure was applied and they were regularly inadvertently cut. The resultant 
gap acted as a barrier to regrowth in the slice, which confounded attempts to  
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Figure 3. Example of the needle used as the preliminary lesioning tool for slice 
cultures. The bevelled edge of the needle tip (21 gauge; 4 cm total length) was used 
as the cutting edge during lesioning, illustrating the simplicity of the preliminary 
tool’s design. 
 
measure, for example, the infiltration of microglia into the lesion site. Second, both 
the confetti and the insert were not fixed in position within the Petri dish and would 
frequently move during lesioning. Third, multiple transecting motions were often 
required to completely sever the spinal cord slices, which exhibited variability in the 
ease of cutting (possibly related to the age of the tissue and the presence of the lining 
of the spinal canal). These factors delayed the completion of the procedure and most 
of the preliminary lesioned slices dried out, with adverse effects on viability 
confirmed by live/dead staining and a more opaque/white appearance evident when 
viewed with a dissection microscope. However, it was necessary for lesioning to be 
performed within the culture chamber, as the manipulation involved in transferring 
culture inserts and/or confetti into a separate dish/holder was found to reduce slice 
viability and further increase the chances of infection, inherent to these complex 
procedures. The development and optimisation of the focal lesioning method is 
discussed in greater detail section 3.3.2. 
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Additionally, Isopore membranes (Millipore) were evaluated as a replacement 
to the Omnipore membranes used to produce the confetti, for both the culture and 
lesioning of slices. They were comparable to the Omnipore membranes because they 
were hydrophilic, contained a similar pore size (c.a. 0.05 µm smaller) and could be 
autoclaved.  
 
3.2.4. O-ring slice culture inserts  
An alternative method of culturing slices on re-useable ‘O-rings’ has been 
published, which is based on the use of a PTFE membrane filter with very similar 
properties to the commercial insert membrane (also PTFE; pore size 50 nm smaller) 
and a re-useable O-shaped plastic plate with feet. To prepare O-ring inserts for use, 
the membranes were placed onto the O-rings and wetted with medium, causing the 
membrane to loosely adhere to the O-ring. Then confetti was added to the membrane 
over the central hole (culture area). The suitability of re-useable O-ring slice culture 
inserts for generating the slice lesion model, including the development of an in-
house produced alternative is discussed in section 3.3.4. 
 
3.2.5. Staining and imaging procedures 
Both live/dead and immunocytochemical staining of slices were performed 
following the protocol described in section 2.2.5. However, the duration and 
temperature of antibody incubations are detailed in section 3.3.1. The blocking 
solution for lectin consisted of 10% NDS in PBS and for TUJ-1 staining was 5% 
NDS with 0.3% Triton X-100. Samples were incubated with lectin (1:200) and anti-
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β-III tubulin antibody (TUJ-1; 1:1000) in blocking solution, followed by respective 
Cy3- and/or- FITC-conjugated secondary antibodies (1:160 anti-biotin, otherwise 
1:200). Slices were imaged and processed using the protocol as described in section 
2.2.6.1. 
 
3.2.6. Analyses 
 
3.2.6.1. Slice viability 
An assay was developed to determine the proportions of live and dead cells 
within the intact slices, using the readouts from live/dead staining and adapting an 
existing method of quantifying image fluorescence.186 Slices (P0-P5; n = 3) were 
cultured for 6-16 DIV prior to staining. Corresponding green (live) and red (dead) 
fluorescence micrographs of a central field within the length of each slice were 
captured at X 50 magnification and with consistent exposure settings. All 
micrographs were converted into greyscale and the integrated density (mean grey 
value per unit area) from both live- and dead-stained micrographs were calculated 
using ImageJ software (version 1.45s; NIH). The mean control integrated density 
values from four acellular areas adjacent to the slice was calculated for each 
micrograph and subtracted from that obtained for the whole micrograph, producing a 
corrected density value. Thus, the viability for each slice was calculated by 
expressing the corrected integrated density of the live-stained micrograph as a 
percentage of the sum total from both stained groups.  
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3.2.6.2. Lesioning tool blade spacing 
To assess the reproducibility of lesioning tool construction, the diameter of 
lesions induced in slices was investigated across five litters; 3-14 slices in each litter. 
Fluorescence micrographs of slices stained with DAPI were used to calculate the 
mean distance between lesion margins from each culture, representing different 
experiments with independent assembly of the lesioning tool.  
 
3.2.6.3. Astrocyte reactivity analysis 
An assay was devised to quantify the relative expression of GFAP (as a 
function of immunofluorescence intensity) at slice lesion margins versus areas in the 
body of the slice. P0-P2 slice cultures were established and lesioned after 1 DIV. 
Slices were left for a further 6 days before fixing and immunocytochemical staining 
with antibodies raised against GFAP. Each half of a lesioned slice was separately 
imaged at X100 magnification, with consistent exposure settings across all captured 
images. Micrographs were converted to greyscale and a grid was merged and 
adjusted with each image to identify three equidistant and clearly stained points 
along the length of the lesion margins. The grid points marked the beginning of 
optical density (OD) profiles that were generated using ImageJ software, and 
extended 400 µm perpendicularly into the slice body. The three profiles generated 
from each slice half were adjusted, so that the first OD values began at the lesion 
margin, and averaged with the corresponding slice half to form a single profile for 
each slice. A separate region was defined in the body of each slice half, at ca 1 mm 
from the lesion site, which was representative of baseline intensity values, where the 
GFAP+ astrocytes displayed characteristically un-reactive morphologies and low 
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GFAP expression levels. A corrected fluorescence intensity profile from the lesion 
margin of each slice (n = 6) was produced by subtracting the baseline intensity from 
each value in the averaged trace. Each corrected profile was averaged with traces 
from the other slices and the average OD in the zones 0-100 µm, 100-200 µm and > 
200 µm from the lesion boundary were compared to quantify differences in intensity.  
 
3.2.6.4. Microglial infiltration analysis 
An assay was developed to determine whether an acute microglial infiltration 
occurred into the lesion sites. Spinal cords were extracted from P0-P2 mice, lesioned 
after 2 DIV and fixed 0, 5 and 10 days post-lesioning (n = 3 per time point). The 
numbers of lectin-positive (lectin+) microglia were counted within the lesion site of 
each slice, using a grid overlaid onto each image. The total number of microglia per 
unit area per slice was averaged at each time point. 
 
3.2.6.5. Statistical analysis 
Data were analysed using GraphPad Prism statistical analysis software 
(version 5.0). All data are expressed as mean ± S.E.M. The number of experiments 
(n) refers to the number of slices obtained across different animals, often from 
different litters. Lesioning tool blade distance analysis: A one-way analysis of 
variance with Bonferroni’s post-hoc tests was used to assess differences between the 
blade distances from each instance of tool construction. Astrocyte reactivity 
analysis: the average OD in the zones 0-100 µm, 100-200 µm and >200 µm from the 
lesion boundary were square-root transformed and compared by a one-way ANOVA 
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with Bonferroni’s post-hoc tests. Microglial infiltration analysis: a log-
transformation of the average total number of microglia per unit area per slice at 
each post-lesioning time point (n = 3) was conducted. A one-way ANOVA with 
Bonferroni’s post-hoc tests was used to compare differences. 
 
3.3. Results 
 
3.3.1. Optimisation of organotypic spinal cord slice culture and immunostaining 
protocols 
A series of pilot studies highlighted the need for improvements to the existing 
methodology of slice preparation, to address: the prevention and containment of 
infection; the sub-optimal viability of slices; and the post-culture immunostaining of 
slices. Fungal contamination was a recurring problem during these initial studies, as 
each insert (up to six per 6-well plate) was repeatedly exposed to air (and 
contamination) during culture, medium changes, lesion induction and application of 
treatments, with greater risk of fungal spores from contaminated wells spreading to 
neighbouring wells. The placement of culture inserts into individual Petri dishes 
improved their isolation and the use of a large Petri dish to hold up to five individual 
dishes acted as a further barrier for added protection against the spread of any 
infection present in the culture. Further, Fungizone (amphotericin B) was introduced 
into the slice culture medium as a preventative measure, without any negative effects 
observed on the viability of slices cultured thereafter. Additional steps to improve 
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containment during the induction of slice lesions are detailed in the following 
section. 
The established live/dead staining protocol provided a good indication of slice 
viability and guided the optimisation of slice production. As expected, dead cells 
generated by the slicing procedure accumulated around the edges of the slices during 
the initial culture (recovery) period.185 However, the live/dead staining of slices 
revealed sub-optimal viability, as judged by the presence of considerable numbers of 
dead cells within the body of the slice (Figure 4A-C). The incubation of the slices 
on ice immediately following the trauma of sectioning from the spinal cord is a 
crucial step for tissue recovery because it reduces cell death. Increasing the duration 
of this step from 30 min to 1 h produced slices with reduced numbers of dead cells 
present in the main body (Figure 4D-F). The viability of the slices quantified using 
the method developed was 96% (± 2%), suggesting that the slices were generated 
with high viability.  
The initial immunostaining protocol produced relatively low fluorescence 
intensity necessitating optimisation. The incubation lengths of lectin and anti-GFAP 
antibodies were increased from 16 h to 36 h (at 4oC) to facilitate antibody 
penetration through the tissue. The NDS component of the blocking solution for 
lectin was increased to 10% to reduce non-specific background staining during the 
longer incubation periods. Samples stained with TUJ-1 antibodies were incubated for 
24 h at RT to further facilitate the penetration, with no change in the intensity of 
background staining detected at the increased temperature. Secondary antibody 
incubations were increased from 2 h at 4oC, to 3 h at 4oC (anti-biotin and GFAP) and 
4 h at RT (TUJ-1). 
113 
 
114 
 
Figure 4. The contrasting viability of slices following different incubations on 
ice prior to culture. (A) Representative fluorescence micrographs of a slice (P5; 
fixed at 6 DIV; n = 6) incubated on ice for 30 min, stained with calcein for live cells. 
(B) The same field as (A) with ethidium bromide straining for dead cells. (C) 
Corresponding merged micrograph of (A) and (B). A considerable number of dead 
cells were found around the slice edges (white arrows) and in the main body of the 
slice (white arrow heads), the latter indicative of a slice with poor viability. (D-F) 
Micrographs of a slice (P5; fixed at 6 DIV; n = 6) incubated on ice for 60 min, with 
the same stains as (A-C). Predominantly live cells can be found in the main body of 
the slice with fewer dead cells found in the main body and around the slice edges 
(white arrows), typical of a slice with good viability. 
 
3.3.2. SCI model development and optimisation 
 
3.3.2.1. Lesioning protocol optimisation 
The first procedural alteration was the use of a dissection microscope with 
greater magnification (X 12.5), providing superior operator imaging for placement of 
the tool over the slice, in turn reducing the induction of tears in the confetti. A 
surgical mask with hair protection was worn during the procedure when the 
microscope was used, to improve overall sterility. To improve lesioning 
reproducibility, the shape of the confetti supporting slices (Figure 5) was redesigned  
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Figure 5. Inducing defined lesions in slice cultures. Following a defined culture 
period, slices were lesioned by holding an elongated section (red arrow) of confetti 
(purple) together with the wall of the insert (grey) using forceps, thus keeping the 
slice stationary. 
 
to feature elongated tabs on the sides, which facilitated the use of forceps to grip the 
culture insert wall and confetti together, thus stabilizing the slice during lesioning. 
An aspirator fitted with a 200 µL pipette tip was found to effectively remove the 
debris, from the lesion site itself and adjacent to the slice, where most of the debris 
gathered post-lesioning. Direct aspiration of the lesion site without prior withdrawal 
of the material to one side often resulted in aspiration of slice parts beyond the 
transecting cuts and more poorly defined lesion boundaries.  
A significant proportion of nerve fibre outgrowth from the lesion margins of a 
small number of the younger slices appeared to follow the aligned membrane (PTFE) 
fibres that formed the confetti (Figure 6). Ideally the orientation of nerve fibre 
growth should not be influenced by the culture substrate, to mimic the random  
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Figure 6. Evidence of nerve fibre outgrowth following the aligned fibres of the 
confetti membranes. (A) Bright-field image showing the confetti fibres (aligned left-
to-right). (B) Counterpart fluorescence micrograph showing the outgrowth of nerve 
fibres from a lesion margin (white dashed line) in a P0 slice lesioned at 1 DIV and 
fixed at 5 DIV. Nerve fibres that appear to follow the direction of the confetti fibrils 
are marked with white arrowheads.  
 
orientation of outgrowth found in vivo and to robustly evaluate the effects of 
scaffolds with aligned topographies on inducing unidirectional nerve fibre outgrowth 
(Chapter 4). Isopore membranes were the only alternative available for purchase 
from the supplier Millipore without a fibrous construction. However, they were more 
compliant than the Omnipore membranes, which made cutting the confetti to the 
correct size during setup and their transfer (± slices attached) with forceps extremely 
difficult. Additionally, they were optically opaque so the informed placement of 
slices after sectioning was not feasible and further observation during culture and 
lesioning was not possible until post-culture staining. Therefore a permanent 
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alternative to the Omnipore membrane was not found. However, it was discovered 
that wetting the Omnipore membranes with 70% ethanol revealed the orientation of 
the membrane fibres before they were cut to make confetti. In this way they could be 
orientated parallel with the lesion margins and the unidirectional growth of any 
spared nerve fibres due to the confetti fibrils would be instantly recognisable. 
 
3.3.2.2. Development of a lesioning tool 
 
3.3.2.2.1. Preliminary tools 
The fine needle (Figure 3) adopted as the lesioning tool in preliminary 
experiments was the least effective of the tools tested, because it was difficult to 
accurately and reproducibly apply a force to the slice without disturbing the confetti 
and insert membrane beneath it, which often generated unclear lesion margins. In 
comparison, the extra sharpness and length of a conventional scalpel blade made it 
easier to cut across slices. However, all single-bladed cutting instruments required 
two sequential, parallel transecting motions to produce the injury, increasing the 
procedural difficulty and lesion size variability, whilst restricting the minimum 
possible lesion size to approximately 750 µm. In this context, once the first 
transecting cut was made, inducing the lateral transecting motions close to the first 
tended to loosen the slice from the confetti. Due to this added difficulty, slices were 
exposed to the air in the flow hood for long periods and a noticeable reduction in the 
slice viability was observed by live/dead staining.  
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3.3.2.2.2. Double-bladed prototypes 
A new lesioning tool was conceived based on two thin wires (ca. 50 µm). It 
was envisaged that they could be adhered to the bottom surface of a holder, with a 
central space left in the middle to facilitate pressing the tool through the slice. As no 
such tool was commercially available, one was produced in-house using a tooth pick 
to fashion a plastic holder and wire from a metal scourer, which was glued to the 
holder (Figure 7A). Two equally spaced parallel grooves were created at either end 
of the operational side of the tool, in order to hold the metal wires in place (Figure 
7B), with the distance between them measured using a micrometer. Four prototypes 
ranging from 250-1000 µm were produced in order to show that they could be 
maintained less than 1 mm apart. The tool was drawn through each slice with small 
lateral movements made to ensure the complete severing of nerve fibre tracts. 
However, the tool did not reproducible generate lesions with straight edges. This was 
mainly due to the wires used, which: tended to twist, reducing the effectiveness of 
the cutting surface; did not remain parallel along their length; were prone to moving 
apart, with greater inaccuracies between them observed at the smaller distances; and 
were not strong enough to use repeatedly over a number of cultures. Nonetheless, the 
length of time to lesion the slices was significantly shortened as the procedure was 
much easier to perform, setting a precedent for future prototypes.   
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Figure 7. The first custom-designed lesioning tool prototype with two cutting 
surfaces. (A) Photograph showing a horizontal view of the plastic holder with wires 
attached to one end with glue. The wires are applied at the intended lesion site with 
the handle oriented perpendicular to the slice [black arrow indicates the perspective 
in (B)]. (B) View from below showing the parallel wires with an approximate 
separation of 1 mm. 
 
A further double-bladed prototype tool was constructed, consisting of two 
single-edged blades attached together. This much simpler design, in combination 
with a reliable cutting surface, was intended to address the problems encountered 
with the wire tool. However, the blades were far too long to comfortably manoeuvre 
into position over the slice given the limited space available within the confines of 
the culture insert while using a microscope to visualise the procedure. Attempts to 
manually reduce the length of the unused sections of the blades, without 
sophisticated machinery/methods, proved too difficult due to the strength of the 
material. Furthermore, a shortened tool would only be re-useable in the short-term 
until the sharpness of the blades would noticeably deteriorate, requiring a 
replacement to be produced.  
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3.3.2.2.3. Final tool design and optimisation 
Upon evaluation of the prototypes assembled and their performance during 
testing, scalpel blades were considered the most effective for the intended purpose, 
as they are designed to cut through tissue, are inexpensive, come in a variety of sizes 
and fit a holder that is comfortable to operate by hand. Given these clear advantages 
a double-bladed prototype was designed to improve upon the advantages of using a 
single-bladed scalpel. Two surgical scalpel blades (size 15) were taped together to 
ensure they were fixed in position relative to each other (Figure 8A) and glued into 
an empty scalpel holder. The application of tape in-between the blades was shown to 
act as a spacer to increase the lesion size induced. This more facile design improved 
maneuverability, and the sharp cutting edge significantly improved the speed and 
accuracy with which lesions could be induced. The efficient cutting of the tissue 
facilitated the complete removal of slice debris in between regular, evenly spaced, 
distinct lesion margins (Figure 8B), which enabled the visualization of regenerative 
events across lesion sites. 
The only improvements made to this prototype were extra steps taken to 
aseptically assemble the tool with fresh, sterile blades prior to lesioning each slice 
culture. The sample holder was sterilized in 70% ethanol for 10 minutes and allowed 
to dry. New pre-sterilized scalpel blades were fixed with tape, placed in an empty 
scalpel holder and secured inside. Initially it was thought that a spring loaded catch 
could be used to hold blades in place, facilitating their addition and removal from the 
holder. However, it was hypothesized that the spring would have to apply 
considerable pressure on the blades in order to sufficiently fix them in place, so an 
easier way of achieving the same goal was to fasten them in place with tape and 
plastic paraffin film (Parafilm). 
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Figure 8. Inducing lesions in spinal cord slices with a double-bladed scalpel. (A) 
Photograph of the assembled scalpel blades, demonstrating equal spacing along the 
length of the blades. (B) A tissue slice stained with DAPI at 2 days post-lesioning, 
showing clear demarcation of lesion margins (white broken lines). (C) Bar chart of 
the distances between lesion margins, showing the reproducibility of the lesioning 
procedure across different experiments (each culture was derived from a separate 
litter, and five slices were lesioned for each culture; n = 5; for each culture, a 
lesioning tool was freshly assembled). (D) Representative live/dead-stained 
fluorescence micrograph of a slice 5 days post-lesioning reveals some dead cells 
within the lesion (white broken lines) with high viability in the main body of the 
slice. 
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Using this tool, the measurements of induced lesions revealed a mean distance 
of 439 µm (± 4 µm; coefficient of variation = 2 %) between lesion margins, which 
was highly reproducible across five separate cultures, each representing separate 
occasions of tool assembly (Figure 8C). Live/dead staining of lesioned slices 7 days 
post-injury (Figure 8D) demonstrated that the procedures did not significantly 
impact overall slice viability for further experimentation, as evidenced by a central 
band of live cells within the slice body with few dead cells interspersed around the 
area of injury. 
 
3.3.3. Characterisation of the cardinal pathological responses of cells within 
lesioned slices 
 
3.3.3.1. Astrogliosis at lesion margins 
Clear and even GFAP staining was observed throughout slices; notably, 
GFAP+ cells at lesion margins were intensively reactive and hypertrophic (Figure 
9A). These cells differ markedly from GFAP+ astrocytes away from the lesion site, 
which exhibited normal, polygonal morphologies and fluoresced with lesser intensity 
(Figure 9B). The average GFAP fluorescence intensity profile from the lesion 
margins across multiple slices is shown in Figure 10A. Quantification of the 
fluorescent intensity profiles shows significantly greater intensity in the first 100 µm 
adjacent to lesion margins, indicating an increase in astrocyte reactivity (Figure 
10B). 
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Figure 9. Astrocytes show reactive properties at lesion margins suggestive of 
astrocytosis. (A) Representative fluorescence micrograph of a lesion margin 12 days 
post-lesioning shows intensely reactive astrocytes with increased GFAP (astrocyte 
marker; arrowheads) expression and hypertrophic morphologies (arrows). (B) 
Representative fluorescence micrograph of a field within a slice body shows 
astrocytes with polygonal morphologies and with reduced GFAP expression 
compared to those at the lesion margins of (A). 
 
 
Figure 10. Quantification of fluorescence intensity corresponding to GFAP 
expression in astrocytes. (A) Line graph of the mean optical density profiles (red) 
for GFAP+ astrocytes in six lesioned slices 7 days post-lesioning showing a peak in 
expression at lesion margins. (B) Bar graph showing a significant difference 
50 µm 
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between the average optical densities for GFAP+ slices between the first 100 µm 
from the lesion margins and two adjacent regions further into the slice body (one-
way ANOVA with Bonferroni’s post-tests; ***p < 0.001; n = 6). 
 
3.3.3.2. Microglial infiltration into lesion sites 
Lectin+ microglia were identified in immunostained slices and displayed 
rounded ‘activated’ morphologies within the lesion site (Figure 11A). In contrast, 
‘resting’ microglia located in the main body of slices exhibited numerous ramified 
processes. A significant increase in the number of microglia within the lesion site 
was found at 5 days post-lesioning (Figure 11B) with a decrease in number after 10 
days. 
 
 
Figure 11. Infiltration of microglia into lesion sites. (A) Representative 
fluorescence micrograph of a lesion margin 12 days post-lesioning shows the 
infiltration of rounded, lectin+, activated microglia into the lesion site (white dotted 
line: lesion margin). (B) Bar graph quantifying numbers of lectin+ microglia in 
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lesion sites at 0, 5 and 10 days post-lesioning, demonstrating a peak in infiltration at 
5 days (*p < 0.05, **p < 0.01; n = 3 per time point). 
 
3.3.3.3. Intrinsic nerve fibre outgrowth from lesion margins 
After seven days of culture, nerve fibre outgrowth into the lesion within young 
slices was extensive, randomly orientated and comparable from both margins of the 
lesion (Figure 12A). In each slice approximately half of the area enclosed between 
lesion margins contained outgrowing nerve fibres, which in some areas joined both 
slice halves together. By contrast the outgrowth in older slices was relatively limited, 
but also with random orientations (Figure 12B). Nerve fibres were never observed to 
extend more than one quarter of the distance between the lesion margins (ca. 110 
µm) in the central half of lesion sites and the incidences of spontaneous nerve fibre 
sprouting along the width of the lesion margins was significantly less than in the 
younger slices. Additionally, a sub-population of TUJ-1+ cells displayed the 
morphological phenotypes of spinal cord interneurons (Figure 12C), which were 
particularly evident along the lesion margins of the older slices due to the lower 
density of nerve fibre outgrowth present in this region. 
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Figure 12. The spontaneous and randomly orientated outgrowth of nerve fibres 
from lesion margins is dependent on the age of the slice at derivation and the 
duration of pre-lesion culture. (A) Representative fluorescence micrograph of 
extensive, random outgrowth of TUJ-1+ (pan-neuronal marker) nerve fibres in 
lesions in young slices (P0; lesioned at 1 DIV; stained 7 days later: n = 6). (B) 
Representative fluorescence micrograph of relatively limited, random outgrowth of 
TUJ-1+ nerve fibres in older slices (P5; lesioned at 8 DIV; stained 7 days later: n = 
6). (C) Representative fluorescent micrograph of a likely TUJ-1+ interneuron at the 
lesion margins of older slices. 
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3.3.4. Reducing the expense of the lesioned slice culture model for screening 
applications 
 
3.3.4.1. Commercial culture inserts and the existing alternative  
The slice injury model developed here was considered cost-prohibitive with 
regards to its use as a screening tool. The main expenses incurred (Table 2) were 
associated with obtaining the animal tissue, the commercial slice culture inserts and 
the antibodies used for immunostaining. Antibodies represented the greatest expense, 
but the volumes of antibodies could not be reduced as the staining procedure could 
only be reliably performed within suitably sized containers (12-well plates). This 
estimate is likely to vary depending on the particular antibodies used and the number 
of slices that require staining. The price for the animal tissue represented less than 
10% of the total cost. The commercial inserts (Figure 13A) represented 28% of the 
total cost and are required for each culture because they cannot be re-used, as the 
materials do not withstand autoclaving and there is no way of replacing the 
membrane. An alternative method of culturing slices on re-useable ‘O-rings’ has 
been published (Figure 13B). The membrane is relatively expensive but the use of 
this technique to culture slices can reduce the overall cost by 16%. 
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Table 2: The main costs incurred to produce and characterise each lesioned 
slice culture 
Item Units required 
per culture 
Cost per unit (£) Cost per culture 
(£) 
Animal tissue 
(Mouse litter) 
1.00 20.00 20.00 
Dissection medium 1.50 1.40 2.10 
Commercial inserts 16.00 4.90 78.40 
OR 
O-ring inserts 16.00 2.10 33.60 
Confetti membranes 6.00 2.10 12.60 
Culture medium 2.00 1.30 2.60 
Antibodies  170.00 
Total using Commercial inserts: 284.70 
Total using O-rings: 239.70 
[Estimates are based on: 7 spinal cords extracted per animal; 48 slices generated per 
culture; 3 slices cultured per insert; 75 mL dissection medium and 100 mL culture 
medium required; 42 slices used for immunostaining (14 slices used for each of the 
three primary antibodies)]. 
 
Figure 13. Existing commercial and re-useable slice culture inserts. (A) 
Photograph of a commercial organotypic slice culture insert available from 
Millipore. (B) Schematic showing a view from underneath existing O-rings (feet in 
black). (C) Schematic of a prototype O-ring developed in-house (same view as B). 
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The O-ring inserts were re-designed to address the problems for culturing and 
lesioning spinal cord slices. The O-ring inserts have a smaller area available for 
culture than the commercial inserts and were developed for substantially smaller 
sized hippocampal brain slices and it was not possible to fit more than two spinal 
cord slices over the culture area. Additionally when the tool was pressed into slices, 
the membrane (not adherent to the O-rings) would yield and not offer sufficient 
resistance for successful lesioning. A further issue during culture was the presence of 
bubbles that formed beneath the culture area. This could occur due to agitation of the 
insert during slice/confetti transfer or when the medium was changed, as discarding 
spent media lowered the medium level below the membrane, such that air could 
become trapped here even as fresh medium was added. It is not clear whether these 
bubbles would be detrimental to slice health, but the issue was resolved by gently 
lifting and replacing the membranes over a full complement of medium  
The first prototype produced was a minor alteration to explore the limitations 
of the existing design. The insert assembly process was kept unchanged, but the 
dimensions of the O-ring culture area were altered (Figure 13C) to accommodate the 
rectangular shape of slices. Additionally, it was reasoned that the wider O-ring 
sections parallel to the length of the slice could be used to keep the slice stationary 
when the lesioning tool was pressed downwards, by providing a surface onto which 
the culture membrane and the confetti tabs could be pinned down with forceps for 
stability. However, in practise the membrane could not be sufficiently secured to 
induce lesions effectively and the design still permitted the culture of only two slices, 
so a new design was required with significant alterations. 
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3.3.4.2. Production of in-house designed slice culture inserts 
A factor critical to the replication of lesioning procedures achieved with the 
commercial inserts was finding a way to secure the membrane to the O-ring. The 
incorporation of an expanded culture area would also increase the number of spinal 
cord slices that could be simultaneously cultured and increase their overall 
separation relative to each other. However, it was considered desirable to continue 
using the O-rings within 35 mm Petri dishes, and it was recognised that there were 
limits to the extent that the insert diameter and ring width could be altered, as, 
respectively, space was still required surrounding the outer perimeter of the insert to 
perform medium changes and the membrane needed sufficient space to be adhered to 
the sides of the insert to be kept effectively taut.   
The design features of commercial inserts (Figure 14A) were analysed in order 
to conceive a novel re-useable insert design that addressed the problems found with 
the existing O-ring inserts for slice culture, whilst retaining the fundamental aspects 
that make the technique work. To maintain the culture membrane at the air-medium 
interface the feet needed to be retained to raise the culture membrane off the bottom 
of the Petri dish, up to the surface of the medium. The commercial inserts have a lip 
surrounding the perimeter, reducing the chances of medium splashing over slices 
during transport and these could be exploited for increased slice stability during 
lesioning by pinning the elongated confetti tabs to this lip with forceps (Figure 5). 
However, part of the insert wall immediately surrounding the membrane was sloped, 
which actually increased the difficultly of gripping the insert with forceps and this 
was identified and a feature that could be improved. It was envisaged that an insert 
composed of three identical, ring-shaped units (PTFE), four screws and four nuts 
(cellulose acetate) could address the above considerations (Figure 14B-D). The  
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Figure 14. Design of an alternative re-useable slice culture insert. (A) Schematic 
illustrating a cross-sectional view of commercial organotypic slice culture inserts 
purchased from Millipore, with the main features highlighted (arrow: insert lip; 
arrowhead: sloping wall; block arrow: feet). Note: not to scale. (B) Schematic 
illustrating a cross-sectional view of in-house designed O-ring inserts (O-rings: 
grey; screws: blue; nut: black). (C) Photograph of assembled in-house produced O-
ring inserts. (D) Schematic illustrating the assembly of O-ring inserts with a 
separate OmniporeTM membrane placed between the stacked O-rings to form the 
slice culture membrane. Note: not to scale. 
 
simple design and use of relatively inexpensive materials aimed to reduce the 
manufacturing costs, with only the rings requiring bespoke tooling. The overall 
diameter of each ring and the culture area were enlarged (and the ring width slightly 
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decreased), compared to the O-ring inserts, permitting the culture of up to three 
slices per insert while also providing access around the insert to change the medium. 
The stacking of each ring and the placement of the culture membrane between the 
bottom two rings introduced a lip that was uniform in thickness from top to bottom, 
making it easier to grip the wall and confetti with forceps and therefore further 
improve slice stability during lesioning. The incorporation of four identically placed 
holes around the ring perimeter facilitated the use of four screws (with nuts) to 
adhere the rings in place and secure the membrane in a level configuration. The 
screws that protruded from underneath the bottom ring were produced with sufficient 
length to raise the level of the insert off the bottom of the container. It was 
considered advantageous to assemble the inserts prior to autoclaving to ensure 
reproducible production and sterility.  
 
3.3.4.3. Testing the robustness and performance of assembled inserts  
The inserts were subjected to a number of assessments to validate their 
suitability as a re-useable replacement for commercial inserts and the existing O-ring 
inserts in the long-term (Table 3). To establish whether the inserts were affected by 
commonly used laboratory chemicals and fixatives that would be used in conjunction 
with slice staining procedures, inserts were submersed in 4% PFA, 2.5% 
glutaraldehyde and 70% ethanol for 1 hour each, with washing between incubations. 
No discolouration of the materials or leaching was observed and there was no effect 
noted on the structural integrity of the inserts following manual testing, with regards 
to deformation and breakability, flatness as judged with a spirit level and the ease of 
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assembly afterwards. Also there was no noticeable effect with respect to the insert 
integrity following autoclaving. 
Table 3. Validating the reusability of in-house produced O-ring inserts 
 Outcome measure 
Test Discolouration Deformation Breakability Level surface 
4% PFA 
   
 
2.5% glutaraldehyde 
   
 
70% ethanol 
   
 
Autoclave (ca. 30 
cycles)     
 
To assemble the inserts correctly, the membrane between the O-rings needed 
to be taut so that it could be fixed in a level position once the screws were tightened. 
Whilst the membrane was found to deform to a greater extent than did commercial 
inserts, it did not impact on the lesioning procedure. The membrane could be secured 
with greater tension but with increased risk of tearing, so the method of assembly 
required alteration to produce greater membrane tautness, e.g. use of a restraint. 
When the inserts were used for slice culture the volume of medium used per well 
was increased two-fold to take into account the overall increase in height of the 
membrane compared to existing inserts. This did not result in increased use of 
medium, as the medium was changed every four days, compared to every two days 
with the commercial inserts and existing O-rings. The design of the inserts still 
occasionally resulted in air bubbles becoming trapped underneath the membrane. 
One solution to this problem would be the removal of the bottom O-ring underneath 
the culture membrane, to mimic the design of commercial inserts. However, this was 
readily resolved by tilting the inserts, which was far more effective than performing 
the same procedure with the existing O-rings, as the whole structure (including fixed 
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membrane) was more stable. The viability of cultured slices was 95% (± 3%), which 
was comparable to slices cultured on commercial inserts. These inserts were 
successfully adopted for the culture and lesioning of slices over 30 subsequent 
cultures, with no further issues found and generating a saving of approximately 
£1350. 
 
3.4. Discussion 
This is the first report of a 3-D model of SCI in vitro that displays multiple 
cardinal features of injury in vivo: an enhanced order of complexity compared to 
existing models. From the organotypic spinal cord slice cultures, 5-7 spinal cord 
slices can be routinely obtained from a single animal (depending on age), permitting 
the assessment of several treatment conditions (with control) within the same batch 
of slices, thereby reducing experimental variability and successfully addressing the 
3R’s principle of reducing animal usage. The procedures used to generate, culture 
and visualise slices were meticulously optimised to determine the most effective 
protocol for generating the injury model and, given the added complexity of the 
tissue, may be considered relatively facile compared to many other in vitro 
models.169 Furthermore, the optimisation of the lesioning procedure when using the 
in-house produced culture insert and lesioning tool significantly improved the 
robustness and reproducibility of the lesions induced. The developed culture also 
reduced the overall cost of performing the experiments, which is a significant factor 
for increasing the utility and practicability for screening applications. Overall the 
model illustrates the potential for organotypic slice cultures to mimic a biologically 
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relevant, 3-D injury environment and further expands the potential utility of 
organotypic slice cultures for screening potential treatments for injury. 
 
3.4.1. Development and optimisation of procedures to generate a reproducible 
model of SCI 
The poor viability of slices produced during the pilot studies and the 
inadequate prevention of fungal infections emphasised the requirement to refine and 
optimise slice production and culture. The modifications made were mainly 
associated with slice handling as opposed to major procedural changes, as the 
protocols were adapted from established cerebellar187 and spinal cord44 slice culture 
protocols. The use of the live/dead staining kit gave a simple and rapid readout of 
slice viability to guide the optimisation process throughout. The results from the 
optimised procedure demonstrated that slices could be produced with high viability 
from a range of animal ages and maintained for three weeks. The immunostaining 
protocol routinely used for 2-D culture was adapted to effectively stain slices, and 
compares favourably to the alterations made for the constructs in chapter 2. In this 
regard, antibody incubations were increased in duration to enhance their penetration 
through the depth of the sample, 12-well plates being the smallest containers that 
could accommodate slices for staining, given the sample size and the aim of keeping 
the volumes of expensive antibodies to a minimum. 
A superior and successful slice lesioning protocol was developed by making a 
series of improvements to the initial procedures. The preliminary aim was to limit 
the trauma inflicted on the slices to the induced lesion, in order to maintain the 
overall viability of slices for subsequent culture and analysis of cellular pathology. In 
136 
 
this regard, increasing the ease with which the procedure was performed was key to 
decreasing the total time taken to lesion each slice and thus the susceptibility of the 
slices to dehydration. This was achieved by maintaining individual inserts within 
separate culture chambers, incorporating elongated tabs into the design of the 
confetti membrane and designing an efficacious, double-bladed lesioning tool. 
Additionally, following the relocation of the lesioning procedure to within a sterile 
flow hood (with the necessary precautions taken to limit the risk of operator-caused 
contamination within this environment) and the use of isolated culture chambers, the 
incidences and spread of fungal contamination was markedly reduced within 
cultures. These procedural changes reduced the number of failed experiments, 
successfully addressing the 3R’s principle of reduced animal usage. Increasing the 
reproducibility of the lesioning procedure was required to produce a standardised 
screening model of injury, capable of providing directly comparable, biologically 
relevant predictions of the response of spinal cord tissue to materials and treatments 
with reduced methodological and resultant physiological variability. First, the use of 
a microscope with a more powerful (X12.5) objective improved the accuracy with 
which lesions could be induced and permitted more accurate quality control through 
the identification of incorrectly lesioned slices. Second, the confetti tabs facilitated 
the stabilisation of the slice, reducing procedural difficulty. Third, the facile 
assembly of the tool allowed for reproducible blade spacing and a defined lesion 
size.  
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3.4.2. Lesioning tool development and future tool design for further process 
refinement 
Of the various tool designs conceived the most robust, efficient and 
reproducible was also the simplest. The lesioning tool was developed to produce 
lesions with a diameter greater than 100 µm (the smallest lesion width attainable 
using a single cut with a conventional scalpel)44 and less than 1 mm, which was 
considered ample space for clear visualisation of the cellular/tissue responses to 
injury. Although the lesion tool produces a particular (minimum) distance between 
lesion margins when assembled as described here, the use of a spacer of defined 
thickness can increase this variable to meet the demands of the application. In this 
regard, the trauma of removing a substantial proportion of the slice (≥ 1 mm) was 
found to be detrimental to slice viability, so modelling such a large lesion may 
require additional methods to increase the distance without reducing the length of 
tissue, e.g. placing the slice on top of pre-folded confetti that can be pulled apart 
following lesion induction, separating the two pieces of tissue.  
The lesioning protocol and established lesioning tool induced high quality 
lesions with defined, straight margins and the removal of debris, within which 
cardinal features of pathology were subsequently observed. Nonetheless, the whole 
procedure was technically difficult to perform and there will be a degree of 
variability inherent in the lesions produced between experimenters, due to the 
necessary skill and experience required to perform the technique reproducibly. A 
further refinement to the design of the tool would be its attachment to a stand for 
support, simplifying and steadying the movements required (Figure 15). The stand 
would require optimisation to ensure: it could be sterilised before use; the scalpel 
could be easily mounted; and it would allow enough range of movement to position 
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the scalpel over the slice and be easily controlled by the experimenter. The 
movement required could be simplified further by mounting a spring between the 
scalpel and the stand so that a downward push would depress the tool and cut the 
tissue. There are still opportunities to improve the tool design further for 
simplification of operation, although these refinements may become increasingly 
complex and cost-prohibitive. In this context, the model could be adapted using  
 
Figure 15. Schematic illustrating a potential improvement to the design of the 
lesioning tool. Fixing the scalpel holder of the tool to a stand would remove lateral 
movement, allowing more precise placement of the tool. A linker segment between 
the tool and stand could increase the range of movement for positioning over the 
slice. 
 
automation to scale-up processes for even higher-throughput pre-clinical screening 
(multiple cultures at once), exploiting the increase in accuracy and reproducibility 
that technology can provide. For example, in theory with the co-ordinates of a slice a 
robotic arm could be programmed to replicate the series of pre-defined movements 
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typically required to lesion slices (completely or semi-autonomously), making the 
labour-intensive procedure more manageable on a larger scale and further reducing 
variability. However, currently this application may be an unrealistic option, given: 
(i) the inherent difficulties associated with the precision cutting of soft nervous tissue 
on a delicate membrane; (ii) the possibility that a typical protocol (number of 
movements) for lesioning slices may be impossible to generate without the need to 
e.g. improvise or repeat movements; (iii) the risk of increasing the number of wasted 
slices due to methodological errors and optimisation problems; (iv) in practise, 
unanticipated difficulties requiring experimenter input to resolve e.g. 
partial/incomplete cutting; and (v) it may be prohibitively expensive and/or time-
consuming to setup and optimise.  
Depending on the scale that screening would be conducted on, opportunities 
exist to further automate the entire culture and lesioning process, from the generation 
to the fixation of slices post-culture, using a robotic cell culture system such as the 
CompacT SelecT (TAP Biosystems). The sealed environment within such systems 
reduces contact between the experimenter and the sample, which maintains the 
optimum conditions for culture and has the potential to further reduce incidences of 
infection. Additionally, equipment may be integrated for the production of a 
customised process, such as the hypothesised robotic lesioning setup (discussed 
above) and e.g. equipment (in parallel) designed to deliver biomolecules or culture 
and transplant cell populations into lesion sites for screening purposes. 
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3.4.3. Pathology of lesioned slices 
This study demonstrates that three cardinal pathological features of SCI in vivo 
can be mimicked in slice lesions, viz. post-traumatic astrogliosis,188 infiltration of 
lesions by activated microglia185,189 and limited random outgrowth of nerve fibres160 
from the lesion margins of slices derived from older animals. Reactive and 
hypertrophic astrocytes as seen within the lesion model here are hallmark features of 
the glial scar in vivo.28 Microglial infiltration dynamics in the lesion model are 
broadly comparable with their acute infiltration characteristics in vivo.22,189 This 
indicates that acute inflammatory responses can be mimicked within the lesion sites 
in vitro. The mechanisms underpinning their transient infiltration of lesion sites is 
not fully clear. Further, in vivo reports suggest that a second, more sustained wave of 
microglial infiltration can occur later in the injury process (ca. 60 days post-
lesioning).190 It will be of interest to determine if this phenomenon is mimicked in 
this model. The above findings highlight the utility of the model in mimicking in 
vivo neurological injury and subsequent neuropathological sequelae. The analyses 
developed here can be used to quantify pathological responses following lesion 
induction. These methods can be further repeated to monitor changes in the response 
following various interventions/treatments, for example pharmacological agents, 
transplant populations etc.  
Responses of cells of the myelinogenic lineage (OPCs and oligodendrocytes) 
and the extent of myelin damage were not assessed here. It should be noted that the 
onset of myelination in mouse spinal cord in vivo occurs by the day of birth (P0) 
with extensive myelination reported by P10.191,192 Therefore, it can be expected that 
inhibitory molecules associated with myelin and its breakdown products will be 
expressed in the slice lesions. Some pilot experiments were conducted, which 
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demonstrated the presence of myelin within injury sites using immunostaining. 
However, this approach was deemed inappropriate to accurately quantify myelin 
damage/loss in lesion sites. Detailed electron-microscopic analyses will be required 
to robustly address this issue, which was out of the scope of the current study and 
timeframes. 
Whilst this model cannot provide functional readouts of regenerative events, 
such as locomotor activity, possible using in vivo models, the slices are entirely 
compatible with electrophysiological recording methods. Indeed, 
electrophysiological recordings from spinal cord slices have been reported by several 
groups.193–197 Pilot studies conducted using the developed injury paradigm have 
shown that it is possible to introduce a platinum/iridium stimulating electrode and 
glass recording electrode on either sides of the lesion margins and deliver a 0.1 mA 
stimulus. It was possible to record small responses at 72 hours post-lesioning when a 
small lesion diameter was induced (data not shown). However, ion channel blocker 
studies would be required e.g. voltage-gated sodium channels with tetrodotoxin, in 
order to validate these observations. 
The culture paradigm described here cannot currently serve as a complete 
replacement of in vivo SCI models because, for example, the influence of the 
systemic circulatory components on repair cannot be addressed. Further refinements 
to the model are possible, for example, there is the potential to add both circulating 
immune and blood brain-barrier components, to further enhance the sophistication 
and biological relevance of the system. The basic model may also be adapted to the 
study of compressing and contusing (as opposed to transecting) spinal cord injuries. 
Two models of injury (older and younger) have been described here by modulating 
the age of tissue for slice derivation as well as timings of lesion induction. The 
142 
 
spontaneous sprouting of nerve fibres observed from the margins of lesioned spinal 
cord slices in this paradigm, which declines with the age of donor tissue and is 
influenced by pre-lesioning culture time, has been reported previously.44 The two 
models can be exploited for different biomedical applications for example drug 
therapies to stimulate axonal regeneration in older tissue. Both models are suitable 
for studying the responses of the non-neuronal, (supporting) glial cells in lesions.  
 
3.4.4. Commercial applications of the in-house developed inserts 
The issues that prevented reliable lesioning of spinal cord slices in existing, 
reusable O-ring slice culture inserts were successfully addressed to produce 
customised inserts in-house, by incorporating design features from the commercial 
inserts,184 the gold standard insert for organotypic slice culture, along with 
application-specific requirements to aid lesioning. In general, the problems were 
associated with an overly simplified design with respect to the commercial inserts 
and with the size of the insert membrane, which was insufficient for the 
accommodation of multiple spinal cord slices. The in-house developed inserts are 
relatively simple in design for ease of assembly. Slice viability was comparable 
between the in-house and commercial inserts, thus validating the utility of the in-
house design as an alternative insert for slice culture. Furthermore, the in-house 
inserts were preferred to the commercial inserts for generating the model, as the 
slices were more stable during the lesioning procedure and more infrequent medium 
changes were required during culture. Additionally, the overall cost of slice culture 
was successfully reduced, which is an important factor when considering the number 
of inserts required for the use of slice cultures as a screening system, on an ongoing 
143 
 
basis. The robust design compared to existing O-rings, with the enhanced 
performance and reduced cost compared to commercial inserts, suggests that the 
inserts could have potential as a commercial product (Figure 16). 
 
 
Figure 16. Strengths weaknesses opportunities threats (or SWOT) analysis. An 
evaluation of the commercial potential of the in-house produced O-ring inserts, with 
respect to the existing inserts available. 
 
After further assessment, the main practical disadvantages of using the inserts 
as a reusable alternative compared to commercial inserts is the time required for 
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assembly, ca five minutes per insert (and additional time to sterilise in an autoclave), 
which could increase the slice culture preparation time by an average of 80 minutes 
(based on an average of 16 inserts used per culture). Cost-related issues include 
sourcing a less expensive workshop for the production of the rings that is capable of 
manufacture at a larger-scale. The cost per insert is reduced by half compared to 
commercial inserts, with purchase of the culture membrane representing the main 
material expense (also the case with the existing O-rings). From a commercial 
perspective the inserts are not patentable because there a number of potential ways to 
reproduce the same simple design as the established commercial and existing O-ring 
inserts. Additionally, the target market for using the developed inserts is small, given 
that the benefits of using the new inserts are currently only associated with 
generating the spinal cord slice injury model (although the increased membrane area 
may prove suitable for the culture of slices derived from older animals and larger 
species) and it is unclear how widespread the adoption of the lesioning model will 
be. Thus, there may be no need to purchase them compared to the existing O-rings. 
To compound the potentially low demand is the duration that the other inserts have 
been used for (commercial inserts: 13 years; existing O-rings: 7 years), which could 
be a barrier to significant market penetration. Furthermore, as the design of the 
inserts is very simple and the materials are widely available, they are easy to 
replicate or improve by a commercial competitor. An established brand synonymous 
with quality and greater marketing capability would threaten to limit the market 
penetration for the in-house developed inserts. However, a small market size and the 
one-off cost of purchasing the inserts are likely to deter commercial competitors 
from developing their own, at least in the short-term until a significant share of the 
insert market is gained. 
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Through consideration of all the above factors, the inserts are likely to have 
limited commercial potential if sold in their current form as individual reusable 
inserts. One approach to increase demand is to sell them as part of a kit with the 
other tools used to make the SCI model, i.e. the lesioning tool (and future 
derivatives), confetti templates etc. Indeed, the dissemination of the model could 
prompt wide-spread adoption in the research community for screening purposes and 
this kit would provide researchers with a convenient, more inexpensive means of 
generating the model. Additionally, the inserts could also be used to establish injury 
models in slice cultures generated from other CNS regions, or non-neural tissues. 
However, it is considered that the inserts could be customised further for various 
novel applications depending on the particular physical manipulation of the slices 
and the requirements of the procedures involved. In this context, the basic features of 
the inserts can remain the same but many design aspects could be altered, for 
example, the height of the culture membrane in the dish, the height and shape of the 
wall surrounding the culture membrane and the overall size and shape (rectangular, 
multi-chambered etc.). The dish could also be customised to include multiple 
chambers, partitions or holders to help with the particular procedure, deliver the 
treatment and/or monitor the slices e.g. microscopy or electrophysiology. Expanding 
the range of inserts for various novel applications in this way is likely to increase the 
overall demand. Furthermore modifications such as these would be patentable. In 
every case, however, the inserts would need to be rigorously tested to ensure 
production of typical slices and high viability.  
With the emergence of 3-D printing and increasingly wider access to such 
technology in research institutions, scope exists to license the designs for consumer 
production in-house via online distribution channels e.g. Authentise 
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(http://www.authentise.com), which would eliminate production and delivery costs, 
and may discourage groups from producing their own inserts in-house. However, the 
use of such design distribution technology is generally restricted to non-scientific 
items, raising the possibility for producing a more scientific version to meet the 
needs of bespoke tools in the science community. Additionally, the PTFE that is 
currently used to form the in-house designed O-rings cannot be used for 3-D 
printing, so potentially suitable alternatives such as cellulose acetate could be tested. 
 
3.4.5. Conclusions 
The production and handling of slices has been optimised to produce a robust 
and reproducible model of SCI in vitro that replicates multiple cardinal features of 
neurological injury in vivo. This increase in complexity compared to other in vitro 
models described to-date demonstrates the potential of injured organotypic slice 
cultures for investigating injury pathology and could provide a model for the 
screening of novel treatment strategies for neurological repair, whilst reducing the 
high current reliance on live animal testing. The in-house production of customised 
O-ring inserts facilitated a reduction in the overall expense of the lesion model; a 
particularly important consideration for screening applications.b 
 
 
 
b Most of the data in sections 3.3.1-3.3.3 have been published. The main article is 
included here as Appendix 3 and features in an article included as Appendix 4.  
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Chapter 4: Evaluating the screening utility 
of an in vitro model of SCI for nanofibre-
based repair strategies  
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4.1. Introduction 
‘Combinatorial’ neural tissue engineering strategies have been suggested to be 
essential in promoting various aspects of neural regeneration within the complex, 
multi-faceted pathology of SCI, such as nerve fibre regeneration, suppression of scar 
formation and immune responses and promotion of blood vessel growth.198–202 The 
use of implantable synthetic bridges can aid regeneration by providing: aligned 
topographies and gradients of chemical guidance cues to direct regeneration; 
inhibitory molecule suppressors to promote growth; components of the ECM to 
promote the adhesion of neural cells to the scaffold; and transplant cell populations 
to replace lost/damaged cells.51,54,59  
Evaluation and optimization of bridges is currently the subject of intensive 
research globally although no approaches have been successfully translated into the 
clinic to-date.121 The results from rat SCI injury models have shown that the 
implantation of aligned nanofibre scaffolds in particular is an approach with high 
regenerative potential.120 For example, Liu, et al., (2012) produced a tubular scaffold 
(2.5 x 2.0 cm) of either aligned or randomly orientated collagen nanofibres folded 
into a spiral arrangement (4-5 layers).126 Scaffolds comprised of aligned nanofibres 
were still visible one month following implantation into a hemi-section injury model 
(C3 level), compared to randomly orientated nanofibre scaffolds which had almost 
completely degraded. Significant cell penetration and infiltration was observed into 
all scaffolds with an absence of neuroglial scarring. Scaffolds also supported nerve 
fibre sprouting. While these results show aligned nanofibres are a favourable 
scaffold for neural regeneration, there were some limitation with regards to the 
design and complexity of the scaffolds used. Firstly, the nanofibres were collected as 
a dense, handleable mesh. This was necessary to process the nanofibres into an 
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implantable form, which limited cellular infiltration within the thickness of each 
scaffold nanofibre layer. Secondly, by design the spiral structure contains a low 
cross-sectional surface area for the attachment of cells. This limited the potential of 
the aligned nanofibres to guide the regeneration of tissue from lesion margins. 
Thirdly, the incorporation of cells and/or biomolecules in combination with 
implanted scaffolds could have promoted regeneration to a greater extent.  
Indeed, studies utilising aligned nanofibre scaffolds as part of a combinatorial 
repair strategy have seen significant functional improvements in hindlimb function 
following implantation.  
Zhu, et al. (2010) produced a two-layered scaffold made of a PLGA/PLA 
blend, which was a half-cylindrical shape (4 mm length; 600 µm thickness).130 The 
outer layer (500 µm) consisted of randomly orientated nanofibres, whist the inner 
layer was aligned in the longitudinal axis. Rolipram was immobilised to the 
nanofibres of some scaffolds to enhance axonal growth and suppress inflammatory 
mechanisms. Scaffolds were implanted into rat spinal cord hemi-sections at the T9-
11 level. Three months later scaffolds containing rolipram had increased axonal 
growth predominantly in the inner layer of aligned nanofibres and increased blood 
vessel sprouting into the scaffolds. The number of astrocytes and amount of CSPGs 
found in the proximity of the injury site had decreased and significantly increased 
BBB scores were obtained.  
A separate study by Rochkind, et al. (2006) produced a proprietary tubular 
scaffold (4 x 2 mm) containing a central bundle of nanofibres ( <100 µm) 
embedded in a laminin-hyaluronic acid gel (± human nasal olfactory mucosa or 
embryonic spinal cord cells).131 Three months following the induction of complete 
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transecting lesions (T7-T8 level) partial recovery of hindlimb function was attained 
according to the BBB scale. Scaffolds contained neuroglial scar tissue and blood 
vessels, with some evidence of axonal outgrowth and re-myelination.  
Finally, Gelain, et al. (2011) produced a ‘neural prosthetic’ between 2-3 mm in 
length, consisting of multiple tubular, longitudinal microchannels of electrospun 
nanofibres (a PCL/PLGA blend; approx.  600 nm) filled with self-assembling 
nanofibre peptide hydrogels.129 Some treatment groups contained ChABC and 
neurotrophic cytokines. Microchannelled scaffolds (≤ 10 in total) were individually 
placed within the void space of cysts one month after contusive weight drop trauma 
to rat spinal cords and left during animal rehabilitation for 6 months. In biomolecule-
treated scaffolds, the majority of the cyst volume was replaced by regenerated tissue 
consisting of both neural and stromal cells, extensive growth of nerve fibres was 
observed and a vascular network had formed within the scaffold. Improvements in 
motor function were observed that suggest successful scaffold integration and 
promotion of regeneration within the spinal cord. This study demonstrates the 
potential of using many different strategies synergistically within the same 
engineered bridge to promote regeneration. However, overall, the number of 
different material, cell and biomolecule permutations that could be used together 
raises important questions about the most efficacious combinations for repair and the 
screening of strategies in live animal SCI models. This is especially pertinent in the 
absence of higher-throughput, biologically-relevant in vitro screening models of 
SCI.59,169  
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4.1.1. Technological gap: can lesioned organotypic slice cultures be used to 
screen neuroregenerative materials? 
There are only a few reports using organotypic slice cultures of neural tissue 
for screening materials ± cells or biomolecules. Overall, they were used to guide the 
optimisation of scaffold materials (e.g. composition, toxicity), their formulations 
(e.g. porosity) and provide readouts of the basic interactions with multiple neural cell 
types (Table 1). Ishihara, et al. (2011) used cortical motor neurons outgrowing from 
organotypic slice cultures of the sensorimotor cortex (dissected from coronal slices 
of rat brain) into adjacent Matrigel containing either Schwann cells or NIH 3T3 cells, 
as an axonal outgrowth assay to screen for the most promising transplant cell 
populations that promote nerve fibre outgrowth.203 Nerve fibres were detected 
through the depth of the Matrigel structure and the co-culture system permitted the 
investigation of interactions between nerve fibres and transplant populations. 
However, the model was not used to screen regenerative properties of the Matrigel 
material per se and the Matrigel was not in direct contact over the slice body. In 
another study by Fabbro, et al. (2012), mouse embryonic (E12-13) spinal cord 
transverse slices were cultured with carbon nanotubes using the roller drum culture 
method, to examine the interactions with multilayered neural tissue.193 The slices 
interfaced with nanotubes provided complex readouts of neural growth, morphology 
and synaptic activity following short-term culture (two weeks). Finally, Jurga, et al. 
(2011) produced rat (P7-9) hippocampal slice cultures to test the responses of either 
cryogelated, laminin cross-linked dextran or gelatin scaffolds in a comparative study 
with a live animal injury model.204 Readouts of scaffold degradation and 
immunogenicity were obtained, although the degradation was significantly more 
rapid in vivo. Astrocytes were found to interact with the edges of the scaffold
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Table 1: Qualitative comparison of studies utilising organotypic slice cultures of neural tissue for complex in vitro readouts following 
culture with materials, cells and/or biomolecules 
Study aim CNS tissue region and 
plane of slicing 
Insult 
inflicted? 
Material / cell / biomolecule / 
drug tested? 
Results 
mimicked 
in vivo?  
Ref. 
Setup a 3-D axonal outgrowth model in 
vitro to screen for neuroregenerative 
transplant cell populations. 
Sensorimotor cortex 
dissected from coronal 
slices of rat brain. 
No Matrigel (± primary Schwann 
cells or NIH 3T3 fibroblast cells). 
Yes 203 
Study the optimal chemical and biological 
properties of two different scaffolds, using 
multicellular readouts in vitro and in vivo. 
Rat hippocampal 
slices produced in the 
transverse plane. 
No Cryogelated gelatin or dextran, 
both cross-linked to laminin. 
Yes 204 
Culture slices with carbon nanotubes to 
establish optimal features and examine the 
interactions with multiple cells in a relevant 
tissue cytoarchitecture, including the 
synaptic activity of neurons. 
Mouse embryonic 
(E12-13) spinal cord 
(transverse plane; 
roller drum culture 
method). 
No Carbon nanotubes  N/A (No 
supporting 
study) 
193 
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Investigate potential neuroprotective effects 
of cells complexed with microparticles in 
vitro and in vivo, in models of ischemia. 
Rat hippocampal 
slices (transverse 
plane). 
Yes (via 
oxygen-glucose 
deprivation) 
Fibronectin- coated PLGA 
microparticles (± marrow-isolated 
multilineage inducible cells) 
Yes - 
where 
applicable 
205 
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although no significant astroglial scarring was detected, which mimicked the results 
found in vivo. Additionally, neuroblast migration was detected in scaffolds cultured 
with slices, albeit at significantly higher levels than in vivo. This suggests that 
organotypic slice cultures are compatible for the robust and reproducible testing of 
introduced scaffolds. Importantly, the induction of cellular responses to introduced 
materials comparable with those in live animal injury models206 highlights the value 
of the biological predictions obtained with the model. It also lends support to the use 
of organotypic slice culture models for screening applications with more spatial and 
cellular complexity. These readouts are invaluable for the development and 
preliminary assessment of novel neural tissue engineering strategies prior to testing 
in vivo.  
However, despite their critical advantages such organotypic models have never 
been utilised to examine the interactions of nanomaterials (as part of combinatorial 
therapies) with multiple cells types in an injury simulated environment for the 
regeneration of neural tissue. Garbayo, et al. (2011) attempted to show 
protective/regenerative effects of materials (microparticles) and cells on injured 
slices cultures, by inducing ischemia via acute oxygen-glucose deprivation.205 
However, the use of this relevant injury model is less applicable when considering 
other mechanisms of primary injury to the CNS, such as contusion or penetrating 
lesions. Furthermore, the evaluation of the microparticles in the study was primarily 
as an accessory to enhance the survival and neuroprotective effects of the 
transplanted cells, rather than directly promote regeneration of spared tissue per se.  
The utility of in vitro slice cultures to screen for materials has never been 
evaluated within a reproducible model of injury before. In this context, the spinal 
cord slice injury paradigm (Chapter 3) has the potential to act as an in vitro screening 
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model for structural bridges with more spatial and cellular complexity than other in 
vitro injury models described to-date. 
 
4.1.2. Objectives 
The aims of this chapter are to:  
(i) Assess the potential of using the developed lesioned organotypic spinal cord slice 
culture model as a screening system for synthetic nanofibre scaffolds (specifically 
aligned PLLA nanofibres) intended to promote spinal cord regenerative processes 
post-injury.  
(ii) Establish appropriate technical methods to incorporate nanofibre-bearing 
constructs across injury foci.  
(iii) Evaluate the potential regeneration-enhancing properties of the implanted 
constructs using histological and morphometric analyses. 
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4.2. Materials and methods 
 
4.2.1. Development of nanofibre constructs for incorporation into lesioned 
spinal cord slice cultures  
 Fluorescent and non-fluorescent nanofibres were produced using the same 
operational parameters as described previously (section 2.2.2). Nanofibres were 
desiccated overnight and sterilized in a UV chamber before use in all experiments. 
The line density of nanofibres used was tailored specifically for slice experiments 
(detailed in section 4.3.1).  
 
4.2.1.1. Design of a portable nanofibre delivery device 
Frames were made from cellulose acetate paper (Figure 1A), to deliver sheets 
of aligned nanofibres into lesioned slice cultures. The frames were designed with 
respect to the dimensions of the slice culture inserts and the largest slices that were 
generated (Figure 1B). The border width of the acetate frames needed to be greater 
than 1.5 mm, which was previously found to be too flexible (section 2.3.2.2). With a 
width of 2 mm there were no complications removing frames from the 
collector/densification tool after they were adhered to the nanofibres. No distortion 
was observed following storage and the frames could be accurately placed over 
slices. Additionally, there was insufficient room to place more than two acetate 
frames within the culture area of each insert, so a maximum of two slices were 
cultured per insert for nanofibre treatment, compared with three slices in control 
lesioned groups. However, for nanofibre experiments O-ring inserts developed in- 
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Figure 1. Portable acetate frames for the delivery of aligned fluorescent 
nanofibres to lesioned spinal cord slices. (A) Photograph of aligned (vertical) 
fluorescent nanofibres adhered to portable acetate frames. (B) Schematic diagram 
showing the dimensions of the frames (black) with respect to the lesioned slices 
(pink) following placement (units in mm).  
 
house were only used for control lesioned slices as the final frame size was 
fractionally too large to place over two slices within the culture area.  
When multiple nanofibre frames were stored together within a single 
compartment, the aligned nanofibre configuration was regularly disrupted due to 
adherence either together or to the bottom surface of the container, making them 
difficult to handle with forceps. To overcome this problem, a Petri dish with 50 
individual sub-compartments was used, to keep the nanofibre frames separated and 
stored in an upright position. 
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4.2.1.2. Development of nanofibre coating procedures 
A procedure to incubate multiple sterile, portable nanofibre frames 
sequentially with poly-D-lysine (PL; 20 µg/mL; 12 hr; RT) and laminin (LAM; 10 
µg/mL; 5 hours; RT) solutions was developed. These biomolecules are widely used 
to coat surfaces for cell culture. The simplest method conceived involved the 
placement of nanofibre frames on a non-stick PTFE block (fibre side facing 
upwards) with the solutions then applied over the nanofibres (with three PBS washes 
after each incubation). However, the solutions were found to completely evaporate 
during incubations, which caused nanofibres to form dense bundles. This disrupted 
the aligned configuration and reduced the surface area for cell attachment along the 
width of lesion margins following the delivery of frames into lesioned slices. The 
use of a sealed dish and the application of PBS around the frames to maintain a 
humid environment during incubations prevented the coating solutions from 
completely evaporating. However, difficulties remained in washing the frames 
numerous times with PBS and picking the frames up with forceps after coating was 
completed. Therefore, a coating chamber was designed and produced in-house to 
address these issues (Figure 2). The solutions were added into a modified Petri dish 
so that levels reached the nanofibres located on the underside of each suspended 
acetate frame. The design of the chamber assisted the addition and removal of 
solutions without disturbing the nanofibres and facilitated a rapid and efficient 
procedure to deliver the nanofibres, as they were easy to handle with forceps when 
held in suspension. The use of a lid prevented the solutions from evaporating and the 
ability to coat up to six frames simultaneously reduced the total procedural 
manipulation required. Following the last wash, nanofibres were kept moist for 
subsequent placement (within 15 mins) over slice lesions.  
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Figure 2. A chamber developed in-house to coat multiple nanofibre frames. 
Schematic diagram illustrating the coating chamber, modified from a small-sized 
Petri dish, with a central support (grey) added to facilitate suspension of multiple 
acetate frames (black) simultaneously. Coating/washing solutions (light blue) were 
sequentially added via pipette (right) up to the level of the nanofibres (black 
arrows). A lid was placed on top for the duration of the coating steps (not shown).  
 
Fourier transform infrared (FTIR) spectroscopic analysis was conducted to 
verify coating procedures, using an IS50 ThermoFisher instrument fitted with a 
germanium single bounce ATR. Spectra were recorded at 4 cm-1 resolution taking an 
average of 128 spectra. An air background was taken immediately prior to the 
sample. Micrographs of nanofibres ± rhodamine B were obtained as described 
previously (section 2.2.6.3) and the nanofibre line density calculated (section 
2.2.7.1). 
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4.2.1.3. Incorporation of nanofibre frames into lesioned slice cultures 
The technical challenge of incorporating delicate, aligned nanofibres over 
lesioned slices was overcome by gently placing the nanofibres, located on the 
underside of the acetate frames, downwards over the slice (Figure 3), so that the 
slice was positioned within the inside edge of the frame and the frame orientated 
parallel to the longitudinal axis of the slice. A microscope was necessary to correctly 
position the frame relative to the slice and the confetti membrane. Once in place, the 
acetate frames were gently pushed downwards onto the confetti to ensure contact 
with the slice. To fix the frame in place, 50 µL of a 3 mg/mL neutralized collagen 
hydrogel solution was applied to the confetti, around the outside edge of the acetate 
frame, thus ensuring stability and that the nanofibres remained in contact with the 
slice during culture and post-experimental staining procedures. The area of the 
confetti was increased to provide sufficient space for the application of hydrogel 
around the frame and to prevent any hydrogel from spreading off the confetti onto 
the culture membrane. Additionally, the slices with attached nanofibres were easy to 
handle with forceps due to the elongated sections of confetti, which assisted the 
stability of the acetate frame during transfer to well plates and microscope slides for 
post-experimental processing and image analysis.  
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Figure 3. Method of placing aligned nanofibre frames over lesioned slices. 
Schematic illustrating the placement of aligned nanofibre frames (black) over a 
lesioned slice (pink), within the culture area of an insert. 
 
4.2.2. Evaluating the cellular interaction between host slice tissue and implanted 
constructs 
 To investigate the use of the injury model as a screening tool, nanofibre 
scaffolds ± coating were placed rapidly over slices immediately post-lesioning. 
Slices from both ‘younger’ (P0 mice: lesioned after 1 DIV; fixed 7 days later) and 
‘older’ (P5 mice: lesioned after 8 DIV; fixed 7 days later) models of intrinsic nerve 
fibre outgrowth (section 3.2.2) were used. Slices bearing nanofibres were initially 
live/dead stained to validate nanofibre delivery procedures (section 2.2.5). Slices 
were immunostained (section 3.2.5) with antibodies raised against GFAP, lectin and 
β-III tubulin (TUJ-1), for histological and morphometric analysis of astrocytes, 
microglia and neurons across injury sites, respectively. Slices were co-stained with 
DAPI to assist with the identification of lesion margins. 
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4.2.2.1 Quantification of nerve fibre outgrowth 
A method was conceived to quantify the average outgrowth density and 
variation of outgrowth density of nerve fibres across lesion sites ± nanofibres. 
Fluorescence micrographs of slices immunostained with TUJ-1 antibodies were used 
to generate OD profiles in ImageJ software of the number of TUJ-1+ nerve fibres 
parallel to the lesion margins, across the width of the slice regions demonstrating 
nerve fibre outgrowth. Fluorescence micrographs were generated at X 200 
magnification and merged together into a single panoramic micrograph for each 
slice, using Kolor Autopano Giga software (version 2.6). A rectangular grid was 
subsequently overlaid onto each panoramic image, with marks at 18 µm intervals 
along the length of the lesion site. OD profiles were then generated at the level of 
each interval, across the width of the slice regions with nerve fibre outgrowth. The 
data were copied into Microsoft Office Excel software (2007) in order to distinguish 
within these traces the OD values (in some cases up to 2000 values) that 
corresponded to nerve fibres and background staining. Two conditional formulae 
were used to identify the number of peaks present within the trace for each interval 
along the lesion site: 
Formula 1: [=IF(AND(A1<A2,A3<A2),A2,""] 
Formula 2: [=COUNTIF(B1:B1000,">25"] 
Formula 1 identified peaks within the trace for each cell (e.g. cell A2 in 
column ‘A’) and plotted the value in the adjacent column (e.g. ‘B2’) with the 
premise that each peak within the trace was defined as a cell with a value greater in 
magnitude than both the preceding (e.g. ‘A1’) and following (e.g. ‘A3’) cells. 
Formula 2 was used to count the number of peaks identified (e.g. in column ‘B’) that 
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were above a specified background OD value (e.g. ‘25’). The background value was 
determined for each panoramic image from a combination of: (i) the minimum 
threshold OD value for TUJ-1+ nerve fibres; (ii) the maximum OD values obtained 
across acellular regions of confetti; and (iii) the maximum OD of areas where any 
bleed-though of red nanofibres into the green channel was apparent. To normalize 
the number of nerve fibres detected according to the width of slices, the total number 
detected at each grid interval was expressed as the total number of peaks per mm2, 
by calculating the area of the 18 µm long section of the lesion site that nerve fibres 
extended across. The average total number of peaks per mm2 was then calculated for 
each slice as a measure of the density of nerve fibre outgrowth. Control slices from 
both ‘younger’ and ‘older’ outgrowth models were used to compare outgrowth levels 
without nanofibres. 
 
4.2.2.2. Evaluation of nerve fibre alignment 
A method was conceived to quantify the alignment of TUJ-1+ nerve fibres with 
coated and uncoated nanofibres across the lesion sites of both younger and older 
slice models used for outgrowth quantification. It was similar in design to the 
outgrowth density analysis, except the OD profiles were generated perpendicular to 
the lesion margins, parallel to the direction of nanofibre alignment.  
It was hypothesised that the profiles would give a measure of misalignment, 
because the detection of a nerve fibre would indicate lateral growth perpendicular to 
the direction of the aligned nanofibres. Thus, a greater number of nerve fibres 
detected across the width of the nanofibre constructs would suggest less 
unidirectional outgrowth of nerve fibres. However, this method did not work 
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because: (i) even when the direction of nerve fibre outgrowth was distinctively 
unidirectional, there were still a considerable number of incidences along the length 
of the construct where they would deviate laterally; (ii) the high number of cells and 
processes growing out from lesion margins introduced variability between slices in 
the interaction of nerve fibres with coated nanofibres and therefore the overall 
alignment observed; and (iii) the line density of nanofibres used, which may have 
reduced the topographical influence acting on the nerve fibres in comparison with 
e.g. the more extreme alignment observed with astrocytes on hydrogel constructs 
with a single layer of nanofibres at a lower line density (section 2.3.3). Therefore a 
semi-quantitative method was used to assess the alignment of nerve fibres. Two 
subjects that were blinded to the slice model and nanofibre treatment groups 
estimated the percentage of TUJ-1+ nerve fibres within the micrographs that were 
orientated vertically (n ≥ 3 per group). Five bins, each with a range of 20%, were 
used to classify any potential alignment observed. 
 
4.2.3. Statistical analysis 
Data were analysed using GraphPad Prism statistical analysis software 
(version 5.0). All data are expressed as mean ± S.E.M. The number of experiments 
(n) refers to the number of slices obtained across different animals and litters. 
Nanofibre line density analysis: Data were square-root transformed and a Student’s 
t-test (two-tailed) was used to quantify differences in nanofibre line density between 
nanofibres ± rhodamine B. Nerve fibre outgrowth density analysis: A one-way 
ANOVA with Bonferroni’s post-hoc tests was used to compare differences in 
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outgrowth density between control lesioned slices without nanofibres and those with 
nanofibres incorporated into lesion sites (± coating; n ≥ 3 per group). 
 
 
4.3. Results 
 
4.3.1. Optimisation of nanofibre line density 
A pilot study was performed to establish the optimal nanofibre density for slice 
experiments. Nanofibres were collected either from a single unit operation between 
5-10 mins in duration and directly transferred to acetate frames, or from one or more 
unit operations over a total duration between 10-15 mins and processed onto a 
densification tool. Using a fluorescence microscope for visualisation, the optimal 
density of nanofibres was from a single ten minute unit operation processed onto the 
densification tool (Figure 4A). Using these parameters, densities were great enough 
to provide sufficient nanofibre surfaces for cells to interact with along the width of 
the slice, but not so dense as to obscure the visualisation of cellular events in lesions 
and reduce the effect of the aligned scaffold topography on the direction of 
outgrowth. As the total area of nanofibres on the densification tool was far greater 
than the area of an individual frame it was considered that a grid consisting of two 
rows of five frames would cover the majority of the area (Figure 4B). This improved 
the ease with which the frames could be detached from the tool and increased the 
throughput of nanofibre frames fabricated per unit operation. No problems were 
experienced cutting each frame from the grid following the application of adhesive 
and the alignment of the nanofibres was maintained after this process (Figure 4C). 
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The average mass of individual acetate frames with attached nanofibres was 11.2 ± 
0.8 mg. No significant difference was found between the line density of fluorescent 
and non-fluorescent nanofibres (498 ± 85 nanofibres/mm versus 493 ± 102 
nanofibres/mm), respectively, with representative SEM micrographs shown in 
Figure 5. 
 
 
Figure 4. Nanofibre processing for the production of acetate frames containing 
nanofibres with an optimal line density. (A) Schematic showing the dimensions of 
the densification tool (blue) with nanofibres (grey) attached from a single 10 min 
unit operation. (B) The placement of a grid of 10 acetate frames (black) across the 
area of nanofibres on the tool (white dashed lines demarcate a single frame). (C) 
Representative fluorescence micrograph showing the alignment of fluorescent 
nanofibres is maintained following attachment to portable acetate frames. 
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Figure 5. Representative SEM micrographs showing the line density of 
nanofibres used in lesioned slice experiments. (A) Non-fluorescent nanofibres. (B) 
Fluorescent nanofibres. 
 
4.3.2. Evaluation of nanofibre coating procedures 
There was no difference observed in the overall appearance and stability of the 
coated nanofibre frames compared to the uncoated nanofibre frames. FTIR 
spectroscopic analysis (conducted by Dr. Paul Roach, Keele University) confirmed 
the presence of protein on the surface of treated nanofibres, verifying surface coating 
procedures. Peaks corresponding to laminin are apparent in the amide region, with 
amide I (~1640 cm-1 centre) and II (1535 cm-1) clearly present on fibres treated with 
laminin (Figure 6A) and not on untreated fibres (Figure 6B). The free carboxyl of 
the poly-L,D-lactic acid backbone can be observed at 1754 cm-1 in both samples. 
Aliphatic C-H stretch (2990-2840 cm-1) is also much more apparent in laminin 
treated samples. The band in the O-H stretching region (3640-3030 cm-1) is also 
more distinct in the laminin treated samples, indicating the presence of water within 
the adsorbed protein structure. 
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Figure 6. Verifying nanofibre coating procedures. (A) FTIR ATR spectrum of 
PDL-laminin treated nanofibres. (B) FTIR ATR spectrum of untreated poly-L,D-
lactic acid nanofibres. (Both spectra generated by Dr. Paul Roach, Keele University). 
 
4.3.3. Incorporation of nanofibres into lesioned slices  
The overall viability after incorporation of uncoated nanofibre scaffolds over 
lesioned slices (Figure 7A) remained high, with comparatively few dead cells 
present around the lesion site and within the body of the slice. Some evidence of 
cellular attachment to nanofibres across the lesion was also demonstrated (Figure 
7B; white arrow heads), indicating nanofibre-slice contact over the culture period. 
No leaching of rhodamine B was detected at the concentration used. 
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Figure 7. Incorporation of nanofibres into lesioned slice cultures. (A) 
Fluorescence micrograph showing placement of portable, aligned, uncoated 
nanofibres over a lesioned slice. (B) Live/dead staining of a lesioned slice 3 days 
after placement of aligned uncoated nanofibres, verifying safe nanofibre-placement 
procedures (white arrowheads mark cells likely to be in contact with nanofibres 
across the lesion). 
 
4.3.4. Interactions of astrocytes with nanofibres (± coating) 
Evaluation of the topographical influence of the nanofabricated scaffolds ± 
coating (n ≥ 3 slices in each treatment group) on cells in lesion sites showed that 
gliotic scar formation occurred similar to control slices (without nanofibres), with an 
intense region of GFAP expression at the first 100 µm of lesion margins. Following 
incorporation of uncoated nanofibres, no evidence of astrocyte attachment/alignment 
was observed (Figure 8A). In striking contrast, PL-LAM coating of nanofibres 
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induced extensive alignment of astrocytes, notably extending long thin processes 
(c.a. 100-200 µm) across the lesion site (Figure 8B).   
 
 
Figure 8. The coating of nanofibres with poly-lysine and laminin is necessary 
for the attachment and elongation of astrocytes. (A) Representative fluorescence 
micrograph of GFAP+ scar-forming astrocytes shows no interaction with aligned 
uncoated nanofibres. (B) Representative fluorescence micrograph showing the 
attachment, outgrowth and alignment of scar-forming GFAP+ astrocytes on poly-
lysine/laminin coated nanofibres across slice lesions. 
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4.3.5. Interactions of microglia with nanofibres (± coating) 
Extensive attachment of microglia to both uncoated (Figure 9) and coated 
nanofibres was observed over lesion sites. Notably, elongated microglia were visible 
over the entire area of the slice in contact with nanofibres. 
 
Figure 9. The interaction of microglia with nanofibres occurred regardless of 
nanofibre coating or proximity to the lesion site. Representative fluorescence 
micrograph showing attachment and alignment of lectin+ microglia to uncoated 
nanofibres across the body of a slice. Similar cellular profiles were observed with 
coated nanofibres. 
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4.3.6. Nerve fibre outgrowth across lesion sites 
Limited attachment of TUJ-1+ nerve fibres was observed from the margins of 
lesions with uncoated aligned nanofibres (Figure 10A). By contrast, the 
incorporation of coated nanofibres appeared to result in the extensive outgrowth of 
TUJ-1+ nerve fibres from lesion margins (Figure 10B). The effects were most 
evident within the ‘older’ lesion model, with more limited intrinsic regeneration 
compared to the ‘young’ model.  
The quantification of nerve fibre outgrowth performed in both models of 
intrinsic regeneration showed no significant effect following incorporation of 
uncoated nanofibres, whereas coated nanofibres enhanced nerve fibre outgrowth 
(Figure 11A). The coefficients of variation (Figure 11B) suggest fairly consistent 
outgrowth ± nanofibres across the young lesion model, whereas the outgrowth is 
significantly more variable in the older lesion model ± uncoated nanofibres, 
compared to slices with coated nanofibres. 
Some slices were double-immunostained, with non-fluorescent nanofibres 
incorporated into lesion sites. Occasionally evidence was seen of nerve fibre 
extension that was coincident with elongated astrocytes (Figure 12). This suggests 
that a component of nerve fibre elongation may occur secondary to topographical 
cues from aligned astrocytes.  
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Figure 10. Nanofibres coated with poly-lysine and laminin are necessary for the 
outgrowth and alignment of TUJ-1+ nerve fibres from the lesion margins of 
slices. (A) Representative fluorescence micrographs of the same field showing 
limited attachment and alignment of TUJ-1+ nerve fibres (left-hand panel) to 
uncoated aligned nanofibres (right-hand panel) in an ‘older’ lesion model 
displaying limited intrinsic regeneration (P5 slices; lesioning and nanofibre 
placement after 8 DIV; fixed 7 days later). (B) Representative fluorescence 
micrographs of the same field showing extensive outgrowth and alignment of TUJ-1+ 
nerve fibres (left-hand panel) on aligned coated nanofibres (right-hand panel) in the 
same lesion model as in (A). 
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Figure 11. Quantification of nerve fibre outgrowth across lesioned slices. (A) Bar 
chart quantifying TUJ-1+ nerve fibre outgrowth density across lesions with uncoated 
and coated nanofibre (NF) treatment groups, compared to controls without 
nanofibres, in both ‘younger’ (P0 slices; lesioned after 1 DIV) and ‘older’ (P5 
slices; lesioned after 8 DIV) slice models (one-way ANOVA with Bonferroni’s post-
tests; ***p < 0.001). (B) Line graph quantifying the variation in the outgrowth 
density across the lesions for the same treatment groups as (A). 
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Figure 12. Multiple mechanisms of nerve fibre outgrowth on coated nanofibres. 
Fluorescence micrograph showing incidences of TUJ-1+ nerve fibre contact-
guidance with aligned GFAP+ astrocytes (white arrowheads) in lesions with coated 
nanofibers (P5; lesioned at 8 DIV; stained 3 days later). 
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4.3.7. Nerve fibre alignment across lesion sites 
A semi-quantitative analysis of nerve fibre alignment across lesioned slices 
with nanofibres (Figure 13) revealed a greater proportion of aligned nerve fibres in 
the presence of coated nanofibres than uncoated nanofibres. The distribution of 
scores also shows a greater percentage of alignment in the younger (P0) model of 
nerve fibre outgrowth than the older (P5) model.  
 
Figure 13. The alignment of nerve fibres outgrowth across the lesions is greater 
with coated nanofibres (semi-quantitative assessment). Bar graph showing the 
distributions in scores of TUJ-1+ nerve fibre alignment for both uncoated and coated 
nanofibre treatment groups in both younger and older models. 
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4.4. Discussion 
This is the first report of a 3-D in vitro model of SCI used to screen the pro-
regenerative properties of nanomaterials. Technical methods were successfully 
developed to deliver sheets of aligned nanofibres (± coating with biologically 
relevant molecules) into slice lesions. Interactions of neural cells with the delivered 
nanofibres could be evaluated using standard microscopy, with methods established 
to quantify parameters such as axonal outgrowth. The striking similarity of 
histopathological responses observed compared with live animal models of SCI 
confirm the value of the in vitro model as a biologically relevant predictive tool.  
 
4.4.1. Development of a strategy to incorporate aligned nanofibres into lesioned 
slices 
The utility of portable acetate frames for the delivery of aligned nanofibre 
sheets in multiple applications was demonstrated by the incorporation of nanofibre 
frames into lesioned slice cultures. In this regard, the portable acetate frames were an 
ideal delivery device because they: provided mechanical stability to the nanofibres; 
permitted a choice of nanofibre density; were relatively straightforward to place over 
lesioned slices; and maintained nanofibre alignment throughout culture. 
Additionally, with respect to the use of the model for screening, the acetate frames 
obviated the requirement for including a supporting substrate (e.g. a hydrogel) into 
the scaffold design. This would have added complexity to the construct and 
increased the difficulty of interpreting the basic pro-regenerative readout of different 
nanofibre materials and surface treatments on multiple neural populations across 
injury sites. 
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Importantly, the viability and sterility of lesioned slice cultures was unaffected 
following the incorporation of nanofibre frames into slices, despite the additional 
time and manipulation required following the lesioning procedure. This also suggests 
that the nanofibre frame were lightweight and no additional compressive effect was 
exerted on the slices. No leaching of rhodamine B was detected from nanofibres over 
the culture period and following storage for two years post-culture, in concurrence 
with the previous (3-D) collagen hydrogel experiments using the same concentration 
of dye. The development of a coating chamber for these studies permits the 
sequential coating and washing of multiple nanofibre frames in suspension with 
different biomolecules.  
The nerve fibre outgrowth analysis developed to characterise the density and 
extent of growth across the lesion was a fast and accurate method. In this context, the 
use of the formulae to identify TUJ-1+ nerve fibres above background levels of 
fluorescent staining was crucial. Despite the problems encountered trying to quantify 
nerve fibre alignment across lesions, there is an opportunity to develop a quantitative 
analysis based on existing image processing techniques that have been used to 
characterise the randomness, alignment and periodicity of nerve fibre outgrowth, by 
analysing Fourier transforms of the fluorescent micrographs generated.207 
 
4.4.2. Potential of nanofibre-based bridges to promote repair 
The cellular responses observed in slice lesions following incorporation of 
PLA scaffolds or laminin-coated scaffolds are comparable to published reports in 
vivo, using a complete transecting injury model. In this regard, PLA is approved for 
clinical use by the FDA as it creates non-toxic waste products and has been widely 
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used as a scaffolding material in the tissue engineering research community. 
Uncoated, hydrophobic PLA scaffolds generally exhibit low levels of host neuronal 
regeneration and typically result in the formation of a gliotic scar at the interface 
between host tissue and the implant.208–211 By contrast, the incorporation of laminin 
(or a suitable hydrogel e.g. fibrin)125 into bridges increases axon regeneration and 
disrupts gliotic scar formation in vivo.212–215 PL has additional effects in promoting 
neuronal cell adhesion.100 The decision to use both coatings in this study was based 
on reports in the literature that suggest the attachment and extension of neuronal 
processes is enhanced on PL-LAM coated surfaces, compared to PL alone.216  
The nanofibre-induced alignment of scar-forming astrocytes and the 
concurrent outgrowth of nerve fibres from lesion margins highlight the potential of 
aligned nanofibres to direct the growth of multiple neural cell types across lesion 
sites. Such potential to promote and support tissue growth has only been 
demonstrated before in scaffolds containing aligned nanofibres arranged in tubular 
structures, surrounding a central core of SANPs.129 For the studies utilising purely 
nanofibre-based scaffolds, a relatively high density of nanofibres was used, which 
was necessary in order to process the nanofibres collected into an implantable form. 
This is likely to have reduced the extent of cellular infiltration and growth within the 
3-D scaffolds compared to the density of nanofibres used in this study.217,218  
Additionally, biological coronas have been shown to form around materials 
that come into contact with components from culture media.219 It is possible that the 
surface of the PL-LAM nanofibres were coated by biomolecules from the serum 
used in the slice culture medium, which could have contributed to the extent of 
cellular attachment observed. In this regard, a mass spectrometry analysis of the 
nanofibres used in lesioned culture experiments with and without the PL-LAM 
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coating would identify the presence of any additional components associated with 
the nanofibres.  
 
4.4.3. Applicability of the lesioned slice model for screening studies 
The observation that cells in the 3-D slices can distinguish between different 
surface coatings suggests that they are able to make sophisticated choices regarding 
material interactions, within a complex environment in vitro. This highlights the 
utility of the lesioned spinal cord slice cultures in acting as a reliable predictor of in 
vivo neural cell behaviours in response to various materials and surface chemistries, 
and hence its value as a bio-screening method. In this context the morphological 
reorganization of scar forming astrocytes, which normally form a critical barrier to 
nerve fibre regeneration, highlights the potential screening application of the injury 
model. Thus, efficacious molecules and strategies that aim to disrupt the neuroglial 
scar via the re-organization of reactive astrocyte morphology can be screened. The 
extensive attachment of microglia to nanofibres resembles the activity of microglia 
in vivo following transplantation of nanofibre scaffolds into SCI sites.129 Such 
attachment provides an in vitro readout for the optimization and testing of 
biocompatible materials and coatings that evoke minimal inflammatory responses. It 
also demonstrates the potential for long-term studies, where preliminary examination 
of the material degradation properties and breakdown mechanisms may be assessed. 
The increased outgrowth and alignment of nerve fibres in response to coated 
nanofibres (and the distinct absence of such responses of neural cells to the uncoated 
fibres) suggests that the model can enable comparative investigations of various 
combinatorial strategies to enhance nerve fibre outgrowth and alignment. These 
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include: different polymer formulations and other potentially efficacious substrates 
with an aligned topography; fibre densities and diameters; scaffold functionalization 
with therapeutic biomolecules (promoting growth or targeting major CNS inhibitors) 
and therapeutic stem/progenitor cell populations. In addition, the ability to 
simultaneously examine the response of multiple cell types (e.g. scar-forming 
astrocytes and outgrowing nerve fibres) within the same complex injury environment 
will allow for the design and development of more efficacious growth-promoting 
strategies for repair of SCI in vivo. In this regard, the incidences of nerve fibre 
contact-guidance with aligned astrocytes lend support to the use of scaffolds 
containing aligned astrocytes as a favourable biological substrate for nerve fibre 
outgrowth.60,138–140  
The readouts of outgrowth and alignment from the younger and older models 
of regeneration highlight their use in examination of different aspects of scaffold 
design. The extensive, random nerve fibre outgrowth in younger slices is suited to 
the examination of axonal outgrowth on bioengineered substrates with an aligned 
topography. By contrast, the older slices that recapitulate cardinal neural features of 
traumatic injury in the adult CNS such as limited nerve fibre outgrowth are suited to 
the examination of the regeneration-enhancing properties of novel biomaterials. Both 
models are suitable for studying the responses of the non-neuronal, (supporting) glial 
cells in lesions. Further functional assessments of regeneration i.e. 
electrophysiological recordings may provide a more detailed readout of scaffold 
regeneration-enhancing properties within this model.178 
The full potential of combinatorial strategies utilising aligned nanofibres with 
combinations of cells, and biomolecules has yet to be elucidated, due in part to a 
heavy reliance on in vivo SCI models, in the absence of high-throughput, 
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biologically-relevant in vitro screening models of SCI.59,169 It can be predicted that 
the screening model presented here will allow for the identification of novel pro-
regenerative materials, whilst significantly reducing reliance on live animal 
experimentation in keeping with the 3 R’s principles of Reduction, Refinement and 
Replacement, thereby accelerating the rate of discovery of nanotherapeutic agents 
for neural tissue engineering, as summarised in Figure 14. 
 
 
Figure 14. Schematic diagram illustrating the potential screening utility of a 
‘neural injury-nanomaterial’ interface paradigm. 
 
4.4.4. Conclusions 
A method to coat and place portable sheets of aligned nanofibres into lesioned 
slices was developed. Functionalised nanofibres were able to induce dramatic 
responses in multiple cell types in the injury sites; these are comparable to those 
induced in live animal models. This study demonstrates the high potential of the 
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slice lesion model to function as a prototype screening system for promising 
nanotherapeutic interventions, either in isolation, or as part of a combinatorial 
treatment strategy. The use of higher-throughput in vitro models of SCI such as the 
one described here can aid in overcoming a growing bottleneck in the therapeutic 
testing of promising new materials and combinatorial therapies, whilst reducing the 
high current reliance on live animal testing.c 
 
 
 
 
 
 
 
 
 
 
 
 
c Most of the data in this chapter has been published. The main article is included 
here as Appendix 3 and features in an article included as Appendix 4.  
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Chapter 5: Conclusions and general 
discussion  
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5.1. Summary of thesis findings 
It has been shown in this thesis that the complexity of neural tissue engineering 
platforms may be increased, towards the production of both more advanced 
nanofibre-based strategies for spinal cord repair, and higher-throughput in vitro 
screening models to test the regeneration-promoting capacity of such strategies ex 
vivo. The findings obtained in this thesis can be summarised as follows: 
 The assembly process of single layer nanofibre-hydrogel constructs was 
successfully optimised for the culture, attachment and elongation of astrocytes 
or OPCs. 
 Astrocytes, OPCs and microglia derived from the same primary source were co-
cultured together on hydrogel constructs containing a single layer of nanofibres.  
 A bed layer of pre-aligned astrocytes was necessary for the survival and 
elongation of OPCs on nanofibre-hydrogel constructs. The aspect ratios of 
astrocytes and OPCs aligned to the nanofibres were considerably greater in 
magnitude than previous reports. 
 The nanofibre-hydrogel constructs facilitated the proliferation and maturation of 
OPCs in co-culture with astrocytes. 
 Increasing the spatial complexity of constructs was addressed by aligning 
astrocytes over three nanofibre mesh layers, towards the production of an 
implantable device containing a complete supporting system of neuroglia that 
can be used to reconstruct the complex glial circuitry in injury sites. 
 The production and handling of organotypic spinal cord slice cultures were 
successfully optimised for the induction of reproducible, complete transecting 
lesions with a tool designed in-house. 
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 Slice lesions displayed three cardinal pathological features of SCI in vivo: post-
traumatic astrogliosis, infiltration of lesions by activated microglia and limited 
random outgrowth of nerve fibres from the lesion margins of slices derived from 
older animals, demonstrating the tissue-mimetic capacity of the model in 
replicating neural injury. 
 A method has been developed to coat portable sheets of aligned nanofibres with 
poly-D-lysine and laminin and place them into lesioned slices.  
 Functionalisation of nanofibres was necessary in order for the attachment of 
astrocytes and neurons, although microglia attached to both treated and 
untreated nanofibres. 
 A method to quantitatively assess the outgrowth of nerve fibres from lesion 
margins was developed and revealed significant differences between the coated 
and uncoated treatment groups.  
A detailed discussion of the implications directly surrounding these findings 
may be found in each respective chapter. Discussed below are future directions for 
further development of the platforms, in the context of complexity, testing and 
promoting repair in neurological injury.  
 
5.2. Future directions 
Prior to further nanofibre-hydrogel construct development, an opportunity 
exists to assess the potential of the aligned glial cell co-cultures to enhance nerve 
fibre outgrowth by culturing isolated DRG explants on top. The distances of nerve 
fibre growth could be quantified compared to control constructs without glial cells. 
Furthermore, electrophysiological and electron microscopic studies could also 
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provide important information with regards to the integration of the neurons with the 
supporting glial cell circuitry e.g. intercellular signaling and the myelination of nerve 
fibres. However, to generate more clinically relevant readouts of repair, the 
constructs require processing into an implantable form for delivery into an injury 
environment. Strategically, the line density of the nanofibre meshes needs to be 
reduced to target the infiltration of spared host tissue and the seeding protocol of the 
glial cell co-cultures requires optimisation to scale-up over multiple nanofibre mesh 
layers. The assembled constructs then need to undergo a plastic compression step to 
reduce the construct volume and the viability of cells within the construct will 
require verification. Finally, a safe delivery method is required to surgically implant 
constructs with the correct dimensions in sites of injury.  
The potential of strategies utilising aligned nanofibres to promote regeneration 
has been demonstrated both in the literature and here in the lesioned spinal cord slice 
culture model. However, the nanofibre frames delivered in lesioned slice 
experiments lack the spatial and cellular complexity of the nanofibre-hydrogel 
constructs developed. Therefore, the next proposed stage in construct testing is the 
delivery of more complex nanofibre-hydrogel constructs into the lesion sites of 
slices, to test the potential of the proposed strategy to enhance repair in a 3-D injury 
environment, using anatomical readouts from multiple cell types. Furthermore, the 
complex readout in vitro facilitates the identification of any potential problems and 
any necessary optimisation work required before the use of live animal neurological 
injury models. 
The final stages of testing would involve a rat model of complete or partial 
transecting injury to evaluate constructs over a period of 4-6 months. This could be 
followed up with a comparative study in primates, as a more clinically relevant 
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model. In the first instance, fundamental questions need to be addressed with regards 
to the stability of the constructs in the lesions sites over this time period, such as the 
correct surgical placement of the scaffolds upon implantation and whether they 
remain in position or dislodge over time. Further physical properties to investigate 
include: characterising scaffold degradation and any undesirable accumulation of 
breakdown products at the injury site; whether the topography of the aligned 
nanofibres is maintained over time to facilitate neural regeneration of host tissue; and 
if there appears to be a mismatch in mechanical properties between the construct and 
the host tissue, which usually results in the formation of scar tissue at the interface.  
With respect to anatomical repair, a detailed investigation is required into the 
effects on neuronal growth enhancement, myelin sheath formation, the interactions 
of host and implanted immune-competent cells with the scaffolds, the reactivity of 
surrounding scar-forming astrocytes and the formation of new microvascular 
networks to connect cell populations within the constructs with the host circulatory 
system. Readouts of functional regeneration may be obtained by assessing hindlimb 
motor function by means of BBB score analysis from e.g. a footprint assay or 
gridwalk test. This may be used in combination with electrophysiological 
investigation to evaluate transmission of electrical impulses across lesion sites, 
through both ascending and descending pathways.  
The complexity of the constructs and therefore their regenerative properties 
could be enhanced further through functionalisation of the nanofibres and/or 
hydrogel. This could be accomplished using spatiotemporal gradients of 
biomolecules such as growth factors, ECM molecules and/or suppressors of 
inhibitory molecules, and genetic modification of the seeded cell populations. The 
use of human-derived glial cells could be used to characterise any differences in the 
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response to the constructs following in vitro culture and will be required before the 
constructs can be implanted into sites of human SCI in the clinic. Additionally, the 
approach described here has a range of further applications in both basic research 
and in clinical product translation. For example, this approach provides an in vitro 
paradigm of increased complexity to study glial interactions in normal culture and 
injury-simulated conditions, and may be used as a model for drug screening and 
evaluation of neurotoxicity in safety assessments of novel pharmaceutical agents. 
In order to determine the extent that the lesioned spinal cord slices mimic SCI 
in vivo, a systematic study is required to compare and contrast all of the known 
pathophysiological responses following injury. This includes the use of sophisticated 
mass spectrometry analyses to generate genomic and proteomic profiles from the 
cells surrounding the injury sites of slices and examine cellular changes at the 
genetic and molecular level e.g. regeneration-associated genes and expression of 
CSPGs, respectively. Preliminary findings from the experiments performed suggest 
that a multi-electrode array would be a more practical and informative method of 
generating an electrophysiological readout of functional repair from the slices, than 
the use of individual stimulating and recording electrodes.  
To seek ways of further increasing the clinical relevance of the model the 
generation of lesioned organotypic spinal cord slice cultures from human cadavers or 
non-human primates could be undertaken as a comparative study.175 Furthermore, 
the induction of compressive trauma via weight-drop could produce a paradigm for 
screening strategies that mimics the most common type of injury found in the clinic. 
Finally, work has been published with the aim of producing customised surfaces that 
permit the long-term culture of organotypic slices of adult neural tissue.220 This 
could be adapted and optimised to produce lesioned slice cultures of adult spinal 
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cord tissue and compared with the ‘older’ lesion model described here, which was 
found to mimic features of axonal regeneration following injury in adults.  
The successful production of a lesioned organotypic spinal cord slice culture 
model with biologically-relevant readouts following delivery of structural bridges 
demonstrates the significant potential of organotypic slice cultures to serve as highly 
versatile bio-screening systems for the identification of pro-regenerative materials 
for a wide range of tissue applications. In the context of SCI, given the biologically-
relevant predictions of the model in response to the introduction of nanofibres coated 
with widely-used cell adhesion and guidance molecules, a systematic study should 
be undertaken of all the materials and coatings that have been shown to promote 
repair following injury. This includes the screening of more complex combinatorial 
strategies utilising cells, materials and multiple biomolecules synergistically. The 
data obtained could be compared with results from comparative studies in vivo to 
further validate the predictive utility of the model. Additionally, it could provide 
feedback for the improved design of neural tissue engineering strategies for repair 
e.g. monitor the release profile of biomolecules from the scaffold (e.g. burst-release) 
during culture to determine the effectiveness of the delivery strategy and the efficacy 
of the concentrations used (although the injury paradigm here may be too simplistic 
as the material would lie at the interface between air and medium, limiting the 
mimicry of the in vivo environment). Finally, high resolution pictures of the slices 
(e.g. SEM) could provide a more comprehensive method of visualising anatomical 
interactions and regenerative events between cells and bridges introduced into the 
lesion sites of slices. It is hoped that this work will demonstrate the feasibility of 
increasing the complexity of neural tissue engineering platforms for the repair of 
neurological injury.  
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Appendix 1: Article published by Nanomedicine (NBM). 
The article in this appendix contains data from Chapter 2.  
 
 
Weightman AP, Jenkins SI, Pickard MR, Chari DM, Yang Y 
Alignment of multiple glial cell populations in 3D nanofiber scaffolds: Toward the 
development of multicellular implantable scaffolds for repair of neural injury 
Nanomedicine vol. 10, no. 2, 291-295, 2014  
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Appendix 2: Biomedical picture of the day 
An image from the study in Chapter 2 (not included in this thesis) published online 
as ‘biomedical picture of the day’ on the 4th April 2014 by the MRC 
(http://bpod.mrc.ac.uk/archive/2014/4/4). 
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Appendix 3: Article published by Biomaterials. 
The article in this appendix contains data from Chapter 3 and 4.  
  
 
Weightman AP, Pickard MR, Yang Y, Chari DM 
An in vitro spinal cord injury model to screen neuroregenerative materials 
Biomaterials vol. 35, no. 12, 3756-3765, 2014 
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Appendix 4: Article feature published by Alternatives to Laboratory Animals. 
The article in this appendix was published on the work from Chapter 3 and 4 and the 
article in Appendix 3.  
  
 
Spinal cord injury model 
Alternatives to Laboratory Animals vol. 42, 3-5, 2014 
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